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Kevan	  Lyons	  –	  I	  am	  blind	  to	  beauty	  
“I	  am	  blind	  to	  beauty	  for	  I	  have	  seen	  the	  ugliness	  of	  war,	  	  
my	  heart	  discard	  my	  soul’s	  an	  open	  sore,	  	  
my	  spirits	  broken	  and	  my	  body	  is	  not	  well,	  	  
for	  I	  have	  seen	  the	  smoke	  and	  fire	  and	  passed	  through	  the	  gates	  
of	  hell,	  	  
I’ve	  held	  a	  dying	  man	  grasping	  for	  last	  breath	  	  
and	  been	  surrounded	  by	  the	  taste	  of	  death	  and	  the	  smell	  of	  
fear,	  	  
I’ve	  buried	  both	  friend	  and	  foe	  	  
in	  fields	  where	  no	  crops	  will	  ever	  grow,	  	  
there	  is	  no	  honor	  in	  taking	  of	  a	  life,	  	  
and	  I	  have	  done	  so	  with	  my	  rifle	  and	  my	  knife,	  	  
and	  I	  do	  not	  sleep	  well	  at	  night,	  	  
for	  in	  my	  dreams	  I	  still	  fight,	  	  
and	  the	  enemy	  I	  see	  is	  a	  soldier…	  and	  its	  me.” 
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Homer,	  ancient	  Greek	  author	  of	  the	  Iliad	  and	  the	  Odyssey,	  describes	  in	  his	  fourth	  book	  of	  the	  Odyssey	  
how	  the	  young	  Telemachus	  is	  searching	  for	  his	  father	  Odysseus.	  In	  the	  course	  of	  this	  quest	  Telemachus	  
is	   invited	   by	   Menelaus,	   king	   of	   Sparta,	   and	   his	   wife	   Helena.	   During	   this	   encounter	   the	   invitees	  
experience	   intense	   negative	   emotions,	   triggered	   by	   the	   remembrance	   of	   the	   atrocities	   of	   the	   Trojan	  
War.	  Helena	  decides	  to	  add	  a	  ‘ne-­‐penthes’	  (literally	  a	  ‘banisher	  of	  sorrow’)	  to	  the	  wine.	  Homer	  describes	  
this	  remedy	  as	  a	  substance	  that	  is	  able	  to	  quell	  all	  sorrows	  with	  forgetfulness,	  even	  if	  one	  had	  witnessed	  
the	   killing	   of	   his	   own	   dear	   brother	   or	   son.	   Later	   commentators	   speculated	   upon	   the	   nature	   of	   this	  
substance	  and	  agreed	  that	  it	  is	  conceivable	  that	  Helena	  mixed	  opium	  in	  the	  wine	  of	  her	  guests	  (Odyssey,	  
book	  4,	  v.	  219-­‐221).	  This	  old	  work	  of	  poetry	  indicates	  that	  the	  use	  of	  substances	  to	  deal	  with	  emotional	  
pain	  caused	  by	  trauma	  is	  neither	  new	  nor	  irrational.	  Despite	  this,	  it	  was	  not	  until	  1980	  that	  Lacoursiere,	  
Godfrey,	   and	   Ruby	   published	   a	   first	   article	   concerning	   the	   apparent	   comorbidity	   between	   post-­‐
traumatic	  stress	  disorder	  (what	  was	  then	  called	  traumatic	  neurosis)	  and	  alcoholism.	  
	   The	  central	  theme	  of	  the	  present	  dissertation	  concerns	  studies	  examining	  the	  role	  of	  trauma	  and	  
posttraumatic	   stress	   disorder	   (PTSD)	   in	   its	   co-­‐existence	   with	   and	   the	   treatment	   of	   substance	   use	  
disorder	   (SUD).	   This	   chapter	   provides	   an	   overview	   of	   the	   characteristics	   of	   patients	   with	   SUD/PTSD	  
comorbidity,	  the	  existing	  theories	  about	  the	  comorbidity,	  the	  treatment,	  the	  guidelines	  and	  daily	  clinical	  
practice.	  Further,	  the	  research	  questions	  of	  the	  present	  dissertation	  are	  introduced	  and	  an	  outline	  of	  the	  
dissertation	  is	  provided.	  	  
	  
Characteristics	  of	  the	  SUD/PTSD	  comorbidity	  	  
According	  to	  DSM	  -­‐5	  “a	  SUD	  describes	  a	  problematic	  pattern	  of	  using	  alcohol	  or	  another	  substance	  that	  
results	   in	   impairment	   in	  daily	   life	  or	  noticeable	  distress”.	  PTSD,	  on	  the	  other	  hand,	   is	  characterized	  by	  
the	  persistent	  re-­‐experiencing,	  the	  avoidance	  of	  trauma	  triggers,	  negative	  alterations	  in	  cognitions	  and	  
mood,	  and	  hyperarousal	  in	  response	  to	  a	  direct	  or	  indirect	  traumatic	  event	  (5th	  ed.;	  DSM-­‐5	  APA,	  2013).	  
SUD	   and	   PTSD	   are	   two	   severe	   and	   often	   long-­‐lasting	   psychiatric	   disorders	   that	   frequently	   co-­‐
occur.	   Since	   Lacoursiere	   et	   al.	   (1980),	   various	   studies	   were	   published	   describing	   the	   heightened	  
prevalence	  rate	  of	  PTSD	  and	  trauma	  exposure	  among	  SUD	  patients.	  The	  prevalence	  of	  current	  PTSD	  in	  
SUD	  patients	  is	  around	  three	  times	  higher	  than	  in	  the	  general	  population,	  and	  nearly	  all	  SUD	  patients	  (9	  
out	   of	   10)	   have	   been	   exposed	   to	   some	   form	   of	   trauma	   (Bonin,	   Norton,	   Asmundson,	   Dicurzio,	   &	  
Pidlubney,	  2000;	  Dansky,	  Saladin,	  Coffey,	  &	  Brady,	  1997;	  Driessen	  et	  al.,	  2008;	  Farley,	  Golding,	  Young,	  
Mulligan,	  &	  Minkoff,	  2004;	  Kessler	  et	  al.,	  2005;	  Ouimette,	  Coolhart,	  Funderburk,	  Wade,	  &	  Brown,	  2007;	  
Read,	  Brown,	  &	  Kahler,	  2004;	  Reynolds	  et	  al.,	  2005).	  SUD	  is	  not	  the	  only	  disorder	  found	  to	  be	  comorbid	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with	  PTSD,	  major	  depressive	  disorder,	  anxiety	  disorders,	  and	  borderline	  personality	  disorder	  also	  share	  a	  
high	   comorbidity	   with	   PTSD	   (Pagura,	   Stein,	   Bolton,	   Cox,	   &	   Sareen,	   2010;	   Spinhoven,	   Penninx,	   van	  
Hemert,	  de	  Rooij,	  &	  Elzinga,	  2014).	  	  
Previous	  studies	  emphasize	  the	  vulnerability	  of	  patients	  with	  the	  SUD/PTSD	  comorbidity	  (Back,	  
Sonne,	  Killeen,	  Dansky,	  &	  Brady,	  2003;	  Dube,	  Anda,	  Feliti,	  Chapman,	  Williamson,	  &	  Giles,	  2001;	  Evren,	  
C.,	   Evren,	   B.,	   Dalbudak,	   Ozcelik,	   &	   Oncy,	   2009;	   Mills,	   Linskey,	   Teesson,	   Ross,	   &	   darke,	   2005;	   Mills,	  
Teesson,	   Ross,	   Darke,	   &	   Shanahan,	   2005;	   Ouimette,	   Brown,	   &	   Najavits,	   1998;	   Pirard,	   Sharon,	   Kang,	  
Angarita,	  &	  Gastfriend,	  2005;	  Read	  et	  al.,	  2004;	  Simpson	  &	  Miller,	  2002).	  Compared	  to	  those	  who	  have	  
SUD	  only,	  patients	  with	  SUD	  and	  comorbid	  PTSD	  have	  a	  history	  of	  more	  alcohol	  and	  drug	  use,	  have	  more	  
prior	  treatment	  attempts,	  have	  a	  greater	  number	  of	  mental	  health	  treatment	  sessions,	  and	  experience	  
higher	   levels	   of	   craving,	   distress,	   and	   general	   psychiatric	   symptoms.	   When	   comorbid	   PTSD	   is	   left	  
untreated,	   SUD	  patients	  have	  a	  higher	   risk	   for	   relapse	  of	   addictive	  behavior,	   as	   compared	   to	  patients	  
with	  SUD	  only.	  These	  abovementioned	  characteristics	  are	  indicative	  for	  the	  vulnerability	  of	  this	  patient	  
group.	  Again,	  note	  that	   this	   is	  a	  sizeable	  group	  of	  vulnerable	  patients.	  More	  than	  a	  quarter	  of	  all	  SUD	  
patients	   in	  treatment	  are	  thought	  to	  have	  comorbid	  PTSD.	  For	  example,	   in	  The	  Netherlands,	  there	  are	  
approximately	  30,000	  patients	  in	  treatment	  for	  alcohol	  dependence	  (IVZ,	  2014),	  meaning	  that	  7,500	  of	  
these	  alcohol	  dependent	  patients	  have	  comorbid	  PTSD.	  To	  improve	  treatment	  outcome	  of	  patients	  with	  
comorbid	  SUD	  and	  PTSD	  it	  is	  thus	  important	  to	  more	  closely	  examine	  the	  role	  of	  PTSD	  in	  these	  patients.	  
	  
Theories	  explaining	  the	  SUD/PTSD	  comorbidity	  
Different	  models	   for	   explaining	   the	   comorbidity	   between	   SUD	   and	   PTSD	   have	   been	   put	   forward.	   The	  
models	  can	  be	  divided	   into	  three	  clusters:	   (1)	   theories	  assuming	  that	  PTSD	  precedes	  SUD,	   (2)	   theories	  
assuming	   that	   SUD	   precedes	   PTSD,	   and	   (3)	   theories	   assuming	   that	   a	   third	   factor	   explains	   the	  
comorbidity,	  including	  a	  maintenance	  model	  based	  on	  learning	  theory.	  	  
	   PTSD	  precedes	  SUD.	  It	  has	  often	  been	  proposed	  that	  PTSD	  is	  a	  risk	  factor	  for	  developing	  further	  
psychopathology,	   including	   substance	   dependence.	   This	   sequence	   of	   PTSD	   preceding	   SUD	  has	   indeed	  
been	  found	  in	  both	  retrospective	  and	  prospective	  studies	  (Berenz	  &	  Coffey,	  2012).	  A	  well-­‐known	  model	  
in	   this	   line	   of	   thinking	   is	   the	   self-­‐medication	   hypothesis	   (Khantzian,	   1997;	   Leeies,	   Pagura,	   Sareen,	   &	  
Bolton,	   2010;	   Ouimette,	   Read,	   Wade,	   &	   Tirone,	   2010).	   This	   hypothesis	   states	   that	   individuals	   use	  
substances	  to	  dull	  PTSD	  symptoms.	  A	  patient	  suffering	  from	  posttraumatic	  hyperarousal	  might	  then	  use	  
alcohol	  to	  feel	  more	  at	  ease	  in	  social	  situations.	  Substance	  use	  thus	  functions	  as	  a	  maladaptive	  coping	  
strategy.	  In	  2010,	  Ouimette	  and	  colleagues	  prospectively	  examined	  associations	  between	  PTSD	  and	  SUD	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symptoms.	   Their	   findings	   support	   the	   self-­‐medication	   hypothesis	   in	   that	   PTSD	   symptom	   fluctuations	  
predicted	  variations	  in	  SUD	  symptoms.	  	  
A	   related	   model	   explaining	   how	   PTSD	   precedes	   SUD	   is	   the	   chemical	   dissociation	   hypothesis	  
(Langeland,	  2009).	  According	  to	  this	  model,	  PTSD	  patients	  typically	  cope	  with	  their	  childhood	  trauma	  by	  
trying	  to	  dissociate:	  patients	  then	  experience	  a	  sense	  of	  detachment	  from	  themselves,	  their	  feelings,	  or	  
their	   consciousness.	   However,	   some	   patients	   do	   not	   follow	   this	   typical	   path	   of	   psychological	  
dissociation,	  but	   induce	  emotional	  detachment	   through	  the	  use	  of	  chemicals;	   that	   is,	  drugs	  or	  alcohol	  
(Klanecky,	  Harrington,	  &	  McChargue;	  2008;	  Langeland,	  Draijer,	  &	  van	  den	  Brink,	  2002;	  Somer,	  Altus,	  &	  
Ginzburg,	   2010;	   Van	  Den	  Bosch,	   Verheul,	   Langeland,	  &	  Van	  Den	  Brink,	   2003).	  Note	   that	   in	   this	   latter	  
sense,	   the	   chemical	   dissociation	   hypothesis	   is	   indistinguishable	   from	   the	   self-­‐medication	   hypothesis.	  
Both	  models	  assume	  that	  SUD/PTSD	  patients	  use	  substances	  to	  alleviate	  PTSD	  symptoms.	  	  
The	  final	  model	  in	  the	  first	  cluster	  is	  the	  dysfunctional	  stress	  reaction	  hypothesis	  (Hien,	  Cohen,	  &	  
Campbell,	   2005).	   According	   to	   this	  model	   neuroanatomical	   alterations	  may	   occur	   as	   a	   result	   of	   early	  
childhood	  trauma:	  an	  inhibition	  of	  the	  medial	  prefrontal	  cortex,	  an	  increased	  activation	  of	  the	  amygdala,	  
and	   a	   reduction	   of	   the	   volume	   of	   the	   hippocampus.	   On	   a	   physiological	   level,	   a	   hyperreactive	  
hypothalamic–pituitary–adrenal	   axis	   is	   noticed	   in	   patients	   with	   repeated	   childhood	   maltreatment	  
(Lupien,	  McEwen,	  Gunnar,	  &	  Heim,	  2009).	  These	  neuroanatomical	  and	  physiological	  changes	  can	  cause	  
problems	   in	   self-­‐regulation	   and	   impulse-­‐control,	   which	   in	   turn	   can	   lead	   to	   alcohol	   or	   drug	   abuse	  
(Langeland,	  2009).	  
	   SUD	  precedes	  PTSD.	   The	   second	   cluster	  of	  models	   suggests	   a	  pathway	   in	  which	   SUD	  precedes	  
trauma	  exposure	  and	  PTSD.	  The	  high-­‐risk	  hypothesis	  assumes	  that	  substance	  abusing	  individuals	  lead	  a	  
more	  risky	   lifestyle,	  exposing	  themselves	  to	  potentially	  traumatic	  experiences,	   like	  accidents,	  violence,	  
or	   witnessing	   an	   overdose	   (McCauley,	   Killeen,	   Gros,	   Brady,	   &	   Back,	   2012).	   There	   is	   evidence	   that	  
substance	  use,	  particularly	  alcohol	  abuse,	  is	  a	  risk	  factor	  for	  being	  exposed	  to	  trauma,	  possibly	  leading	  to	  
PTSD	  (see	  e.g.,	  Gross,	  Winslett,	  Roberts,	  &	  Gohm,	  2006).	  	  
The	  susceptibility	  hypothesis	  also	  proposes	  that	  PTSD	  follows	  SUD.	  According	  to	  this	  model,	  SUD	  
can	  lead	  to	  PTSD	  because	  chronic	  substance	  users	  experience	  increased	  arousal	  and	  anxiety	  (e.g.	  during	  
withdrawal),	  and	  have	  less	  adaptive	  emotion	  regulating	  skills	  rendering	  them	  vulnerable	  to	  developing	  
PTSD	  after	  a	  traumatic	  exposure	  (Haller	  &	  Chassin,	  2014;	  McCauley	  et	  al.,	  2012).	  
	   Third	   factor.	   According	   to	   the	   liability	   model,	   shared	   vulnerability,	   or	   third	   factor	   hypothesis	  
common	   factors	  play	  a	   role	   in	   the	  SUD/PTSD	  comorbidity.	  Variables	   that	  might	   independently	   lead	   to	  
both	   the	   development	   of	   SUD	   and	   PTSD	   have	   been	   studied:	   pre-­‐trauma	   family	   adversity,	   biological	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vulnerability	  (e.g.	  common	  genetic	  liability,	  hyperactivity	  of	  dopamine	  transmission),	  poor	  coping	  skills,	  
trait-­‐level	  neuroticism,	  and	  anxiety	   sensitivity	   (Berenz	  &	  Coffey,	  2012;	  Coffey,	  Read,	  &	  Norberg,	  2008;	  
Haller	  &	  Chassin,	  2014;	  Langeland,	  2009;	  van	  Dam,	  Vedel,	  Ehring,	  &	  Emmelkamp,	  2012).	  	  
	  
Empirical	  support	  for	  the	  presented	  theories	  
The	   self-­‐medication	   hypothesis	   is	   the	   model	   that	   dominates	   the	   SUD/PTSD	   research	   field,	   probably	  
because	  it	  has	  strong	  face	  validity.	  But	  the	  empirical	  evidence	  for	  this	  hypothesis	  is	  also	  strong	  (Coffey	  et	  
al.,	  2002;	  Coffey	  et	  al.,	  2010;	  Nosen	  et	  al.,	  2012;	  Saladin	  et	  al.,	  2003).	  Haller	  and	  Chassin	  (2014)	  utilized	  
longitudinal	   data	   to	   test	   the	   validity	   of	   four	   hypotheses	   (the	   self-­‐medication	  hypothesis,	   the	  high-­‐risk	  
hypothesis,	  the	  susceptibility	  hypothesis,	  and	  the	  shared	  vulnerability	  hypothesis).	  They	  found	  that	  PTSD	  
symptoms	  predicted	  higher	  levels	  of	  addiction-­‐related	  problems	  and	  that	  PTSD	  symptoms	  mediated	  the	  
effect	  of	  pre-­‐trauma	  family	  risk	  factors	  on	  SUD,	  providing	  the	  strongest	  support	  for	  the	  self-­‐medication	  
hypothesis.	  	  
	  
A	  maintenance	  model:	  the	  learning	  theoretical	  view	  
It	  should	  be	  noted	  that	  the	  models	  described	  above	  are	  not	  mutually	  exclusive.	   It	   is	  quite	  conceivable	  
that	  in	  some	  patients	  SUD	  preceded	  PTSD	  and	  that	  in	  other	  patients	  PTSD	  preceded	  SUD.	  In	  both	  cases,	  
however,	   PTSD	   symptoms	   can	  be	   thought	   to	  play	   a	   significant	   role	   in	  maintaining	   the	   SUD	   (Berenz	  &	  
Coffey,	  2012;	  van	  Dam	  et	  al.,	  2012).	  Frequent	  drug	  or	  alcohol	  use	  then	  allows	  for	  multiple	  learning	  trials	  
in	  which	  stress	  associated	  with	  traumatic	   intrusions	  becomes	  associated	  with	  the	  rewarding	  effects	  of	  
substance	  use.	  According	   to	   this	   learning	   theoretical	  view,	   stress	   functions	  as	  a	  Pavlovian	  conditioned	  
drug	   stimulus	   (or	   CS)	   signaling	   an	   unconditioned	   drug	   reward	   stimulus	   (US).	  Moreover,	   to	   the	   extent	  
that	   drug	   intake	   itself	   alleviates	   PTSD	   symptoms,	   substance	   use	   is	   negatively	   reinforced,	   hence	  
promoting	   drug	   intake	   even	   in	   the	   absence	   of	   stress.	   Cue-­‐reactivity	   studies	   have	   suggested	   a	   link	  
between	   traumatic	   memories	   and	   the	   need	   to	   dampen	   the	   induced	   emotions	   with	   the	   use	   of	  
substances.	  What	  these	  studies	  found	  is	  that	  SUD/PTSD	  patients	  experience	  increased	  craving	  after	  the	  
patients	  were	  exposed	  to	  personalized	  trauma	  cues	  (Coffey,	  Saladin,	  Drobes,	  Brady,	  Dansky,	  &	  Kilpatrick,	  
2002;	   Coffey,	   Schumacher,	   Stasiewicz,	   Henslee,	   Baillie,	   &	   Landy,	   2010;	   Nosen,	   Nillni,	   Berenz,	  
Schumacher,	   Stasiewicz,	   &	   Coffey,	   2012;	   Saladin,	   Drobes,	   Coffey,	   Dansky,	   Brady,	   &	   Kilpatrick,	   2003).	  
Without	   shedding	   light	   on	   the	   chicken-­‐or-­‐the-­‐egg	   problem	   of	   comorbid	   SUD/PTSD,	   these	   findings	  
nonetheless	  strengthen	  the	  view	  that	  PTSD	  symptoms	  play	  a	  crucial	  role	  in	  the	  maintenance	  and	  relapse	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of	  SUD.	  Figure	  1	  displays	  a	  model	  of	  how	  different	  associative	  learning	  processes	  are	  viewed	  to	  interact	  




Figure	  1.	  According	  to	  the	  learning	  theoretical	  model	  of	  comorbid	  SUD/PTSD	  suggested	  in	  this	  dissertation,	  PTSD	  
provides	  for	  frequent	  and	  strong	  experiences	  of	  negative	  emotions	  (e.g.,	  stress,	  emotional	  pain,	  and	  anxiety)	  that	  
function	  as	  salient	  internal	  cues	  or	  stimuli	  (S)	  that	  promote	  coping	  behavior.	  Drug	  (or	  alcohol)	  use	  is	  a	  typical	  form	  
of	  maladaptive	  coping	  that	  is	  a	  purposeful	  act	  or	  response	  (R)	  being	  negatively	  reinforced	  by	  the	  outcome	  (O)	  of	  
drug	  intake.	  In	  parallel,	  negative	  emotions	  become	  directly	  associated	  with	  O	  and	  as	  a	  consequence	  of	  this	  
Pavlovian	  conditioning	  process	  become	  endowed	  with	  an	  incentive	  value.	  As	  such,	  negative	  emotions	  can	  come	  to	  
elicit	  a	  strong	  conditioned	  craving	  response	  (CR),	  which	  in	  turn	  promotes	  drug	  (or	  alcohol)	  use.	  
When	   SUD/PTSD	   patients	   continually	   use	   substances	   after	   experiencing	   PTSD	   symptoms,	   the	  
normal	  process	  of	  fear	  extinction	  cannot	  occur,	  meaning	  that	  substance	  use	  can	  in	  fact	  prolong	  the	  PTSD	  
symptoms.	   It	   is	   expected	   that	   SUD/PTSD	  patients	   show	   increased	   craving	  after	   exposure	   to	   traumatic	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cues.	   Moreover,	   it	   is	   probable	   that	   not	   only	   exposure	   to	   traumatic	   triggers	   induce	   craving,	   but	   that	  
stress	  cues	  exert	  this	  same	  influence.	  It	   is	  conceivable	  that	  when	  SUD	  patients	  with	  high	  PTSD	  severity	  
have	   learned	   that	   substance	   use	   leads	   to	   a	   temporarily	   relief	   of	   PTSD	   symptoms,	   this	   powerful	  
connection	  is	  widened,	  such	  that	  stress	  triggers	  also	  lead	  to	  craving	  and/	  or	  substance	  use	  especially	  in	  
patients	  with	  SUD/PTSD	  comorbidity.	  These	  assumptions	  are	  tested	  in	  this	  dissertation.	  	  
	  
Treatment	  
Over	  the	  last	  decade,	  a	  large	  body	  of	  research	  on	  the	  treatment	  of	  SUD	  patients	  with	  comorbid	  PTSD	  has	  
accumulated.	   SUD/PTSD	   treatments	   are	   characterized	   by	   two	   distinctive	   qualities:	   sequential	   versus	  
integrated	   treatment,	   and	   past-­‐focused	   versus	   present-­‐focused	   treatment.	   Sequential	   treatment	   was	  
(and	  perhaps	  still	   is)	   the	  prevailing	  standard	   for	  some	  time.	  Patients	  were	  referred	  to	  PTSD	  specialists	  
only	   after	   a	   certain	   period	   of	   sobriety.	   However,	   integrated	   treatment	   focusing	   on	   both	   disorders	  
simultaneously	   seems	   to	  provide	  a	  better	  outcome	   than	   treatment	   focusing	  on	   just	  one	  disorder	  at	  a	  
time	   (Berenz	   &	   Coffey,	   2012;	   Henslee	   &	   Coffey,	   2010;	   Hien,	   Cohen,	   Miele,	   Litt,	   &	   Gapstick;	   2004;	  
Hildebrand,	  Behrendt,	  &	  Hoyer,	  2014;	  McCauley	  et	  al.,	  2012;	  Mills	  et	  al.,	  2012;	  Najavits,	  Gallop,	  &	  Weiss,	  
2006;	  Najavits	  &	  Hien,	  2013).	  	  
In	   present-­‐focused	   trauma	   therapy	   the	   main	   focus	   is	   on	   symptom	   reduction,	   coping	   skills	  
training	  and	  psycho-­‐education,	  without	  targeting	  the	  traumatic	  memories	  directly.	  Examples	  are	  Seeking	  
Safety	   (SS),	   Helping	   Women	   Recover	   plus	   Beyond	   Trauma	   (HWR/BT),	   Integrated	   Cognitive	   Behavior	  
Therapy	  for	  PTSD	  and	  SUD	  (ICBT),	  Addictions	  and	  Trauma	  Recovery	  Integrated	  Model	  (ATRIUM),	  Trauma	  
Adaptive	  Recovery	  Group	  Education	  and	  Therapy	  or	  Trauma	  Affect	  Regulation:	  Guidelines	  for	  Education	  
and	   Therapy	   (TARGET),	   Transcend,	   CBT	   for	   PTSD	   in	   SUD	   treatment,	   and	   Trauma	   Recovery	   and	  
Empowerment	  Model	  (TREM).	  In	  past-­‐focused	  trauma	  therapy,	  exactly	  the	  opposite	  is	  done;	  that	  is,	  the	  
traumatic	   experience	   is	   then	   the	   main	   focus	   of	   the	   therapy.	   Past-­‐focused	   SUD/PTSD	   therapies	   are	  
Concurrent	  Treatment	  of	  PTSD	  and	  Cocaine	  Dependence	  (CTPCD)	  or	  Concurrent	  treatment	  of	  PTSD	  and	  
SUD	  using	  prolonged	  Exposure	  (COPE),	  Creating	  Change	  (CC),	  and	  Substance	  Dependence	  PTSD	  Therapy	  
(SDPT).	  	  
Recently,	   review	   articles	   were	   published	   on	   the	   treatment	   of	   co-­‐occurring	   SUD	   and	   PTSD,	  
(Berenz	  &	  Coffey,	  2012;	  McCauley	  et	  al.,	  2012;	  Najavits	  &	  Hien,	  2013;	  van	  Dam	  et	  al.,	  2012).	  Despite	  the	  
occurrence	   of	   several	  methodological	   problems	   of	   the	   reviewed	   studies,	   some	   important	   conclusions	  
were	  drawn	  by	   the	   reviewers.	   SUD/PTSD	   treatment	  duration	   is	   long,	   taking	  up	   to	  40	  hours	  of	   face	   to	  
face	   treatment.	   Patient	   satisfaction	   is	   mostly	   high,	   although	   drop-­‐out	   rates	   are	   not	   to	   be	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underestimated,	  especially	  in	  the	  past-­‐focused	  treatments.	  Both	  present-­‐	  and	  past-­‐focused	  studies	  show	  
symptom	   reduction	  and	   seem	  promising.	   The	  past-­‐focused	   therapies	   show	   somewhat	  more	   symptom	  
reduction.	   The	   reviews	   further	   underline	   the	   need	   to	   treat	   SUD	   and	   PTSD	   simultaneously	   and	   in	   an	  
integrated	  manner	  (Berenz	  &	  Coffey,	  2012;	  McCauley	  et	  al.,	  2012;	  Najavits	  &	  Hien,	  2013;	  van	  Dam	  et	  al.,	  
2012).	   The	   reviewed	  studies	   further	   show	   that	  when	  SUD	  and	  PTSD	  are	   treated	   simultaneously,	  PTSD	  
symptoms	  in	  particular	  diminish,	  while	  SUD	  symptoms	  seem	  most	  difficult	  to	  reduce.	  However,	  despite	  
the	  accumulating	  evidence	  suggesting	  that	  an	  integrated	  treatment	  of	  comorbid	  SUD/PTSD	  has	  benefit	  
relative	   to	   sequential	   treatment,	   few	   substance	   dependent	   treatment	   centers	   have	   implemented	   an	  
integrated	   treatment	   approach,	   leaving	   PTSD	   in	  most	   cases	   untreated	   during	   SUD	   treatment	   (Glover-­‐
Graf	  &	  Janikowski,	  2001;	  Najavits,	  Sullivan,	  Schmitz,	  Weiss,	  &	  Lee,	  2004;	  Young,	  Rosen,	  &	  Finney,	  2005).	  
There	   is	   a	   clear	   gap	   between	   science	   and	   clinical	   practice	   here.	   It	   is	   not	   clear	   exactly	  why	   integrated	  




In	  the	  last	  years,	  guidelines,	  focusing	  on	  the	  SUD/PTSD	  comorbidity	  and	  aimed	  to	  improve	  the	  quality	  of	  
healthcare,	   have	   been	   developed.	   These	   guidelines	   are	   by	   and	   large	   consistent	   with	   the	   drawn	  
conclusions	  in	  the	  review	  articles.	  The	  VA/DoD	  developed	  guideline	  recommendations	  for	  co-­‐occurring	  
SUD	  and	  PTSD	  (Kivlahan	  &	  Kaysen,	  2012)	  are	  developed	  In	  the	  USA,	  focusing	  on	  veterans	  with	  combat-­‐
related	  PTSD:	  
1. All	  patients	  diagnosed	  with	  PTSD	  should	  receive	  comprehensive	  assessment	  for	  SUD,	  including	  
nicotine	  dependence.	  
2. Recommend	  and	  offer	  cessation	  treatment	  to	  patients	  with	  nicotine	  dependence.	  (McFall	  et	  al.,	  
2010)	  
3. Patients	   with	   SUD	   and	   PTSD	   should	   be	   educated	   about	   the	   relationship	   between	   PTSD	   and	  
substance	   abuse.	   The	   patient’s	   prior	   treatment	   experience	   and	   preference	   should	   be	  
considered	  since	  no	  single	  intervention	  approach	  for	  the	  co-­‐morbidity	  has	  yet	  emerged	  as	  the	  
treatment	  of	  choice.	  
4. Treat	   the	   disorders	   concurrently.	   Treat	   other	   concurrent	   SUD	   consistent	   with	   the	   SUD	  
guidelines	  including	  concurrent	  pharmacotherapy.	  




§ This	  pharmacotherapy	  should	  be	  monitored.	  
5. Provide	   multiple	   services	   in	   the	   most	   accessible	   setting	   that	   will	   promote	   engagement,	   and	  
coordination	  of	  care,	  for	  both	  SUD	  and	  PTSD	  (integrated	  care).	  
6. Reassess	   responses	   to	   treatment	   for	   SUD	   periodically	   and	   systematically,	   using	   standardized	  
and	   valid	   self-­‐report	   instruments	   and	   laboratory	   tests.	   Indicators	   of	   SUD	   treatment	   response	  
include	   ongoing	   substance	   use,	   craving,	   side	   effects	   of	  medication,	   emerging	   symptoms,	   etc.	  
(measurement-­‐based	  care)	  
7. There	  is	   insufficient	  evidence	  to	  recommend	  for	  or	  against	  any	  specific	  psychosocial	  approach	  
to	  addressing	  PTSD	  that	  is	  comorbid	  with	  SUD.	  
In	   the	   Netherlands,	   guidelines	   were	   developed	   on	   the	   treatment	   of	   comorbid	   SUD	   and	   anxiety	  
disorders.	  The	  SUD/PTSD	  comorbidity	  is	  one	  of	  the	  chapters	  in	  this	  extensive	  manuscript	  (Snoek,	  Wits,	  
Meulders,	  &	  van	  de	  Mheen,	  2012).	   It	   is	  underlined	   that	   in	   case	  of	   comorbid	  SUD	  and	  PTSD,	   clinicians	  
need	  not	  to	  follow	  the	  general	  guidelines	  for	  dual	  diagnosis.	   Instead,	  PTSD	  needs	  to	  be	  a	  focus	  in	  SUD	  
treatment,	   during	   and	   immediately	   after	   detoxification.	   During	   the	   integrated	   treatment	   the	   PTSD	  
treatment	   should	   be	   emphasized.	   The	   usual	   treatment	   advices	   for	   SUD	   treatment	   can	   be	   followed,	  
except	   that	   exposure	   based	   therapies	  might	   be	   less	   efficient	   when	   the	   patient	   is	   intoxicated.	   A	   final	  
advice	  in	  this	  guideline	  is	  never	  to	  treat	  comorbid	  PTSD	  and	  SUD	  with	  pharmacotherapy	  alone.	  
The	   International	   Society	   for	   Traumatic	   Stress	   Studies	   (ISTSS),	   which	   holds	   international	   appeal,	  
developed	   PTSD	   treatment	   guidelines	   in	   2005	   (Foa,	   Keane,	   Friedman,	   &	   Cohen,	   2008).	   One	   chapter	  
describes	  shortly	  the	  quality	  of	  existing	  SUD/PTSD	  treatments.	  The	  present-­‐focused	  SS	  is	  indicated	  as	  a	  
level	  A	   treatment	   (suggesting	   its	   superiority),	  whereas	   the	  present-­‐focused	   treatments	  Transcend	  and	  
TREM,	   and	   the	   past-­‐focused	   treatments	   CTPCD	   and	   CDPT	   all	   received	   C-­‐levels.	   A	   specific	   SUD/PTSD	  
guideline	   was	   developed	   in	   2012	   by	   the	   Substance	   Abuse	   and	   Mental	   Health	   Services	   Association	  
(SAMHSA),	   another	   esteemed	   organization	   in	   the	   USA.	   This	   guideline	   specifically	   addresses	  
pharmacotherapy	  in	  patients	  with	  comorbid	  opioid	  use	  disorder	  and	  PTSD	  and	  advices	  to	  assess,	  screen	  
for	   and,	   if	   necessary,	   treat	   both	   disorders	   simultaneously	   when	   a	   patient	   presents	   himself	   with	   only	  
PTSD	   or	   only	   SUD.	   The	   2004	   American	   Psychiatric	   Association	   (APA)	   practice	   guidelines	   of	   PTSD	   and	  
Acute	  Stress	  Disorder	  acknowledge	   the	  complexity	  of	   treating	  comorbid	  SUD	  and	  PTSD	  and	  posit	   that	  
substance	  use	  should	  be	  addressed	  as	  part	  of	  the	  PTSD	  treatment,	  regardless	  of	  whether	  the	  criteria	  for	  
SUD	  are	  met.	  Likewise,	  in	  the	  2006	  APA	  guideline	  for	  SUD,	  integrated	  treatment	  is	  advised	  and	  empirical	  
evidence	   for	   both	   present-­‐focused	   and	   past-­‐focused	   integrated	   treatment	   approaches	   is	   given.	   The	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prescription	  of	  benzodiazepines	  is	  firmly	  discouraged.	  Overall,	  the	  guidelines	  underline	  the	  importance	  
of	  integrated	  SUD/PTSD	  treatment.	  
	  
Aims	  of	  the	  dissertation	  
The	  aim	  of	  the	  present	  dissertation	  is	  threefold.	  The	  first	  aim	  is	  to	  study	  the	  prevalence	  of	  PTSD	  in	  SUD	  
patients	   and	   to	   analyze	   the	   characteristics	   of	   patients	   with	   the	   SUD/PTSD	   comorbidity.	   Although	  
previous	   studies	   have	   shown	   an	   increased	   prevalence	   of	   PTSD	   in	   SUD	   patients	   (Bonin	   et	   al.,	   2000;	  
Dansky	  et	  al.,	  1997;	  Driessen	  et	  al.,	  2008;	  Farley	  et	  al.,	  2004;	  Kessler	  et	  al.,	  2005;	  Ouimette	  et	  al.,	  2007;	  
Read	  et	  al.,	  2004;	  Reynolds	  et	  al.,	  2005),	  no	  study	  had	  directly	  compared	  the	  prevalence	  of	  current	  PTSD	  
and	  trauma	  exposure	  in	  a	  SUD	  population	  with	  the	  prevalence	  of	  current	  PTSD	  and	  trauma	  exposure	  in	  
the	   general	   population	   using	   the	   same	   diagnostic	   tool.	   Since	   previous	   studies	   found	   substantial	  
differences	   in	   PTSD	   prevalence	   rates	   depending	   on	   which	   diagnostic	   tool	   was	   used	   (Dragan	   &	   Lis-­‐
Turlejska;	   2007),	   it	   is	   deemed	   important	   to	   compare	   prevalence	   rates	   with	   identical	   questionnaires	  
within	   the	   same	   study.	   Furthermore,	   previous	   studies	   examining	   socio-­‐economical	   and	   clinical	  
characteristics	  provided	  contradicting	  results	  with	  regard	  to	  characteristics	  of	  SUD/PTSD	  patients	  (Bonin	  
et	  al.,	  2000;	  Driessen	  et	  al.,	  2008;	  Mills,	  Linskey,	  et	  al.,	  2005;	  Mills,	  Teesson,	  Ross,	  &	  Peters,	  2006;	  Peirce,	  
Kindbom,	  Waesche,	  Yuscavage,	  &	  Brooner,	  2008;	  Ouimette,	  Goodwin,	  &	  Brown,	  2006).	  More	  research	  is	  
thus	  needed	  to	  explore	  the	  prevalence	  and	  the	  characteristics	  of	  SUD/PTSD	  patients.	  	  
A	   second	   aim	   of	   the	   present	   dissertation	   is	   to	   study	   how	   the	   craving	   response	   of	   SUD/PTSD	  
patients	  interacts	  with	  trauma	  and	  stress	  cues.	  More	  specifically,	  the	  assumption	  based	  on	  the	  learning	  
theoretical	   view	   outlined	   above	   is	   tested	   that	   both	   trauma	   and	   stress	   cues	   will	   induce	   craving	   in	  
SUD/PTSD	  patients.	   If	   indeed	  craving	   is	  not	  solely	  related	  to	  trauma	  triggers,	  but	  also	  to	  more	  general	  
stressors,	  this	  might	  have	  important	  treatment	  implications.	  	  
The	   third	   and	   final	   aim	   of	   the	   dissertation	   is	   to	   increase	   our	   understanding	   of	   why	   the	  
implementation	   of	   integrated	   SUD/PTSD	   treatment	   hitherto	   has	   been	   unsuccessful.	   When	   specific	  
factors	  for	  this	  failure	  can	  be	  indicated,	  suggestions	  for	  how	  to	  remove	  these	  blockades	  can	  be	  provided.	  
	  
Outline	  of	  the	  dissertation	  
The	   present	   dissertation	   will	   start	   with	   a	   chapter	   (2)	   examining	   the	   prevalence	   of	   current	   PTSD	   and	  
trauma	  exposure	  in	  an	  SUD	  patient	  sample,	  versus	  the	  prevalence	  of	  PTSD	  and	  trauma	  exposure	  in	  the	  
general	   population.	   By	   comparing	   the	   rate	   of	   PTSD	  measured	  with	   and	  without	   using	   a	   standardized	  
questionnaire,	  it	  was	  assessed	  whether	  PTSD	  can	  be	  detected	  in	  SUD	  treatment	  centers	  when	  relying	  on	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clinical	   judgment	  alone.	  A	  last	  goal	  of	  this	  chapter	  was	  to	  gain	  more	  insight	   in	  the	  socio-­‐economic	  and	  
psychiatric	   characteristics	   of	   patients	  with	   SUD/PTSD.	   This	   chapter	   gives	   a	   good	  understanding	  of	   the	  
magnitude	  and	  vulnerability	  of	  the	  subgroup	  of	  patients	  with	  SUD/PTSD	  and	  gives	  a	  first	  insight	  in	  why	  
PTSD	  treatment	  is	  often	  overlooked	  or	  disregarded	  when	  treating	  SUD	  patients.	  	  
In	   Chapter	   3,	   trauma	   and	   stress	   cue	   induced	   craving	   is	   studied.	   The	   chapter	   describes	   an	  
experiment	  in	  which	  SUD	  patients	  with	  differing	  PTSD	  severity	  were	  exposed	  to	  personalized	  stress	  and	  
trauma	   cues	   while	   craving	   levels	   were	   assessed.	   It	   was	   tested	   whether	   SUD/PTSD	   patients	   showed	  
craving	  as	  response	  to	  trauma	  cues	  and	  in	  addition,	  if	  these	  cued	  cravings	  are	  specific	  for	  trauma	  cues	  or	  
also	  more	  general	  to	  stress	  cues.	  
In	  the	  following	  chapter	  (4)	  the	  focus	  is	  on	  the	  perceptions	  of	  clinicians	  with	  regard	  to	  PTSD	  in	  
SUD	   patients.	   In	   the	   described	   qualitative	   study	   we	   questioned	   the	   current	   procedures,	   the	  
responsibilities,	  and	  the	  possible	  obstacles	  related	  to	  the	  assessment,	  the	  diagnosis,	  and	  the	  treatment	  
of	  SUD/PTSD	  patients.	  This	  chapter	  shows	  clear	  obstacles	  related	  to	  the	   implementation	  of	   integrated	  
treatment.	  
The	   fifth	   chapter	   studies	   the	   views	   of	   SUD	   patients	   with	   different	   levels	   of	   PTSD	   severity.	  
Patients	  were	   surveyed	   about	   their	   ideas	   regarding	   the	   link	   between	   the	   start	   of	   their	   addiction	   and	  
their	  past	  trauma,	  they	  were	  questioned	  about	  their	  motives	  for	  using	  substances,	  and	  lastly,	  they	  filled	  
out	  questionnaires	  about	  the	  relationship	  between	  PTSD	  and	  craving	  and	  relapse.	  While	  the	  reader	  of	  
this	  chapter	  is	  provided	  with	  more	  information	  about	  the	  vulnerability	  of	  patients	  with	  co-­‐occurring	  SUD	  
and	  PTSD,	  the	  main	  focus	  here	  is	  on	  possible	  patient	  factors	  hindering	  the	  implementation	  of	  integrated	  
SUD/PTSD	   treatment.	   Also,	   in	   this	   chapter	   a	   further	   insight	   is	   given	   into	   the	   perceived	   link	   between	  
stress	  cues	  and	  craving/	  relapse	  and	  trauma	  related	  triggers	  and	  craving/	  relapse.	  	  
Building	   further	   on	   the	   perceptions	   of	   patients,	   in	   the	   subsequent	   chapter	   (6),	   results	   of	   a	  
qualitative	  study	  are	  displayed.	  SUD/PTSD	  patients	  were	  interviewed	  about	  their	  first	  substance	  use	  and	  
about	  their	  reasons	  for	  continuing	  their	  drugs	  or	  alcohol	  use.	  Furthermore,	  they	  were	  asked	  about	  their	  
treatment	   preference.	   This	   chapter	   covers	   possible	   causes	   for	   the	   unsuccessful	   implementation	   of	  
integrated	  SUD/PTSD	  treatment	  as	  does	  it	  cover	  preferences	  of	  the	  patient	  regarding	  treatment	  focus.	  
In	  the	  closing	  chapter,	  the	  primary	  results	  of	  the	  present	  dissertation	  will	  be	  summarized	  and	  its	  
implications	  for	  clinical	  practice	  and	  further	  research	  are	  discussed.	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Janis	  Joplin	  -­‐	  What	  Good	  Can	  Drinkin'	  Do	  
	  
What	  good	  can	  drinkin'	  do,	  what	  good	  can	  drinkin'	  do?	  
Lord,	  I	  drink	  all	  night	  but	  the	  next	  day	  I	  still	  feel	  blue.	  
	  
There's	  a	  glass	  on	  the	  table,	  they	  say	  it's	  gonna	  ease	  all	  my	  
pain,	  
And	  there's	  a	  glass	  on	  the	  table,	  they	  say	  it's	  gonna	  ease	  all	  my	  
pain.	  
But	  I	  drink	  it	  down,	  an'	  the	  next	  day	  I	  feel	  the	  same.	  
	  
Gimme	  whiskey,	  gimme	  bourbon,	  give	  me	  gin.	  
Oh,	  gimme	  whiskey,	  give	  me	  bourbon,	  gimme	  gin.	  
'Cause	  it	  don't	  matter	  what	  I'm	  drinkin',	  Lord,	  as	  long	  as	  it	  
drown	  this	  sorrow	  I'm	  in.	  
	  
	  




This	   study	   had	   three	   objectives.	   Firstly,	   the	   prevalence	   of	   post-­‐traumatic	   stress	   disorder	   (PTSD)	   and	  
trauma	  exposure	  was	   compared	  between	   individuals	  with	   and	  without	   substance	  use	  disorder	   (SUD).	  
Secondly,	   we	   compared	   self-­‐rating	   of	   PTSD	   and	   clinical	   judgment.	   Thirdly,	   an	   analysis	   of	   the	  
characteristics	   of	   SUD/PTSD	   patients	  was	   performed.	   The	   sample	   consisted	   of	   423	   patients	  with	   SUD	  
and	  206	  healthy	  controls.	  All	  individuals	  were	  screened	  on	  PTSD	  using	  the	  self-­‐rating	  inventory	  for	  PTSD.	  
Significantly	  higher	  numbers	  of	  PTSD	  and	  trauma	  exposure	  were	  found	  in	  the	  SUD	  group	  (resp.	  36.6	  and	  
97.4%).	   PTSD	  went	   frequently	   unnoticed	  when	   relying	  on	   clinical	   judgment	   alone.	   Patients	  with	   SUD/	  
PTSD	  were	  significantly	  more	  often	  unemployed	  and	  had	  a	   lower	  educational	   level.	  Axis	   I	   comorbidity	  
and	   especially	   depressive	   disorders	  were	  more	   common	   in	   the	   SUD/PTSD	   group.	   It	   is	   concluded	   that	  
patients	  with	  SUD/PTSD	  are	  a	  substantial	  and	  vulnerable	  subgroup	  in	  addiction	  treatment	  facilities	  and	  
that	  a	  systematic	  screening	  for	  PTSD	  is	  required.	  




Previous	   research	   has	   documented	   a	   strong	   link	   between	   substance	   use	   disorder	   (SUD)	   and	  
posttraumatic	  stress	  disorder	  (PTSD).	  The	  prevalence	  of	  current	  PTSD	  (Diagnostic	  and	  Statistical	  Manual	  
of	  Mental	  Disorders,	  Fourth	  Edition;	  DSM-­‐IV)	   in	  SUD	  patients	   is	  around	  three	  times	  higher	  than	   in	   the	  
general	  population,	  ranging	  from	  25.3	  to	  49%	  (Bonin,	  Norton,	  Asmundson,	  Dicurzio,	  &	  Pidlubney,	  2000;	  
Driessen	  et	  al.,	  2008;	  Kessler	  et	  al.,	  2005;	  Ouimette,	  Coolhart,	  Funderburk,	  Wade,	  &	  Brown,	  2007;	  Read,	  
Brown,	  &	  Kahler,	  2004;	  Reynolds	  et	  al.,	  2005).	  Besides	   this	  high	  comorbidity,	  studies	  suggest	  a	  poorer	  
SUD	   treatment	   outcome	   when	   comorbid	   PTSD	   is	   left	   untreated	   (Mills,	   Teesson,	   Ross,	   Darke,	   &	  
Shanahan,	  2005;	  Read	  et	  al.,	  2004).	  	  
Dragan	   and	   Lis-­‐Turlejska	   (2007)	   used	   three	   different	   diagnostic	   tools	   to	   measure	   PTSD	   and	  
found	   substantial	   differences	   in	   PTSD	   prevalence	   depending	   on	   which	   tool	   was	   used.	   Therefore,	  
comparisons	  between	  prevalence	  studies	  are	  hard	   to	  make,	  unless	   they	  used	   the	  same	  measures	   in	  a	  
similar	  way	  to	  assess	  the	  prevalence	  of	  PTSD.	  As	  of	  yet,	  no	  study	  has	  directly	  compared	  the	  prevalence	  
of	   PTSD	   in	   a	   SUD	   population	   with	   the	   prevalence	   of	   PTSD	   in	   the	   general	   population	   using	   the	   same	  
diagnostic	  tool	  within	  one	  and	  the	  same	  study.	  	  
In	  the	  present	  study	  three	  different	  aims	  can	  be	  distinguished:	  (1)	  to	  measure	  the	  prevalence	  of	  
current	  PTSD	  and	  trauma	  exposure	  in	  a	  representative	  SUD	  sample	  relative	  to	  the	  prevalence	  of	  current	  
PTSD	  and	  trauma	  exposure	  in	  the	  general	  population;	  (2)	  to	  assess	  whether	  a	  PTSD	  diagnosis	  is	  detected	  
without	  using	  a	  standardised	  questionnaire;	  (3)	  to	  evaluate	  whether	  patients	  in	  the	  SUD/PTSD	  group	  are	  
a	  more	  vulnerable	  subgroup	  in	  terms	  of	  socio-­‐economic	  factors	  and	  psychiatric	  comorbidity.	  	  
In	   the	   present	   study	   the	   prevalence	   of	   PTSD	  was	   compared	   between	   a	   sample	   of	   individuals	  
without	   substance	   dependence	   or	   abuse	   and	   a	   sample	   of	   treatment	   seeking	   SUD	   patients.	   To	   avoid	  
confounding	  factors	  as	  symptoms	  of	  detoxification	  and	  craving	  and	  thereby	  the	  risk	  of	  overdiagnosis,	  we	  
chose	   to	   measure	   PTSD	   with	   a	   validated	   symptom	   checklist	   [self-­‐rating	   inventory	   for	   PTSD	   (SRIP);	  
Hovens,	   Van	   der	   Ploeg,	   Bramsen,	   &	   Klaarenbeek,	   1994]	   extended	   with	   a	   trauma-­‐exposure	   checklist.	  
Within	   these	   scales,	  we	  measured	   PTSD	   symptoms	   that	  were	   prevalent	   in	   the	   past	   4	  weeks,	   thereby	  
excluding	   lifetime	   and	   sub-­‐threshold	   PTSD.	   Furthermore,	   we	   chose	   to	   explore	   PTSD	   prevalence	   in	   a	  
representative	   SUD	   treatment	   seeking	   sample.	   In	   most	   prior	   prevalence	   studies	   only	   one	   specific	  
substance	   group	   was	   included	   (Dragan	   &	   Lis-­‐Turlejska,	   2007;	   Driessen	   et	   al.,	   2008;	   Johnson,	   2008;	  
Norman,	  Tate,	  Anderson,	  &	  Brown,	  2007).	   In	   clinical	  practice,	  however,	  polydrug	  use	   is	   very	   common	  
and	   the	   same	   treatment	   protocol	   is	   applied	   to	   all	   patients,	   independent	   of	   their	   primary	   substance	  
(Emmelkamp	   &	   Vedel,	   2007).	   To	   further	   improve	   the	   representativeness	   of	   our	   sample,	   no	   other	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exclusion	  criteria	  were	  imposed	  than	  being	  able	  to	  read	  and	  write	  (as	  they	  were	  expected	  to	  complete	  
the	  SRIP).	  	  
A	  second	  objective	  of	  this	  study	  arose	  from	  conclusions	  of	  previous	  research,	  showing	  that	  PTSD	  
often	  remains	  undiagnosed	   in	  SUD	  patients	   (Dansky,	  Roitzsch,	  Brady,	  &	  Saladin,	  1997;	  Najavits,	  2005).	  
This	   is	   important	   given	   that	   untreated	   PTSD	  may	   lead	   to	   a	   poorer	   outcome	   in	   SUD	   treatment	   (Back,	  
Brady,	   Sonne,	   &	   Verduin,	   2006;	   Read	   et	   al.,	   2004).	   A	   diagnosis	   can	   be	   made	   by	   means	   of	   clinical	  
judgement,	  by	  using	  standardised	  assessment	  instruments	  or	  by	  both	  means.	  It	  is	  interesting	  to	  find	  out	  
whether	   PTSD	   is	   correctly	   diagnosed	   by	   clinicians	   without	   using	   a	   standardised	   questionnaire,	   based	  
solely	   on	   their	   clinical	   experience.	   In	   the	  present	   study,	  we	   thus	   compared	   the	  prevalence	  of	   current	  
PTSD	   as	   diagnosed	   by	   the	   clinician	   in	   the	   intake	   phase	   (without	   using	   a	   standardised	   diagnostic	   tool)	  
with	  the	  prevalence	  of	  PTSD	  as	  diagnosed	  with	  the	  SRIP.	  	  
For	  clinical	  practice,	   it	   is	   interesting	   to	  examine	  whether	  SUD	  patients	  with	  PTSD	  are	  different	  
from	  SUD	  patients	  without	   PTSD.	   If	   patients	  with	   SUD/PTSD	  have	   a	   lower	   socio-­‐economic	   status	   or	   a	  
more	  severe	  clinical	  profile,	  treatment	  of	  this	  vulnerable	  subgroup	  should	  have	  a	  more	  elaborated	  focus	  
as	  well.	  Although	  most	  previous	   researchers	  agreed	  upon	   the	  more	  elaborated	  clinical	   comorbidity	  of	  
SUD/PTSD	  patients	   (Bonin	  et	   al.,	   2000;	   Jacobsen,	   Southwick,	  &	  Kosten,	   2001;	  Mills,	   Lynskey,	   Teesson,	  
Ross,	   &	   Darke,	   2005;	   Peirce,	   Kindbom,	   Waesche,	   Yuscavage,	   &	   Brooner,	   2008;	   Read	   et	   al.,	   2004),	  
contradicting	  results	  were	  found	  with	  regard	  to	  socio-­‐economic	  factors	  as	  employment,	  educational	  and	  
relational	  status.	  With	  some	  researchers	  finding	  a	  more	  optimistic	  profile	  (e.g.,	  being	  employed,	  having	  
a	  higher	  educational	   level)	   than	  others	   (Bonin	  et	  al.,	  2000;	  Driessen	  et	  al.,	  2008;	  Mills,	   Lynskey,	  et	  al.,	  
2005;	  Mills,	   Teesson,	   Ross,	   &	   Peters,	   2006;	   Peirce	   et	   al.,	   2008;	   Ouimette,	   Goodwin,	   &	   Brown,	   2006).	  
Inconsistency	  was	  also	  found	  with	  regard	  to	  the	  number	  of	  previous	  treatments,	  with	  Bonin	  et	  al.	  (2000)	  
finding	   no	   differences	   between	   SUD	   patients	   and	   SUD/PTSD	   patients	   and	   Driessen	   et	   al.	   (2008)	   and	  
Jacobsen	  et	   al.	   (2001)	   concluding	   that	   SUD/PTSD	  patients	   had	  more	  previous	   admissions	   to	   addiction	  
treatment	  facilities.	  Therefore,	  in	  this	  study,	  we	  also	  examined	  patient	  characteristics.	  	  
In	  general,	  we	  hypothesised	  (1)	  a	  greater	  prevalence	  of	  PTSD	  and	  trauma	  exposure	   in	  patients	  
with	  SUD	  as	   compared	   to	   the	  prevalence	   in	   the	  healthy	   control	   group,	   (2)	   an	  underdiagnosis	  of	  PTSD	  
when	  not	  using	  a	   standardised	   tool	  and	   (3)	  a	  more	   severe	  clinical	  profile	  and	  a	   lower	   socio-­‐economic	  










For	  this	  study,	  ethical	  approval	  was	  given	  by	  the	  Institutional	  Review	  Board	  of	  Maastricht	  University.	  All	  
control	  participants	  signed	  a	  consent	  form	  prior	  to	  their	  participation.	  	  
Patients	  with	  SUD	  were	  recruited	  from	  11	  different	  addiction	  treatment	  branches	  from	  a	  single	  
organisation	   (Mondriaan)	   all	   located	  within	   the	   same	   region	   (southern	   Limburg,	  with	   a	   population	   of	  
approximately	  620,000	   inhabitants,	   located	   in	   the	  most	   southern	   tip	  of	   the	  Netherlands).	   Participants	  
were	   included	   in	   the	   study	   from	   October	   2008	   to	   May	   2009.	   Patients	   gave	   permission	   that	   the	  
information	   in	   their	   patient	   file	   could	   be	   used	   for	   research	   purpose.	   Data	   on	   the	   SRIP	   and	   trauma-­‐
exposure	   checklist	   of	   the	   patients	   included	   in	   this	   study	  were	   retrieved	   from	   their	   respective	   patient	  
files.	   Since	   October	   2008,	   the	   patients	   in	   treatment	   for	   SUD	   at	   the	  Mondriaan	   treatment	   center	   are	  
structurally	   screened	   with	   the	   SRIP	   and	   trauma-­‐exposure	   checklist.	   Note	   that	   the	   data	   on	   these	  
questionnaires	  were	  obtained	  after	   intake	  and	  sometimes	  even	  after	  years	  of	   treatment.	  As	  such,	   this	  
allowed	  us	  to	  compare	  the	  clinician’s	  diagnosis	  of	  PTSD	  at	  intake	  (i.e.,	  without	  input	  from	  a	  standardized	  
tool	  as	  the	  SRIP)	  against	  the	  prevalence	  of	  PTSD	  based	  on	  SRIP	  scores.	  
	  
Participants	  
Figure	  1	  shows	  a	  flowchart	  for	  the	  inclusion	  and	  exclusion	  of	  participants	  in	  the	  current	  study.	  The	  initial	  
sample	   consisted	   of	   432	   patients	  with	   SUD	   (patient	   group)	   and	   475	   control	   participants	   (non-­‐patient	  
control	  group).	  We	  tried	  to	  match	  the	  control	  group	  as	  closely	  as	  possible	  with	  the	  patient	  group	  on	  the	  
basis	   of	   age	   and	   gender.	   Participants	   from	   the	   non-­‐patient	   group	   were	   contacted	   by	   e-­‐mail.	   These	  
individuals	   had	   previously	   indicated	   on	   the	   Maastricht	   University	   website	   to	   be	   interested	   in	  
participating	   in	   research	  projects.	  From	  the	  475	  contacted	  participants,	  67	  e-­‐mails	  were	  automatically	  
returned	   because	   of	   technical	   problems	   with	   email	   addresses	   of	   the	   recipients,	   and	   144	   individuals	  
chose	  not	   to	  participate.	   The	   remaining	   264	  participants	   in	   the	  non-­‐patient	   group	   received	   a	  website	  



















Figure	  1.	  Flowchart	  inclusion	  participants.	  
	  
Five	   persons	   from	   the	   non-­‐patient	   group	   had	   incomplete	   data	   and	   were	   therefore	   excluded	  
from	  further	  analyses.	  As	  we	  wanted	  to	  compare	   the	  prevalence	  of	  PTSD	   in	  SUD	  patients	  with	   that	   in	  
healthy	   controls,	   we	   excluded	   a	   further	   51	   participants	   from	   the	   non-­‐patient	   group	   because	   they	  
admitted	   abusing	   drugs	   or	   alcohol	   or	   because	   of	   clear	   indications	   of	   other	   psychiatric	   problems.	   An	  
indication	   for	   psychiatric	   problems	  was	   for	   instance	   the	   use	   of	   psychiatric	  medication.	   In	   the	   patient	  
group	  only	  one	  individual	  was	  excluded	  from	  the	  analyses	  due	  to	  deficient	  data	  and	  eight	  patients	  were	  
excluded	   because	   they	   did	   not	   fulfil	   DSM-­‐IV-­‐TR	   criteria	   for	   substance	   dependence.	   As	   we	  wanted	   to	  
match	  groups	  on	  age	  as	  closely	  as	  possible,	  two	  more	  candidate	  participants	  (of	  74	  and	  75	  years	  of	  age)	  
of	   the	   control	   group	   were	   excluded	   from	   further	   analysis.	   Participants	   in	   the	   patient	   group	   were	  
between	  18	  and	  68	  years	  of	  age	  (M	  age	  =41	  years),	  as	  opposed	  to	  an	  age	  range	  of	  22-­‐68	  years	   in	  the	  
non-­‐patient	  group	  (M	  age	  =54	  years).	  In	  the	  patient	  group	  332	  (78.5%)	  participants	  were	  male	  and	  in	  the	  
non-­‐patient	   group	   65%	   was	   male.	   In	   total,	   data	   of	   423	   SUD	   patients	   and	   206	   control	   participants	  
remained	   for	   further	   analyses.	   Participant	   characteristics	   for	   the	   total	   sample	   and	   the	   SUD	   patient	  
sample	  (with	  and	  without	  PTSD)	  are	  displayed	  in	  Tables	  1	  and	  2,	  respectively.	  
	  
	   	  
Start of the study	  
SUD patients  
(n=432)	  
Incomplete data  
(n=1)	  
Complete data  
(n=431)	  






Healthy controls  
(n=475)	  




Incomplete data  
(n=5)	  




No psychiatric  
problems 
(n=208)	  
Age ≥ 70 
(n=2)	  




Table	  1.	  Total	  sample	  characteristics	  (SUD	  vs.	  Control).	  
	  








U	  =	  16117	  
r	  =	  -­‐.51	  
p	  <	  .001	  
Gender	  (%)	   	   	   	   	   	  
	  	  Male	   74	   78.5	   65	   χ2	  (1)	  =	  13.03	   p	  <	  .001	  
	  	  Female	   26	   21.5	   35	   	   	  
Education	   	   	   	   	   	  
	  	  Low	   28.1	   38.5	   6.8	   χ2	  (2)	  =	  
161.99	  
p	  <	  .001	  
	  	  Medium	   32.4	   24.1	   49.5	   	   	  
	  	  High	   16.7	   4.3	   42.2	   	   	  
	  	  Missing	   22.7	   33.1	   1.5	   	   	  
PTSD	  as	  
measured	  by	  
the	  SRIP	  (%)	  
28.6	   36.9	   11.7	   χ2	  (1)	  =	  43.17	   p	  <	  .001	  
	  
	   	  
	   Total	  sample	  
(N	  =	  629)	  
SUD	  
(N	  =	  423)	  
Control	  
(N	  =	  206)	  
Statistics	   Significance	  
Demographics	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Table	  2.	  SUD	  patient	  sample	  characteristics	  (SUD/PTSD	  vs.	  SUD/no	  PTSD).	  
	   SUD	  	  
(N	  =	  423)	  
SUD/PTSD	  
(N	  =	  156)	  
SUD/no	  PTSD	  
(N	  =	  267)	  
Statistics	   Significance	  









U	  =	  19708	  
r	  =	  .04	  
.390	  
Gender	  (%)	   	   	   	   	   	  
	  	  Male	  	   78.5	   75.6	   80.1	   χ2	  (1)	  =	  1.186	   .276	  
	  	  Female	  	   21.5	   24.4	   19.9	   	   	  
Primary	  
substance	  (%)	  
	   	   	   	   	  
	  	  Alcohol	  	   43.7	   46.2	   42.3	   χ2	  (4)	  =	  2.686	   .612	  
	  	  Heroin	  	   33.6	   33.3	   33.7	   	   	  
	  	  Cocaine	   7.1	   7.1	   7.1	   	   	  
	  	  Cannabis	  	   10.9	   7.7	   12.7	   	   	  
	  	  Speed	   3.5	   3.2	   3.7	   	   	  
	  	  Missing	   1.2	   2.6	   .4	   	   	  
	  
Measurement/data	  sources	  
Self-­‐rating	  inventory	  for	  PTSD	  
In	  all	  participants	  PTSD	  was	  assessed	  using	  the	  SRIP.	  The	  SRIP	  is	  a	  Dutch	  self-­‐report	  questionnaire	  with	  
22	   items	   covering	   the	   17	   symptoms	   and	   the	   3	   symptom	   clusters	   (i.e.,	   re-­‐experiencing,	   persistent	  
avoidance	  and	  increased	  arousal)	  of	  PTSD	  following	  the	  DSM-­‐IV	  (Van	  Balkom,	  De	  Beurs,	  Hovens,	  &	  Van	  
Vliet,	   2004).	   Note	   that	   the	   SRIP	   does	   not	   cover	   criteria	   A,	   E	   and	   F	   as	   formulated	   in	   the	   DSM-­‐IV.	  
Participants	  are	  asked	  to	  rate	  their	  symptoms	  over	  the	  previous	  4	  weeks	  on	  a	  4-­‐point	  Likert	  scale	  (1	  =not	  
at	   all,	   4	  =extremely).	  Psychometric	  properties	  of	   the	  SRIP	  have	  proved	   to	  be	  good	   in	  different	   clinical	  
samples,	   including	   trauma	   patients	   (Hovens,	   Bramsen,	   &	   Van	   der	   Ploeg,	   2002;	   Hovens	   et	   al.,	   1994).	  
Cronbach’s	  alpha	  reliabilities	  are	  0.90-­‐0.94	   for	   the	  total	  SRIP	  score,	  0.77-­‐0.87,	  0.80-­‐0.88	  and	  0.76-­‐0.85	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for	   the	   subscales	   intrusion,	   avoidance	   and	   hyperarousal,	   respectively.	   The	   questionnaire	   has	   an	  
excellent	  test-­‐retest	  reliability,	  with	  Pearson’s	  r	  =0.92	  for	  the	  total	  score	  and	  for	  the	  subscales	  intrusion,	  
avoidance	  and	  hyperarousal	  the	  correlations	  are	  0.84,	  0.91	  and	  0.85,	  respectively	  (Hovens	  et	  al.,	  2002).	  
Sensitivity	  and	  specificity	  of	  the	  SRIP	  were	  measured	  with	  the	  clinician-­‐administered	  PTSD	  Scale	  (CAPS)	  
(Blake	   et	   al.,	   1995;	   Weathers,	   Keane	   &	   Davidson,	   2001),	   as	   an	   external	   criterion.	   Sensitivity	   (true	  
positives	  according	  to	  the	  CAPS/true	  positives-­‐false	  negatives)	  was	  high,	  ranging	  between	  0.83	  and	  0.86,	  
and	   a	   good	   specificity	   (true	   negatives	   according	   to	   the	   CAPS/true	   negatives-­‐false	   positives)	   ranging	  
between	  0.69	  and	  0.73	  was	  found	  (Hovens	  et	  al.,	  2002;	  Witteveen,	  Bramsen,	  Hovens,	  &	  Van	  der	  Ploeg,	  
2005).	  The	  high	  sensitivity	  reflects	  a	  low	  risk	  for	  false	  positives,	  i.e.,	  a	  low	  risk	  for	  overdiagnosis.	  On	  the	  
basis	   of	   the	  balance	  between	   sensitivity	   and	   specificity	   an	  optimum	  cut-­‐off	   score	   for	   the	  diagnosis	   of	  
PTSD	  of	  52	  was	  established	   (Hovens	  et	  al.,	  2002;	  Witteveen	  et	  al.,	  2005).	  Concurrent	  validity	  was	  also	  
examined.	   Correlations	  with	   two	  other	   frequently	   used	   PTSD	   scales	   (Mississippi	   Combat-­‐related	   PTSD	  
Scale,	   civilian	   version	   and	   the	   Keane	  MMPI-­‐PTSD	   subscale)	   are	   0.80	   and	   0.82,	   reflecting	   an	   adequate	  
concurrent	  validity	  (Hovens	  et	  al.,	  2002).	  
	  
Trauma-­‐exposure	  checklist	  
To	  prevent	  the	  risk	  of	  overdiagnosis	  of	  PTSD,	  the	  SRIP,	  which	  is	  a	  symptom-­‐only	  measure	  and	  does	  not	  
cover	   criteria	   A	   of	   DSM-­‐IV,	   was	   complemented	   with	   a	   trauma-­‐exposure	   checklist.	   This	   checklist	   was	  
based	   on	   different	   questionnaires	   and	   diagnostic	   interviews	   (Interview	   for	   Traumatic	   Events	   in	  
Childhood;	   Lobbestael,	   Arntz,	   Harkema-­‐Schouten	   &	   Bernstein,	   2009;	   Traumatic	   Experiences	  
Questionnaire;	   Nijenhuis,	   Van	   der	   Hart,	   &	   Kruger,	   2002	   and	   the	   Dutch	   translated	   version	   of	   the	  
Structured	  Childhood	  Trauma	  Interview;	  Van	  der	  Bossche,	  Kremers,	  Sieswerda,	  &	  Arntz,	  1999)	  to	  include	  
a	  broad	  range	  of	  possible	  traumas,	  such	  as	  a	  life-­‐threatening	  situation,	  being	  attacked	  or	  threatened.	  In	  
the	  present	  study,	  a	  positive	  diagnosis	  of	  PTSD	  was	  possible	  only	  when	  all	  of	   the	   following	  conditions	  
were	  fulfilled:	  total	  SRIP	  is	  52	  or	  higher	  (Hovens	  et	  al.,	  2002),	  at	  least	  one	  intrusion	  item	  is	  ≥3,	  three	  or	  
more	   avoidance	   items	   are	   ≥3,	   at	   least	   two	   hyperarousal	   items	   are	   ≥3	   (H.	   Hovens,	   personal	  
communication,	   September	  2008)	   and	  participants	   indicate	  on	   the	   trauma-­‐exposure	   checklist	   to	  have	  
been	  exposed	  to	  one	  or	  more	  traumatic	  events.	  
	  
Mini	  International	  Neuropsychiatric	  Interview	  (MINI)	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To	  ensure	   that	  participants	   in	   the	  control	  group	  were	  not	  abusing	  drugs	  or	  alcohol,	   substance-­‐related	  
questions	  were	  added	  derived	  from	  the	  MINI	  (Sheehan	  et	  al.,	  1997).	  As	  participants	  in	  the	  patient	  group	  
were	  all	  patients	  in	  addiction	  treatment	  SUD	  was	  not	  measured	  in	  this	  group.	  	  
	  
Statistical	  methods	  
All	   analyses	   were	   conducted	   using	   SPSS	   18.0	   for	   Windows.	   The	   differences	   in	   PTSD	   prevalence	   and	  
trauma-­‐exposure	   prevalence	   between	   groups	   were	   analyzed	   by	   using	   chisquare	   tests.	   To	   compare	  
different	  characteristics	  of	  SUD/PTSD	  patients	  with	  SUD/non-­‐PTSD	  patients	  we	  used	  chi-­‐square	  tests	  (for	  
categorical	  variables)	  or	  t-­‐tests	  for	   independent	  samples	  (for	  continuous	  variables).	  Cramer’s	  V	   is	  used	  
to	   indicate	  the	  effect	  size	   for	   the	  results	  of	   the	  chi-­‐square	  tests.	  The	  Mann-­‐Whitney	  test	  was	  used	  for	  
continuous	  data	  when	  the	  assumption	  of	  normality	  was	  violated.	  Logistical	  regression	  was	  used	  to	  test	  
whether	  age	  and	  sex	  predicted	  PTSD.	  
	  
Results	  
Prevalence	  of	  current	  PTSD	  and	  trauma	  exposure	  (SUD	  vs.	  Control)	  	  
In	  the	  sample	  of	  SUD	  patients,	  36.6%	  scored	  positive	  on	  current	  PTSD.	  In	  the	  control	  group	  10.2%	  could	  
be	   diagnosed	  with	   PTSD.	   There	  was	   a	   significant	   relation	   between	   SUD	   and	  whether	   or	   not	   a	   person	  
scored	  positive	  on	  PTSD	  χ2	  (1)	  =48.09,	  p	  <	  0.001,	  with	  Cramer’s	  V	  =0.28,	  representing	  a	  small	  effect	  size.	  
This	  reflects	  the	  fact	  that	  based	  on	  odds	  ratio	  individuals	  are	  5.27	  times	  more	  likely	  to	  score	  positive	  on	  
PTSD	  if	  they	  are	  patients	  with	  SUD	  than	  if	  they	  are	  not	  patients	  with	  SUD.	  	  
Since	   patients	   with	   alcohol	   dependence	   and	   patients	   with	   heroin	   dependence	   constituted	   a	  
large	  sample	  of	  the	  SUD	  patients	  (resp.	  43.7	  and	  33.6%),	  PTSD	  prevalence	  was	  also	  calculated	  for	  these	  
subgroups.	  These	  numbers	  were	  comparable	  with	  PTSD	  prevalence	  in	  the	  SUD	  group	  (38.4	  and	  36.6%,	  
respectively).	  	  
Since	  age	  and	  sex	  were	  not	  equally	  distributed	  between	  the	  SUD	  group	  and	  the	  control	  group,	  
we	  conducted	  another	   logistic	  regression	  analysis	  controlling	  for	  sex	  and	  age.	  The	   inclusion	  of	  sex	  and	  
age	  in	  the	  model	  did	  not	  have	  any	  influence,	  nor	  were	  there	  any	  interaction	  effects.	  Only	  the	  group	  (SUD	  
vs.	  healthy	  control)	  was	  a	  significant	  predictor	  for	  PTSD	  (B	  =	  -­‐1.632	  (.251),	  p	  <	  .001).	  	  
To	   analyze	   the	   continuous	   SRIP	   scores	   (with	   a	   higher	   score	   representing	   a	  more	   severe	   PTSD	  
symptomatology),	   we	   employed	   a	   non-­‐parametric	   test	   as	   the	   assumption	   of	   normal	   distribution	  was	  
violated.	  Patients	  with	  SUD	  (median	  =47)	  had	  a	  significantly	  higher	  score	  on	  PTSD	  (total	  SRIP	  score)	  than	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control	  subjects	  (median	  =33),	  U	  =18880.00,	  p	  <	  0.001,	  r	  =-­‐0.44.	  This	  again	  confirms	  the	  proposed	  strong	  
association	  between	  SUD	  and	  PTSD.	  
In	  the	  control	  group	  86.3%	  had	  been	  exposed	  to	  criterion	  A1	  trauma.	  In	  the	  SUD	  group,	  97.4%	  
had	   encountered	   such	   a	   trauma	   in	   their	   lifetime.	   There	   was	   a	   significant	   relation	   between	   SUD	   and	  
whether	  or	   not	   an	   individual	   had	  been	  exposed	   to	   trauma,	   χ2	   (1)	   =28.89,	  p	   <	   0.001,	  with	  Cramer’s	  V	  
=0.22,	  representing	  a	  small	  effect	  size.	  On	  the	  basis	  of	  the	  odds	  ratio,	   individuals	  are	  5.91	  times	  more	  
likely	   to	   have	   been	   exposed	   to	   trauma	   if	   they	   are	   SUD	   patients	   than	   if	   they	   are	   not	   SUD	   patients.	  
Subjects	  were	  asked	  to	  indicate	  on	  a	  trauma-­‐exposure	  checklist	  to	  which	  trauma	  they	  were	  exposed	  to	  
in	  their	  lifetime.	  Table	  3	  displays	  the	  different	  types	  of	  exposed	  trauma	  as	  indicated	  by	  the	  subjects.	  
	  
Table	  3.	  Type	  of	  trauma	  (SUD	  vs.	  Control).	  
	   Total	  sample	  
(N	  =	  629)	  
SUD	  
(N	  =	  423)	  
Control	  
(N	  =	  206)	  
Statistics	   Significance	  
Any	  kind	  of	  trauma	   93.8	   97.4	   85.9	   χ2	  (1)	  =	  29.005	   p	  <	  .001	  
Life	  threatening	  situation	   46.7	   53.3	   33.2	   χ2	  (1)	  =	  22.498	   p	  <	  .001	  
Being	  attacked	  or	  
threatened	  with	  a	  
weapon	  
42.1	   55.3	   15.6	   χ2	  (1)	  =	  88.620	   p	  <	  .001	  
Witnessing	  death/	  
severe	  injury	  
50.3	   55.1	   40.5	   χ2	  (1)	  =	  11.807	   p	  <	  .001	  
Hearing	  that	  something	  
terrible	  has	  happened	  to	  
a	  close	  relative	  	  
73.1	   80.2	   58.5	   χ2	  (1)	  =	  32.807	   p	  <	  .001	  
Being	  hit,	  hurt	  or	  injured	  
(as	  a	  child	  or	  as	  an	  adult)	  
35.7	   43	   21	   χ2	  (1)	  =	  28.959	   p	  <	  .001	  
Being	   forced	   to	   endure	  
or	   to	   perform	   sexual	  
acts.	  	  




Relation	  between	  PTSD	  as	  diagnosed	  during	  intake	  and	  PTSD	  diagnosed	  with	  the	  SRIP	  	  
A	  total	  of	  37.9%	  of	  patients	  with	  SUD	  mentioned	  a	  traumatic	  experience	  during	  the	  intake	  interview	  as	  
reported	  in	  the	  corresponding	  patient	  files.	  A	  chi-­‐square	  analysis	  was	  performed	  to	  check	  whether	  this	  
was	  correlated	  with	  a	  positive	  PTSD	  diagnosis	  as	  assessed	  with	  the	  SRIP.	  There	  was	  a	  significant	  relation	  
between	  trauma	  mentioned	  at	  intake	  and	  whether	  or	  not	  a	  person	  scored	  positive	  on	  PTSD	  as	  assessed	  
with	  the	  SRIP,	  χ2	  (1)	  =15.15,	  p	  <.005,	  with	  Cramer’s	  V	  =0.19,	  representing	  a	  small	  effect	  size.	  
In	  the	  anamnestic	  phase,	  one-­‐fifth	  (20.2%)	  of	  the	  patients	  had	  complained	  about	  one	  or	  more	  
PTSD	   symptoms	   (e.g.,	   recurrent	   nightmares,	   avoidance	   of	   traumatic	   stimuli,	   exaggerated	   startle	  
response,	   etc.).	   There	   was	   a	   significant	   relation	   between	   PTSD	   symptoms	   mentioned	   at	   intake	  
(mentioning	  vs.	  no	  mentioning)	  and	  whether	  or	  not	  a	  person	  scored	  positive	  on	  PTSD	  as	  assessed	  with	  
the	  SRIP	  χ2	  (1)	  =15.57,	  p	  <.001,	  with	  Cramer’s	  V	  =0.19,	  representing	  a	  small	  effect	  size.	  	  
In	  4.8%	  of	  the	  intakes,	  possible	  PTSD	  was	  noted	  by	  the	  interviewer	  (mere	  clinical	  judgment,	  no	  
use	  of	  questionnaires).	  After	  intake,	  a	  multi-­‐disciplinary	  staff	  decides	  which	  diagnoses	  should	  be	  written	  
in	   the	   patient	   files	   (again	  mere	   clinical	   judgment,	   no	   use	   of	   questionnaires).	   Only	   2.1%	   (n	   =9)	   of	   the	  
admitted	  SUD	  patients	  were	  actually	  diagnosed	  with	  PTSD.	  When	  comparing	  this	  result	  with	  the	  number	  
of	   PTSD	   diagnoses	   as	   measured	   with	   the	   SRIP	   (36.6%),	   it	   is	   clear	   that	   a	   large	   discrepancy	   in	   PTSD	  
diagnosis	   exists,	   depending	  on	  whether	   or	   not	   a	   questionnaire	   is	   used.	   In	   four	   of	   these	  nine	  patients	  
where	   PTSD	   was	   diagnosed	   type	   II	   error	   seemed	   to	   be	   prevalent	   given	   that	   the	   clinical	   judgment	  
diagnosis	  was	  not	  confirmed	  by	  the	  SRIP.	  
	  
Clinical	  profile	  and	  socio-­‐economic	  status	  of	  SUD	  patients	  with	  vs.	  without	  PTSD	  
We	   derived	   information	   on	   clinical	   profile	   and	   socioeconomic	   status	   of	   the	   patients	   from	   their	  
respective	   patient	   files.	   The	   SUD/PTSD	   patients	   appeared	   to	   be	   quite	   similar	   to	   the	   SUD/no	   PTSD	  
patients.	  No	  significant	  differences	  were	  found	  with	  regard	  to	  the	  criminal	  past	  [χ2	  (1)	  =0.95,	  p	  =0.35],	  
financial	  debts	  [χ2	  (1)	  =3.19,	  p	  =0.08]	  and	  relationship	  status.	  Both	  groups	  were	  comparable	  regarding	  
their	   time	   in	   treatment	   [χ2	   (3)	  =1.75,	  p	  =0.63],	  number	  of	  previous	   treatments	   [χ2	   (3)	  =3.78,	  p	  =0.29]	  
and	   treatment	   outcome	   [χ2	   (1)	   =	   0.80,	   p	   =0.67].	   Two	   demographic	   factors	   were	   markedly	   different	  
between	  the	  two	  groups:	  education	  level	  [χ2	  (2)	  =14.38,	  p	  <0.01]	  and	  current	  employment	  status	  [χ2	  (1)	  




We	  further	  examined	  whether	  there	  might	  be	  a	  more	  severe	  pattern	  of	  comorbidity	  (axis	  I	  or	  II)	  
in	   patients	   with	   SUD/PTSD.	   A	   significant	   relation	   existed	   between	   depressive	   disorders	   and	   PTSD.	  
Patients	  with	   SUD/PTSD	  were	  more	   likely	   to	   have	  depressive	   disorders	   [χ2	   (2)	   =13.32,	  p	   <0.001,	  with	  
Cramer’s	  V	   =0.19]	   than	   SUD/no	   PTSD	   patients.	   Secondly,	   SUD/PTSD	   patients	   were	   significantly	   more	  
likely	   to	   be	   patients	  with	   other	   axis	   I	   disorders	   compared	   to	   SUD/no	   PTSD	   patients	   [χ2	   (1)	   =13.78,	  p	  
<0.001,	   with	   Cramer’s	   V	   =0.19].	   No	   other	   significant	   results	   were	   found	   in	   examining	   axes	   I	   and	   II	  
disorders	  in	  both	  groups.	  
	  
Discussion	  
A	   first	  goal	  of	   the	   study	  was	   to	  gain	   insight	   into	   the	  prevalence	  of	  PTSD	  and	   trauma	  exposure	   in	  SUD	  
patients	  and	  to	  compare	  these	  numbers	  with	  the	  prevalence	  of	  current	  PTSD	  and	  trauma	  exposure	  in	  a	  
healthy	  control	  group	  using	  the	  same	  diagnostic	  tool.	  In	  the	  present	  study,	  we	  found	  that	  36.6%	  of	  SUD	  
patients	   scored	   positive	   on	   PTSD.	   Almost	   every	   patient	   had	   encountered	   at	   least	   one	   traumatic	  
experience	   in	   his/her	   lifetime.	   As	   hypothesized,	   these	   numbers	  were	   significantly	   lower	   in	   individuals	  
without	  substance	  dependence.	  In	  this	  group	  we	  found	  a	  PTSD	  prevalence	  rate	  of	  10.2%,	  and	  86.3%	  of	  
the	  persons	  in	  this	  control	  group	  had	  experienced	  some	  kind	  of	  traumatic	  event.	  	  
We	  cannot	  directly	  compare	  these	  results	  with	  earlier	  research,	  because	  this	  study	  is	  the	  first,	  to	  
our	  knowledge,	  that	  contrasts	  the	  prevalence	  of	  current	  PTSD	  in	  a	  heterogeneous	  SUD	  population	  with	  
PTSD	  in	  a	  control	  group	  within	  the	  same	  study	  using	  the	  same	  questionnaire.	  Nevertheless,	  the	  results	  
of	   some	   comparable	   studies	   (measuring	   current	   PTSD	   in	   a	   heterogeneous	   SUD	   population)	   are	  
consistent	  with	  our	  prevalence	  data.	  In	  prior	  studies	  in	  SUD	  populations,	  current	  PTSD	  was	  found	  to	  be	  
prevalent	  in	  25.3	  -­‐	  41%	  of	  cases	  (Bonin	  et	  al.,	  2000;	  Driessen	  et	  al.,	  2008;	  Ouimette	  et	  al.,	  2007;	  Read	  et	  
al.,	  2004;	  Reynolds	  et	  al.,	  2005).	   Studies	   in	  SUD	  populations	   that	  assessed	  prevalence	   rates	  of	   trauma	  
exposure	   typically	   report	   percentages	   between	   89	   and	   95%	   (Dansky,	   Saladin,	   Coffey,	   &	   Brady,	   1997;	  
Farley,	   Golding,	   Young,	   Mulligan,	   &	   Minkoff,	   2004;	   Read	   et	   al.,	   2004;	   Reynolds	   et	   al.,	   2005),	   which	  
concurs	  with	  the	  present	  results.	  	  
One	  discrepant	  finding	  with	  previous	  research	   is	  the	  relatively	  high	  number	  of	  current	  PTSD	  in	  
the	   control	   group;	   in	   this	   study,	   10.2%	   of	   the	   control	   subjects	   had	   a	   positive	   diagnosis.	   It	   should	   be	  
noted	   that	   the	   present	   sample	   of	   healthy	   controls	   does	   not	   represent	   the	   general	   population.	   These	  
healthy	   controls	   signed	   up	   as	   voluntary	   participants	   for	   psychology	   research	   in	   response	   to	   a	  
recruitment	   advertisement	   on	   the	   university	   website.	   Conceivably,	   individuals	   who	   suffer(ed)	   from	  
psychological	  problems	  may	  be	  more	  readily	  inclined	  to	  participate	  in	  psychological	  research	  such	  as	  the	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present	  study.	  Indeed,	  other	  researchers	  have	  found	  a	  typical	  prevalence	  rate	  below	  4%	  in	  the	  general	  
population	  (Bromner,	  Peek,	  Bronner,	  Last,	  &	  Grootenhuis,	  2009;	  Creamer,	  Burgess	  &	  McFarlane,	  2001;	  
Darves-­‐Bornoz	  et	  al.,	  2008;	  De	  Vries	  &	  Olff,	  2009).	  Another	  possible	  explanation	  for	  the	  high	  number	  of	  
PTSD	  in	  the	  control	  group	  might	  be	  that	  the	  SRIP	  overestimates	  PTSD.	  This	  option	  does	  not	  seem	  valid	  
because	  of	  two	  reasons.	  Firstly,	  researchers	  documented	  a	  good	  specificity	  for	  the	  SRIP,	  reflecting	  a	  low	  
risk	  for	  overdiagnosis	  (Hovens	  et	  al.,	  2002;	  Witteveen	  et	  al.,	  2005).	  Secondly,	   if	  the	  SRIP	  overestimates	  
PTSD,	  the	  same	  profile	  should	  be	  noted	  in	  the	  SUD	  group.	  	  
The	  fact	  that	  many	  SUD	  patients	  score	  positive	  on	  PTSD	  has	   important	   implications	  for	  clinical	  
practice.	  At	  present,	  PTSD	  receives	  little	  attention	  in	  SUD	  treatment	  (Najavits,	  Sullivan,	  Schmitz,	  Weiss,	  
&	  Lee,	  2004)	  and	  systematically	  conducted	  screening	  with	  a	  validated	  questionnaire	  does	  not	  take	  place	  
in	  more	  than	  80%	  of	  SUD	  patients	  (Young,	  Rosen,	  &	  Finney,	  2005).	  This	  study	  emphasizes	  the	  need	  to	  
identify	  the	  SUD/PTSD	  patients	  as	  a	  substantial	  and	  important	  subgroup	  and	  to	  systematically	  screen	  for	  
PTSD	  in	  all	  SUD	  patients	  at	  intake.	  	  
Our	  second	  aim	  was	  to	  assess	  whether	  PTSD	  would	  be	  correctly	  diagnosed	  by	  interviewers	  and	  
clinicians	  without	  using	  a	  standardized	  questionnaire.	  As	  expected,	  PTSD	  remained	   largely	  undetected	  
when	  no	  standardized	  tool	  was	  used.	  These	  findings	  are	  important	  because	  they	  draw	  attention	  to	  the	  
fact	   that,	  with	   regard	   to	   the	  diagnosis	   of	   PTSD,	   SUD	   treatment	   facilities	   should	  not	   solely	   rely	   on	   the	  
opinions	  of	  clinicians	  and	  interviewers.	  Clinical	  judgement	  is	  prone	  to	  bias	  and,	  when	  possible,	  validated	  
assessment	  tools	  should	  be	  used	  (Dawes,	  Faust,	  &	  Meehl,	  1989;	  Garb,	  2005).	  	  
The	  third	  and	  final	  goal	  was	  to	  evaluate	  whether	  patients	  in	  the	  SUD/PTSD	  group	  have	  a	  more	  
severe	  clinical	  profile	  and	  a	  lower	  socio-­‐economic	  status.	  Somewhat	  surprisingly,	  the	  SUD/PTSD	  patients	  
and	  the	  group	  of	  SUD/no	  PTSD	  patients	  proved	  comparable	  on	  most	  patient	  characteristics.	  There	  were,	  
however,	   four	   significant	   differences	   between	   the	   groups:	   (1)	   patients	   in	   the	   SUD/PTSD	   group	   were	  
more	   often	   less	   educated,	   (2)	   the	   SUD/PTSD	   comorbid	   patients	   were	   more	   often	   unemployed,	   (3)	  
patients	  with	  PTSD	  were	  more	  likely	  to	  have	  depressive	  disorders	  and	  (4)	  patients	  with	  PTSD	  were	  more	  
likely	  to	  have	  another	  axis	  I	  disorder.	  	  
In	  sum,	  the	  present	  study	  provides	  further	  evidence	  for	  the	  heightened	  prevalence	  rate	  of	  PTSD	  
among	   SUD	   patients.	   The	   treatment	   facilities	   participating	   in	   this	   research	   did	   not	   employ	   structural	  
testing	  for	  PTSD	  among	  newly	  admitted	  patients.	  Clearly,	  this	   is	  associated	  with	  severe	  underdiagnosis	  
of	  PTSD.	  This	  is	  a	  problem	  as	  it	  has	  been	  shown	  that	  SUD	  patients	  with	  comorbid	  PTSD	  may	  benefit	  from	  
parallel	  treatment	  of	  their	  PTSD	  (Amaro	  et	  al.,	  2007;	  Cocozza	  et	  al.,	  2005;	  Coffey,	  Stasiewicz,	  Hughes,	  &	  
Brimo,	   2006;	   Morrissey	   et	   al.,	   2005;	   Najavits,	   Gallop,	   &	   Weiss,	   2006;	   Van	   Dam,	   Vedel,	   Ehring,	   &	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Emmelkamp,	   2012),	   and	   patients	   are	   denied	   a	   potentially	  more	   favourable	   treatment	   outcome	  when	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Chapter	  3
Craving	  after	  trauma	  and	  stress	  cue	  exposure	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Previous	   research	   shows	   that	   patients	   with	   substance	   use	   disorder	   (SUD)	   and	   post-­‐traumatic	   stress	  
disorder	  (PTSD)	  experience	  more	  craving	  for	  a	  substance	  after	  exposure	  to	  their	  personal	  trauma	  cues	  
compared	  to	  neutral	  cues.	  However,	  it	  is	  not	  clear	  if	  their	  substance	  cravings	  are	  triggered	  by	  specifically	  
trauma	   cues	   or	   by	   stress	   cues	   in	   general	   and	   whether	   the	   level	   of	   PTSD	  matters.	   The	   current	   study	  
examined	  the	  impact	  of	  trauma	  cues	  and	  stress	  cues	  on	  substance	  craving	  and	  tension	  in	  patients	  with	  
SUD	   and	   different	   levels	   of	   PTSD	   severity.	   Seventy-­‐four	   patients	   attended	   three	   exposure	   sessions	   in	  
which	  the	  patient	  was	  exposed	  to	  one	  tape	  recorded	  script;	  a	  neutral	  script,	  a	  stress	  script	  and	  a	  trauma	  
script.	  Craving	  and	  tension	  were	  measured	  before	  and	  after	  each	  cue	  exposure.	  The	  findings	  show	  that	  
patients	   high	   in	   PTSD	   severity	   craved	   more	   after	   stress	   and	   trauma	   script	   exposure,	   compared	   to	  
exposure	   to	   the	   neutral	   script	   and	   to	   patients	   low	   in	   PTSD	   severity.	   These	   findings	   suggest	   that	  
SUD/PTSD	  patients	  are	  not	  only	  more	  vulnerable	  to	  trauma	  cues,	  but	  also	  to	  more	  general	  stress	  cues.	  
Treatment	  implications	  are	  discussed.	  	  




Substance	  Use	  Disorder	  (SUD)	  and	  Post	  Traumatic	  Stress	  Disorder	  (PTSD)	  frequently	  co-­‐occur.	  Previous	  
studies	  demonstrate	  PTSD	  prevalence	  rates	  of	  around	  35%	  in	  SUD	  patients	  (Driessen	  et	  al.,	  2008;	  Gielen,	  
Havermans,	  Tekelenburg,	  &	  Jansen,	  2012;	  Read,	  Brown,	  &	  Kahler,	  2004).	  This	  rate	  is	  considerably	  higher	  
than	  in	  the	  general	  population,	  where	  the	  lifetime	  prevalence	  of	  PTSD	  is	  between	  6.8%	  and	  9.2%	  (NCS-­‐R	  
lifetime	  prevalence	  rates;	  Keane,	  Marshall,	  &	  Taft,	  2006).	  	  
Experts	   generally	   believe	   that	   substance	   use	   of	   SUD/PTSD	   patients	   regulates	   the	   negative	  
emotions	   associated	   with	   PTSD	   (Simpson	   &	   Miller,	   2002;	   Stewart,	   Pihl,	   Conrod,	   &	   Dongier,	   1998).	  
According	   to	   this	   so-­‐called	   self-­‐medication	   hypothesis,	   trauma	   exposure	   should	   precede,	   rather	   than	  
follow,	  the	  development	  of	  SUD,	  and	  this	  is	  exactly	  what	  has	  been	  found	  in	  a	  recent	  longitudinal	  study	  
(Haller	   &	   Chassin,	   2014).	   Furthermore,	   it	   is	   documented	   that	   a	   positive	   diagnosis	   of	   PTSD	   puts	  
individuals	   at	   risk	   for	   the	   onset	   of	   drug	   abuse	   or	   dependence	   (Breslau,	   Davis,	  &	   Schultz,	   2003;	   Reed,	  
Anthony,	   &	   Breslau,	   2007,	   Simpson	   &	   Miller,	   2002).	   The	   self-­‐medication	   hypothesis	   on	   PTSD	   in	   the	  
development	   of	   SUD	   predicts	   that	   the	   substance	   use	   itself	   should	   alleviate	   PTSD	   symptoms.	   Indeed,	  
Stewart	   et	   al.	   (1998)	   argue	   that	   drugs	   with	   arousal-­‐dampening	   properties	   (e.g.,	   alcohol)	   are	   used	   to	  
reduce	  the	  hypervigilance	  toward	  trauma	  related	  cues.	  
SUD	  patients	  with	  comorbid	  PTSD	  are	   found	  to	  be	  more	  vulnerable	   for	   relapse	  when	   they	  are	  
confronted	  with	   interpersonal	   negative	   emotions,	   as	   compared	   to	   patients	  with	   SUD	   only	   (Ouimette,	  
Coolhart,	  Funderbuck,	  Wade,	  &	  Brown,	  2007).	  Other	  studies	  indicate	  that	  SUD/PTSD	  patients,	  compared	  
to	  those	  who	  have	  SUD	  only,	  use	  more	  alcohol	  and	  drugs,	  were	  more	  often	  in	  treatment,	  receive	  more	  
treatment	   sessions	   and	   experience	   higher	   levels	   of	   craving,	   distress	   and	   psychiatric	   symptoms	   (Back,	  
Sonne,	  Killeen,	  Dansky,	  &	  Brady,	  2003;	  Dube,	  Anda,	  Feliti,	  Chapman,	  Williamson,	  &	  Giles,	  2001;	  Evren,	  
C.,	   Evren,	   B.,	   Dalbudak,	   Ozcelik,	   &	   Oncu,	   2009; Gielen	   et	   al.,	   2012;	   Mills,	   Lynskey,	   Teesson,	   Ross,	   &	  
Darke,	   2005;	   Ouimette,	   Brown,	   &	   Najavits,	   1998;	   Pirard,	   Sharon,	   Kang,	   Angarita,	   &	   Gastfriend,	   2005;	  
Read	  et	  al.,	  2004;	  Simpson	  &	  Miller,	  2002).	  Furthermore,	  some	  recent	  reviews	  report	  evidence	  for	  the	  
effectiveness	   of	   integrated	   SUD-­‐PTSD	   treatment	   (Berenz	   &	   Coffey,	   2012;	   Fareed,	   Eilender,	   Haber,	  
Bremner,	  Whitfield,	   &	   Drexler,	   2013;	  McCauley,	   Killeen,	   Gros,	   Brady,	   &	   Back,	   2012;	   van	   Dam,	   Vedel,	  
Ehring,	  &	  Emmelkamp,	  2012).	  
If	  SUD-­‐patients	  with	  PTSD	  indeed	  misuse	  substances	  specifically	  to	  escape	  or	  suppress	  the	  stress	  
evoked	  by	  trauma	  memories,	  such	  memories	  should	  be	  strongly	  associated	  with	  drug	  use.	  In	  that	  case,	  
the	  trauma	  memories	  might	  function	  as	  conditioned	  drug	  stimuli	  that,	  due	  to	  their	  association	  with	  drug	  
use	  (and	  hence	  a	  drug	  effect),	  easily	  come	  to	  elicit	  strong	  cravings.	  Indeed,	  it	  was	  repeatedly	  found	  that	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patients	  with	  PTSD	  and	  alcohol	  or	  cocaine	  dependency	  experience	  more	  desire	  for	  substance	  use	  after	  
exposure	   to	   personalized	   trauma	   cues	   (Coffey,	   Saladin,	   Drobes,	   Brady,	   Dansky,	   &	   Kilpatrick,	   2002;	  
Coffey,	   Schumacher,	   Stasiewicz,	   Henslee,	   Baillie,	   &	   Landy,	   2010;	   Nosen,	   Nillni,	   Berenz,	   Schumacher,	  
Stasiewicz,	  &	  Coffey,	  2012;	  Saladin,	  Drobes,	  Coffey,	  Dansky,	  Brady,	  &	  Kilpatrick,	  2003).	  In	  2002,	  Coffey	  et	  
al.	  were	  the	  first	  to	  examine	  the	  impact	  of	  trauma	  imagery	  cues	  together	  with	  in	  vivo	  drug	  cues	  on	  cued	  
cravings	   in	  patients	  with	  SUD	  and	  PTSD.	  They	  compared	  alcohol	  dependent	  PTSD	  individuals	  and	  PTSD	  
patients	   with	   cocaine	   dependency.	   Both	   groups	   displayed	   cue	   reactivity	   (i.e.,	   increased	   cravings)	  
following	  simultaneous	  exposure	   to	   the	  personalized	   trauma	  cues	  and	  drug	  cues.	  Saladin	  et	  al.	   (2003)	  
exposed	  alcohol	  and	  cocaine	  dependent	  patients	  with	  and	  without	  PTSD	  to	  four	  pairs	  of	  cues	  (trauma	  +	  
drug,	   trauma	   +	   neutral,	   neutral	   +	   drug	   and	   neutral	   +	   neutral).	   The	   trauma	   scripts	   and	   the	   drug	   cues	  
elicited	   significantly	   higher	   levels	   of	   craving	   compared	   to	   the	   corresponding	  neutral	   script/	   cue.	   PTSD	  
severity	  predicted	  the	  degree	  of	  craving	  after	  the	  trauma	  script	  exposure,	  regardless	  of	  the	  presence	  of	  
substance	  cues.	  Not	  only	  self-­‐reported	  craving	   increased	  after	  trauma	  cue	  exposure,	  also	  physiological	  
cue	   reactivity	   (salivary	   flow)	   was	   demonstrated	   (Coffey	   et	   al.,	   2010).	   Moreover,	   decreased	   drug	   cue	  
reactivity	  was	   found	   in	   SUD/PTSD	  patients	   after	   some	   imaginary	   trauma	  exposure	   treatment	   sessions	  
(Coffey,	  Stasiewicz,	  Hughes,	  &	  Brimo,	  2006;	  Nosen,	  Littlefield,	  Schumacher,	  Stasiewicz,	  &	  Coffey,	  2014).	  	  
Although	   these	   pioneering	   cue-­‐reactivity	   studies	   clearly	   show	   increased	   drug	   cravings	   during	  
exposure	  to	  trauma	  cues,	  the	  studies	  did	  not	  take	  stress	  cue	  reactivity	  into	  account.	  In	  a	  recent	  study	  we	  
found	   that	   SUD/PTSD	   patients	   show	   significantly	   less	   efficient	   coping	   strategies	   as	   compared	   to	   SUD	  
patients	   with	   less	   PTSD	   symptoms	   (Gielen,	   Nederkoorn,	   &	   Havermans,	   2015a),	   and	   recent	  
neurobiological	   studies	   show	   a	   disturbed	   stress	   reactivity	   response	   in	   patients	   trauma	   exposure	  
(Klaassens,	  Giltay,	  Cuijpers,	  van	  Veen,	  &	  Zitman,	  2012;	  Vermetten	  &	  Lanius,	  2012).	  Therefore,	  besides	  
testing	  the	  link	  between	  craving	  and	  trauma	  cues,	  it	  might	  be	  of	  interest	  to	  test	  how	  SUD/PTSD	  patients	  
react	   to	   personalized	   stress	   scripts,	   unrelated	   to	   their	   traumas.	   If	   cued	   cravings	   are	   not	   specific	   to	  
trauma	  and	  drug	  cues	  but	  related	  to	  more	  general	  stressors	  this	  might	  have	  implications	  for	  treatment,	  
e.g.,	  then	  treatment	  might	  benefit	  from	  also	  including	  the	  learning	  of	  coping	  skills.	  In	  the	  present	  study,	  
we	   tested	   whether	   cued	   cravings	   of	   SUD+PTSD	   patients	   are	   specific	   for	   trauma	   cues	   or	   also	   more	  
general	  to	  stress	  cues.	  It	  is	  hypothesized	  that	  patients	  with	  high	  scores	  on	  PTSD	  severity	  will	  experience	  
more	   subjective	   cravings	   in	   response	   to	   stress	   cues	   and	   trauma	   cues	   than	   subjects	   with	   less	   PTSD	  
symptoms.	  We	  further	  expect	  higher	  cravings	  in	  response	  to	  trauma	  cues	  compared	  to	  stress	  cues	  and	  
higher	  cravings	  in	  response	  to	  stress	  cues	  compared	  to	  neutral	  cues.	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SUD	  patients	  with	  a	  history	  of	  trauma	  exposure	  and	  with	  different	  levels	  of	  PTSD	  severity	  will	  be	  
exposed	  to	  neutral	  cues,	  stress	  cues	  and	  trauma	  cues.	  Craving	  and	  tension	  will	  be	  assessed	  before	  and	  




All	   substance	   dependent	   individuals	   engaging	   in	   one	   of	   six	   wards	   of	   an	   intramural	   substance	   abuse	  
treatment	  program	  that	  does	  not	   specifically	  address	  PTSD	  or	   trauma	  were	   informed	  about	   the	  study	  
and	  invited	  to	  participate.	  The	  patient	   information	  letter	  and	  informed	  consent	  were	  explicated.	   If	  the	  
patient	  agreed	  to	  participate	  in	  the	  study,	  inclusion	  and	  exclusion	  criteria	  were	  checked.	  Main	  inclusion	  
criteria	   for	   the	   current	   study	   were	   being	   exposed	   to	   a	   past	   trauma	   (based	   on	   the	   Trauma-­‐Exposure	  
Checklist,	  descript	  below)	  and	  being	   treated	  clinically	   for	  SUD.	  To	  avoid	   influences	  of	  detoxification	  or	  
recent	  substance	  use	  on	  craving	  we	  only	  allowed	  patients	  who	  were	  in	  clinical	  treatment	  for	  at	  least	  20	  
days.	  Although	  complete	  abstinence	  was	  expected	  for	  these	  patients,	  relapse	  during	  clinical	  treatment	  is	  
not	  uncommon.	   Individuals	  whose	   last	   lab	   session	  could	  not	  be	  planned	  2	  days	  before	   their	   inpatient	  
discharge	  or	  earlier	  were	  not	  allowed	  to	  participate	  in	  the	  study.	  Participants	  were	  ineligible	  if	  they	  met	  
criteria	  for	  a	  psychotic	  disorder,	  when	  they	  had	  a	  verbal	  IQ	  lower	  than	  80	  or	  when	  they	  were	  at	  risk	  for	  
suicidality	  or	  self-­‐injurious	  behavior.	  Illiterate	  patients	  or	  patients	  who	  did	  not	  speak	  and	  understand	  the	  
Dutch	  language	  could	  not	  take	  part	  in	  the	  study.	  Patients	  who	  were	  taking	  medications	  that	  prohibited	  
craving	  (e.g.	  naltrexone,	  acamprosate,	  methadone)	  were	  asked	  to	  sustain	  to	  the	  same	  dose	  during	  the	  
study	  period	  (with	  permission	  of	  the	  attending	  psychiatrist).	  	  
In	   total,	   91	   SUD	   patients	   with	   a	   trauma	   history	   were	   included	   in	   the	   study.	   The	   study	   was	  
conducted	  with	  the	  approval	  of	  the	  medical	  ethical	  committee	  of	  Atrium	  MC,	  Orbis	  MC,	  and	  Hogeschool	  
Zuyd	  in	  Heerlen,	  the	  Netherlands.	  All	  participants	  provided	  written	  informed	  consents	  and	  were	  paid	  20	  




Self-­‐rating	  Inventory	  for	  Posttraumatic	  Stress	  Disorder	  (SRIP)	  
PTSD	  symptoms	  were	  diagnosed	  with	  the	  validated	  Dutch	  self-­‐rating	  inventory	  for	  PTSD	  (SRIP;	  Hovens,	  
Van	  der	  Ploeg,	  Bramsen,	  Klaarenbeek,	  Schreuder,	  &	  Rivero,	  1994).	  The	  SRIP	   is	  a	  questionnaire	  with	  22	  
items	  covering	  the	  17	  symptoms	  and	  the	  3	  subscales	  (i.e.	  reexperiencing,	  avoidance	  and	  hyperarousal)	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of	  PTSD	  following	  the	  DSM-­‐IV	  (van	  Balkom,	  de	  Beurs,	  Hovens,	  &	  van	  Vliet,	  2004).	  Participants	  rated	  their	  
symptoms	   over	   the	   previous	   4	   weeks	   on	   a	   4-­‐point	   Likert	   scale	   (1	   =	   not	   at	   all,	   4	   =	   extremely).	  
Psychometric	  properties	  of	  the	  SRIP	  have	  proven	  to	  be	  good	  in	  different	  clinical	  samples,	  including	  PTSD	  
patients	  (Hovens	  et	  al.,	  1994;	  Hovens,	  Bramsen,	  &	  Van	  der	  Ploeg,	  2002;	  Witteveen,	  Bramsen,	  Hovens,	  &	  
Van	  der	  Ploeg,	  2005)	  and	  SUD/PTSD	  patients	  (Kok,	  de	  Haan,	  van	  der	  Velden,	  van	  der	  Meer,	  Najavits,	  &	  
de	  Jong,	  2013).	  A	  positive	  PTSD	  diagnosis	  requires	  a	  SRIP-­‐total	  score	  of	  52	  or	  higher	  (Hovens	  et	  al.,	  2002;	  
Witteveen	  et	  al.,	  2005),	  at	  least	  one	  intrusion	  item	  scored	  ≥3,	  3	  or	  more	  avoidance	  items	  scored	  ≥3,	  and	  
at	  least	  2	  hyperarousal	  items	  scored	  ≥3	  (H.	  Hovens,	  personal	  communication,	  September	  2008).	  	  
	  
Trauma-­‐exposure	  checklist	  
This	   checklist	   is	   based	   on	   different	   questionnaires	   and	   diagnostic	   interviews	   (Interview	   for	   Traumatic	  
Events	   in	  Childhood;	   Lobbestael,	  Arntz,	  Harkema-­‐Schouten,	  &	  Bernstein,	   2009;	   Traumatic	   Experiences	  
Questionnaire;	   Nijenhuis,	   van	   der	   Hart,	   &	   Kruger,	   2002	   and	   the	   Dutch	   translated	   version	   of	   the	  
Structured	  Childhood	  Trauma	  Interview;	  Bossche,	  Kremers,	  Sieswerda,	  &	  Arntz,	  1999)	  to	  include	  a	  broad	  
range	  of	  possible	  traumas,	  such	  as	  a	  life	  threatening	  situation,	  being	  attacked	  or	  threatened.	  	  
	  
Imagery	  cues	  
Trauma	  cues.	  Personalized	  script	  driven	  imagery	  is	  a	  well-­‐validated	  and	  reliable	  procedure	  across	  PTSD	  
populations	   to	   induce	   responses	   that	  are	   similar	   to	  what	  happens	  when	  a	  PTSD	  patient	   is	   confronted	  
with	  a	  traumatic	  trigger.	   It	  has	  been	  shown	  to	  elicit	  stronger	  psychophysiological	  and	  mood	  responses	  
than	  generic	  scripts	  (Coffey	  et	  al.,	  2002;	  2010;	  Saladin	  et	  al.,	  2003;	  Sinha,	  1996).	  Studies	  have	  shown	  that	  
personalized	  scripts	  are	  also	  effective	  for	  inducing	  craving	  in	  patients	  with	  comorbid	  SUD/PTSD	  (Kwako,	  
Schwandt,	   Sells,	   Ramchandani,	   Hommer,	   George	   et	   al.,	   2014;	   Nosen	   et	   al.,	   2014).	   Stress	   cues.	  
Personalized	   scripts	   were	   also	   used	   as	   general	   stressor	   stimuli.	   The	   participants	   first	   listened	   to	   a	  
standard	  instruction	  text	  regarding	  the	  type	  of	  traumatic	  or	  stressful	  event	  that	  the	  study	  aimed	  for.	  This	  
was	   important	   since	  participants	  had	   to	  be	  able	   to	  distinguish	  between	  what	   counts	  as	  a	   trauma	  and	  
what	   counts	   as	   a	   stressful	   event.	   Traumatic	   events	   included	   experiences	   in	   which	   the	   person	   was	  
confronted	  with	  or	  witnessed	  actual	  or	   threatened	  death,	   severe	   injury	  or	  events	   that	   threatened	  the	  
physical	   integrity	   of	   self	   or	   others	   (4th	   ed.,	   text	   rev.;	   Diagnostic	   and	   Statistical	   Manual	   of	   mental	  
disorders;	  American	  Psychiatric	  Association	  [APA],	  2000).	  Stressful	  events	  were	  described	  as	  events	  that	  
were	  often	  associated	  with	   family,	   friends,	   partner,	  work	  or	  money	  and	   in	  which	   the	  person	   felt	   sad,	  
angry	   or	   tensed.	   For	   both	   cues,	   the	   participants	   were	   instructed	   not	   to	   choose	   situations	   in	   which	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substance	  use	  played	  a	  major	  role.	  They	  were	  asked	  to	  think	  about	  events	  (resp.	  trauma	  and	  stress)	  that	  
were	  most	  traumatic/	  stressful	  to	  them.	  Participants	  rated	  the	  impact	  of	  the	  events	  on	  a	  10	  cm	  Visual	  
Analogue	  Scale	  (VAS)	  (0	  =	  not	  at	  all	  stressful/	  traumatic	  and	  10	  =	  the	  most	  stress	  I	  have	  felt	   in	  my	  life/	  
the	  most	  severe	  trauma	  I	  experienced).	  Only	  situations	  rated	  as	  8	  or	  above	  were	  accepted	  as	  appropriate	  
for	   script	   development.	   The	   participants	   were	   then	   interviewed	   about	   each	   event	   and	   they	   were	  
encouraged	   to	   include	   multiple	   sensory	   dimensions	   in	   their	   descriptions.	   The	   interviews	   were	  
audiotaped	   to	   facilitate	   the	   script-­‐making	   after	   the	   session.	   For	   each	   subject	   scripts	   were	   then	  
developed	   portraying	   the	   subject’s	   own	   experience	   in	   the	   second	   person,	   present	   tense.	   The	  
personalized	  scripts	  had	  an	  approximate	  duration	  of	  85	  s	  and	  were	  audiotaped.	  	  
Neutral	  cues.	  Three	  neutral	  situations	  were	  used:	  (1)	  sitting	  on	  the	  beach	  and	  looking	  around,	  (2)	  sitting	  
in	   the	  park,	  near	   the	   river	  and	   looking	  around	  and,	   (3)	   taking	  a	  bath.	  Participants	   rated	   these	  neutral	  
situations	   using	   10	   cm	   VASs	   ranging	   from	   0	   ‘not	   at	   all’	   to	   10	   ‘very	   much’:	   “In	   your	   case,	   is	   there	   a	  
connection	  between	   this	   situation	  and	   substance	  use?”,	   “In	  your	   case,	   is	   there	  a	   connection	  between	  
this	  situation	  and	  stress?”,	  “Can	  you	  imagine	  yourself	  in	  this	  situation?”.	  For	  each	  participant,	  the	  most	  
neutral	  and	  most	   imaginable	  situation	  was	  selected	  as	  neutral	  cue,	  but	  only	  when	  no	  association	  with	  
substance	  use	  was	  reported.	  
	  
Craving	  and	  tension	  	  
Craving	  and	  tension	  were	  rated	  on	  two	  separate	  10	  cm	  VASs,	  ranging	  from	  0	  (no	  craving/tension	  at	  all)	  
to	  10	  (a	  lot	  of	  craving/tension).	  	  
	  
Manipulation	  checks:	  Imagery	  vividness	  and	  intensity	  of	  scripts	  
Participants	   rated	  how	  vividly	   they	  were	  able	   to	   imagine	   the	  scenario	  on	  a	  10	  cm	  VAS	  ranging	   from	  0	  
(not	  at	  all	  clear)	  to	  10	  (perfectly).	  	  
Three	  independent	  reviewers	  rated	  the	  stress	  and	  trauma	  scripts	  on	  intensity	  (“How	  intense	  do	  
you	   experience	   the	   emotions	   elicited	  by	   this	   described	   event?”)	   on	   a	   10	   cm	  VAS	   ranging	   from	  0	   (not	  
intense	  at	  all)	  to	  10	  (very	  intense).	  This	  rating	  was	  included	  to	  ensure	  that	  the	  scripts	  were	  comparable	  
with	  regard	  to	  intensity	  level.	  
	  
Procedure	  
The	   experiment	   included	   four	   sessions	   for	   each	   participant;	   one	   assessment	   session	   and	   three	   lab	  
sessions	  in	  which	  the	  cue	  exposure	  took	  place.	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In	  the	  assessment	  session,	  some	  information	  about	  the	  procedure	  was	  given	  and	  the	  participant	  
filled	  out	   the	   trauma	  exposure	  checklist	   to	  ensure	   that	   there	  was	  a	  past	   trauma	  encounter.	  Next,	   the	  
script	  development	  for	  the	  neutral	  cue	  occurred.	  At	  the	  end	  of	  this	  assessment	  session	  a	  short	  overview	  
was	  given	  about	  the	  next	  session,	  and	  the	  participant	  was	  informed	  that	  it	  was	  important	  for	  the	  study	  
to	  stay	  abstinent	  from	  drugs	  or	  alcohol.	  Finally,	  an	  appointment	  was	  made	  for	  the	  lab	  sessions.	  In	  total,	  
the	  assessment	  session	  lasted	  around	  20	  minutes.	  
	   The	   3	   lab	   sessions	   had	   a	   similar	   structure	   and	   were	   planned	   for	   3	   successive	   weeks.	   At	   the	  
beginning	  of	  each	  lab	  session	  the	  participants	  were	  informed	  that	  the	  researcher	  was	  obliged	  to	  follow	  
an	  outlined	  protocol	  which	  prevented	  him/	  her	  to	  go	  into	  possibly	  emotional	  issues.	  Nevertheless,	  at	  the	  
end	  of	  each	  session	  there	  was	  ample	  opportunity	  to	  evaluate	  the	  session	  and	  to	  ventilate	  experiences.	  
Next,	   compliance	   with	   the	   abstinence	   restrictions	   was	   assessed	   (self-­‐report)	   and	   the	   participant	   was	  
inquired	  about	  unusual	  stress	  or	  cravings,	  and	  about	  possible	  changes	  in	  medication	  dosage.	  Hereafter,	  
the	   participant	   rated	   current	   tension	   (baseline	   tension)	   and	   current	   craving	   (baseline	   craving).	   (S)he	  
then	   put	   the	   headphone	   on	   and	   listened	   with	   closed	   or	   averted	   eyes	   to	   the	   recorded	   text	   (neutral,	  
trauma	  or	  stress).	  Neutral	  cue	  exposure	  was	  always	  planned	  in	  the	  first	  lab	  session,	  while	  the	  two	  other	  
cues	  were	  counterbalanced	  for	  lab	  session	  2	  and	  3.	  The	  participant	  was	  instructed	  to	  imagine	  the	  script	  
as	   vividly	   as	   possible.	   After	   the	   imaginary,	   tension	   and	   craving	   were	   rated	   again.	   Subsequently,	   the	  
vividness	  of	   the	   imagination	  was	   rated.	  The	  participant	  was	  debriefed,	   focusing	  on	  personal	   strengths	  
and	  available	  sources	  of	  support.	  Final	  tension	  and	  craving	  ratings	  were	  obtained	  to	  assure	  the	  safety	  of	  
each	   participant	   upon	  dismissal.	   If	   participants’	   tension	   and	   craving	  were	   still	   above	   baseline	   levels	   a	  
relaxation	   procedure	   was	   suggested.	   Emotion	   regulating	   strategies	   were	   offered	   until	   tension	   and	  
craving	  dropped	  to	  baseline	  levels.	  In	  7	  persons	  the	  tension/craving	  remained	  higher	  than	  baseline,	  even	  
after	   the	  emotion	  regulating	  strategies.	   In	  these	  cases,	   the	  therapist	   involved	  was	   informed	  about	  the	  
increased	  tension/craving	  and	  these	  participants	  received	  special	  attention	  from	  their	  therapist	  after	  the	  
session.	  All	  of	  these	  7	  participants	  completed	  the	  study	  and	  none	  of	  them	  relapsed	  during	  the	  study.	  	  
	   There	   were	   interviews	   added	   to	   the	   end	   of	   each	   lab	   session,	   after	   the	   study	   protocol	   and	  
measures	  were	  completed.	  In	  the	  first	  lab	  session	  the	  script	  development	  for	  the	  trauma	  and	  the	  stress	  
cue	  took	  place,	  and	  it	  included	  a	  structured	  interview	  about	  the	  patient’s	  perceptions	  regarding	  the	  link	  
between	  SUD	  and	  PTSD	  (published	  in	  Gielen	  et	  al.,	  2015a).	  The	  second	  and	  third	  session	  both	  included	  
the	  assessment	  of	  a	  clinical	   interview	  on	  psychiatric	  comorbidity	   (published	   in	  Gielen	  et	  al.,	  2015a).	   In	  
between	  the	  sessions,	  the	  patients	  filled	  out	  some	  self-­‐report	  questionnaires	  (published	  in	  Gielen	  et	  al.,	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All	  statistical	  analyses	  are	  performed	  using	  SPSS	  version	  21	  software.	  A	  2	  (time	  of	  measurement:	  pre	  and	  
post	  cue	  exposure)	  x	  3	  (type	  of	  cue:	  neutral,	  stress	  or	  trauma)	  repeated	  measures	  ANCOVA	  was	  used	  to	  
examine	  differences	  on	  the	  dependent	  measures	  (subjective	  craving	  and	  tension),	  with	  PTSD	  severity	  as	  
covariate.	  For	  the	  two	  ANCOVAs,	  a	  Bonferroni	  adjustment	  was	  employed	  to	  reduce	  type	  I	  error.	  
To	  assess	   the	   impact	  of	  participants’	   imageability	   (vividness	  of	   the	   imagery)	  and	  the	   impact	  of	  
the	   intensity	   of	   the	   scripts,	   Pearson	   correlation	   analyses	   were	   employed	   to	   test	   for	   relationships	  
between	  imageability	  and	  intensity	  with	  cue	  reactivity.	  	  
Although	   data	   of	   74	   patients	   were	   used	   in	   this	   study,	   sample	   size	   varies	   depending	   on	   the	  
completion	  of	  answers	  on	  different	  measures.	  Originally,	  subjective	  tension	  was	  only	  measured	  before	  
cue	   exposure.	  We	   adapted	   the	  protocol	   and	   started	  measuring	   tension	   (post	   cue	   exposure)	   after	   the	  
participation	  of	  the	  first	  20	  patients,	  so	  fewer	  patients	  are	  included	  in	  the	  analyses	  on	  tension.	  
	  
Results	  
Participant	  characteristics	  	  
Participants	  were	  male	  (77%)	  and	  female	  participants	  with	  a	  mean	  age	  of	  39.45	  years	  (SD=9.14).	  They	  
were	   in	   clinical	   treatment	   for	   the	   substance	  dependency	  only	   (47.3%),	   for	  dual	  diagnosis	   (27%)	  or	   for	  
SUD	   +	   forensic	   issues	   (25.7%).	   The	   SUD	   patients	  were	   exposed	   to	   different	   kinds	   of	   traumata	   during	  
their	  past	  (mostly	  to	  multiple	  traumas).	  Physical	  abuse	  was	  most	  common	  (75.7%),	  followed	  by	  exposure	  
to	   life	   threatening	   situations	   (46.6%)	   and	   sexual	   abuse	   (39.2%).	   A	   minority	   was	   traumatized	   in	   war	  
(8.1%).	  Trauma	  exposure	  happened	  mostly	  at	  a	  younger	  age	  than	  first	  use	  of	  the	  primary	  substance	  (M	  =	  
13.27	  [SD	  =	  7.19]	  vs	  M	  =	  22.87	  [SD	  =	  8.49]).	  Only	  8	  patients	  (11.1%)	  experienced	  their	  first	  trauma	  after	  
the	  age	  of	  first	  use	  of	  the	  primary	  substance.	  Mean	  SRIP	  score	  was	  50.49	  (SD	  =	  11.54),	  which	  is	  around	  
the	   52	   cut-­‐off	   score	   for	   PTSD	   which	   was	   defined	   by	   Hovens	   and	   colleagues	   (2002).	   Alcohol	   was	   the	  
primary	   substance	   for	  most	   participants	   (54.1%)	   and	  mean	   abstinence	  was	   13.73	  weeks	   (SD	   =	   19.77,	  
range:	  1	  -­‐	  104).	  Note	  that	  thirty	  five	  percent	  of	  the	  sample	  stated	  that	  they	  (almost)	  never	  craved	  in	  the	  
last	  month.	  	  


























Manipulation	  checks	  	  
Participants	   rated	   the	   vividness	   of	   each	   script	   after	   imagery.	   This	   imageability	   of	   the	   scripts	   differed	  
significantly	  between	  the	  three	  conditions,	  F(1.83,	  132.06)	  =	  7.43,	  p	  =	  .001,	  contrast	  tests	  showed	  that	  
stress	  and	   trauma	  cue	   imageability	  differed	  significantly	   from	  neutral	   cue	   imageability	   (resp.	  F(1,72)	  =	  
10.15,	  p	   =	   .002,	   and	  F(1,72)	   =	   9.25,	  p	   =	   .003)	  while	   stress	   and	   trauma	   cue	   imageability	   did	   not	   differ	  
significantly	  from	  each	  other	  (F(1,72)	  =	  .009,	  p	  =	  .92.	  	  
Three	   independent	   reviewers	   rated	   the	   intensity	   of	   each	   script.	   The	   intensity	   differed	  
significantly	  between	  conditions	  F(1.73,	  119,60)	  =	  5448,09,	  p	  <	  .001.	  Contrasts	  showed	  highly	  significant	  
SUD	  characteristics	  (n=74)	   	  
Primary	  substance	  (%)	   	  
	  	  Alcohol	   54.1	  
	  	  Benzodiazepines	   1.4	  
	  	  Heroin	  	   13.5	  
	  	  Cocaine	   14.9	  
	  	  Cannabis	   10.8	  
	  	  Speed	  (amphetamines)	   2.7	  
	  	  Polydrug	  use	   2.7	  
Craving	  last	  month	  (%)	   	  
	  	  (almost)	  never	   35.1	  
	  	  Sometimes	   32.4	  
	  	  Regularly	   20.3	  
	  	  Often	   8.1	  
	  	  (almost)	  all	  the	  time	   4.1	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differences	  between	  neutral	  and	  stress	  cue	  intensity	  (F(1,	  69)	  =	  7478.73,	  p	  <	  .001),	  between	  neutral	  and	  
trauma	  cue	  intensity	  (F(1,	  69)	  =	  13239.10,	  p	  <	  .001),	  and	  between	  stress	  and	  trauma	  cue	  intensity	  (F(1,	  
69)	  =	  94.33,	  p	  <	  .001).	  Table	  2	  displays	  the	  means	  for	  vividness	  of	  imagery	  and	  rated	  intensity.	  
	  












There	  was	  a	  significant	  relationship	  between	  the	  baseline	  measures	  of	  tension	  in	  the	  stress	  and	  trauma	  
condition	  and	  PTSD	  severity	  (stress	  cue	  exposure:	  r	  =	  .31,	  p	  =	  .01;	  trauma	  cue	  exposure:	  r	  =	  .30,	  p	  =	  .01).	  
There	  was	  no	  significant	  correlation	  between	  tension	  before	  neutral	  cue	  exposure	  and	  PTSD	  severity	  (r	  =	  
.21,	  p	  =	  .07).	  
	  
Effect	  cue	  exposure	  on	  tension	  
The	   2	   (time	   of	   measurement)	   x	   3	   (type	   of	   cue)	   repeated	   measures	   ANCOVA	   with	   PTSD	   severity	   as	  
covariate,	   showed	  no	  main	  effects	   for	   type	  of	  cue	  or	   time	  of	  measurement	  on	   tension.	  We	  did	   find	  a	  
significant	  main	   effect	   of	   PTSD	   severity	   on	   tension,	   F(1,55)	   =	   11.01,	  p	  =	   .002,	   indicating	   that	   patients	  
scoring	  high	  on	  PTSD	  in	  general	  experienced	  significantly	  more	  tension.	  There	  were	  no	  other	  significant	  
effects.	  Table	  3	  displays	  the	  means	  and	  standard	  deviations	  of	  the	  tension	  ratings.	  
	  
Mean	  imagination	  (SD)	   	   n	  
	  	  Neutral	  cue	   7.73	  (2.41)	   73	  
	  	  Stress	  cue	   8.67	  (1.70)	   74	  
	  	  Trauma	  cue	   8.65	  (1.82)	   74	  
Mean	  intensity	  ratings	  (SD)	   	   	  
	  	  Neutral	  cue	   0.10	  (.10)	   3	  
	  	  Stress	  cue	   7.26	  (.69)	   3	  
	  	  Trauma	  cue	   8.19	  (.62)	   3	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Table	  3.	  Subjective	  tension.	  
Neutral	  Baseline	   After	  neutral	  
cue	  	  
Stress	  Baseline	   After	  stress	  cue	   Trauma	  Baseline	   After	  trauma	  
cue	  
3.14	  (2.68)	   1.52	  (1.87)	   2.11	  (2.32)	   4.36	  (3.11)	   2.48	  (2.60)	   5.45	  (2.97)	  




















.97	  (1.81)	   .69	  (1.49)	   .74	  (1.58)	   1.29	  (2.14)	   .79	  (1.74)	   1.79	  (2.59)	  
	  
Baseline	  craving	  	  
Table	   4	   displays	   all	   craving	   ratings.	   There	   was	   a	   significant	   relationship	   between	   all	   three	   baseline	  
measures	  of	  craving	  and	  PTSD	  severity,	  indicating	  that	  patients	  with	  higher	  severity	  of	  PTSD	  craved	  more	  
in	   general	   (neutral	   cue	   exposure:	   r	   =	   .29,	   p	   =	   .01;	   stress	   cue	   exposure:	   r	   =	   .27,	   p	   =	   .02;	   trauma	   cue	  
exposure:	  r	  =	  .38,	  p	  ≤	  .001).	  
	  
Effect	  cue	  exposure	  on	  craving	  
The	   2	   (time	   of	   measurement)	   x	   3	   (type	   of	   cue)	   repeated	   measures	   ANCOVA	   with	   PTSD	   severity	   as	  
covariate	  showed	  no	  significant	  main	  effects	  for	  type	  of	  cue	  or	  time	  of	  measurement	  on	  craving	  (resp.	  
F(2,71)	  =	  1.54,	  p	  =	  .22,	  and	  F(1,72)	  =	  .53,	  p	  =	  .47).	  There	  was,	  however,	  a	  significant	  main	  effect	  of	  PTSD	  
severity	  on	  craving,	  F(1,72)	  =	  15.11,	  p	  <	   .001,	   indicating	   that	  patients	   scoring	  high	  on	  PTSD	   in	  general	  
craved	  significantly	  more.	  There	  was	  also	  a	  significant	  three-­‐way	  interaction	  effect	  between	  type	  of	  cue	  
(neutral,	   stress,	   trauma),	   time	  of	  measurement	   (before	  vs.	  after	   cue	  exposure)	  and	  PTSD	  severity,	  F	   =	  
3.66,	  p	  =	  .03.	  This	  indicates	  that	  PTSD	  severity	  had	  different	  effects	  on	  craving	  depending	  on	  which	  cue	  
was	  presented	   and	  whether	   craving	  was	  measured	  before	  or	   after	   cue	  exposure.	   To	  break	  down	   this	  
interaction	  effect,	   contrasts	  were	  performed	   comparing	   stress	   and	   trauma	   cue	   reactivity	  with	  neutral	  
cue	   reactivity	   and	   comparing	   craving	   after	   and	   before	   cue	   exposure.	   These	   revealed	   significant	  
interactions	  between	  time	  and	  cue	  type	  when	  stress	  cue	  reactivity	  is	  compared	  to	  neutral	  cue	  reactivity	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(F(1,72)	  =	  5.38,	  p	  =	  .02)	  and	  when	  trauma	  cue	  reactivity	  is	  compared	  to	  neutral	  cue	  reactivity	  (F(1,72)	  =	  
4.35,	  p	  =	   .04):	  after	  stress	  and	  trauma	  exposure,	  craving	   is	  higher	   than	  after	  neutral	  exposure.	  Finally,	  
further	   analyses	   showed	   that	   there	  was	  no	   significant	   interaction	  between	  PTSD	   severity	   and	   time	  of	  
measurement	  when	  patients	  were	  exposed	  to	  the	  neutral	  script	   (F(1,72)	  =	  1.81,	  p	  =	   .18),	  but	  that	  this	  
interaction	  effect	  was	  significant	  for	  the	  stress	  script	  (F(1,72)	  =	  5.20,	  p	  =	  .02)	  and	  for	  the	  trauma	  script	  
(F(1,72)	  =	  4.14,	  p	  =	  .04),	   indicating	  that	  patients	  with	  high	  PTSD	  severity	  craved	  more	  after	  both	  stress	  
and	  trauma	  exposure	  compared	  to	  neutral	  exposure.	  	  
	   To	  visualize	  the	  craving	  responses	  we	  performed	  a	  median	  split	  based	  on	  PTSD	  severity	  (median	  
=	  49.5),	  showing	  patients	  scoring	  lower	  and	  higher	  on	  PTSD	  (see	  Figure	  1).	  	  
	  
	  
Figure	  1.	  Effect	  of	  the	  conditions	  on	  craving	  (mean	  difference	  scores	  with	  SEM)	  for	  people	  high	  and	  low	  
in	  PTSD.	  
	  
Correlations	  between	  tension	  and	  craving	  responses	  
Table	  5	  displays	  the	  correlations	  between	  reported	  tension	  and	  reported	  craving	  for	  each	  cue	  (neutral,	  
stress,	  and	  trauma).	  
	  


















Table	  5.	  Correlations	  between	  tension	  and	  craving	  responses.	  




















r	  =	  .41	  
p	  =	  .000	  
n	  =	  74	  
r	  =	  .45	  
p	  =	  .000	  
n	  =	  74	  




r	  =	  .45	  
p	  =	  .000	  
n	  =	  58	  
r	  =	  .58	  
p	  =	  .000	  
n	  =	  58	  




n/a	   n/a	   r	  =	  .58	  
p	  =	  .000	  
n	  =	  74	  
r	  =	  .56	  
p	  =	  .000	  
n	  =	  74	  
n/a	   n/a	  
Tension	  
after	  stress	  
n/a	   n/a	   r	  =	  .30	  
p	  =	  .021	  
n	  =	  59	  
r	  =	  .39	  
p	  =	  .002	  
n	  =	  59	  




n/a	   n/a	   n/a	   n/a	   r	  =	  .49	  
p	  =	  .000	  
n	  =	  74	  
r	  =	  .43	  
p	  =	  .000	  




n/a	   n/a	   n/a	   n/a	   r	  =	  .10	  
p	  =	  .427	  
n	  =	  59	  
r	  =	  .27	  
p	  =	  .038	  
n	  =	  59	  
	  
Discussion	  
The	  aim	  of	  the	  current	  study	  was	  to	  gain	  more	  understanding	  about	  the	  link	  between	  trauma	  exposure,	  
stress	   exposure	   and	   substance	   craving.	   Patients	  with	   SUD	  who	  experienced	   trauma	   in	   their	   life,	  were	  
exposed	  to	  three	  different	  scripts	  (neutral,	  stress	  and	  trauma)	  on	  different	  assessment	  days.	  Craving	  and	  
tension	  were	  measured	  before	  and	  after	  cue	  exposure.	  PTSD	  severity	  was	  included	  as	  a	  covariate	  in	  the	  
analysis.	  We	  expected	  that	  high	  PTSD	  severity	  leads	  to	  more	  craving	  and	  tension	  after	  stress	  and	  trauma	  
cue	  exposure,	  with	  highest	  craving	  after	  trauma	  cue	  exposure.	  	  
The	  results	  showed	  that	  patients	  scoring	  high	  on	  PTSD	  craved	  more	  throughout	  the	  experiment.	  So,	  
even	   before	   any	   kind	   of	   induction	   patients	   with	   high	   PTSD	   severity	   craved	   significantly	   more	   than	  
patients	   with	   less	   PTSD	   severity.	   As	   craving	   is	   an	   important	   predictor	   for	   relapse	   (Back	   et	   al.,	   2010;	  
	  50	  
	  
Schneekloth	  et	  al.,	  2012),	  this	  suggests	  that	  SUD	  patients	  with	  high	  PTSD	  severity	  belong	  to	  an	  especially	  
vulnerable	   subgroup	  of	  patients.	   This	  main	  effect	  of	  PTSD	   severity	  on	   craving	   is	  not	   consistent	  with	  a	  
prior	   study	   in	   which	   cued	   craving	   was	   measured	   in	   a	   sample	   with	   different	   levels	   of	   PTSD	   severity	  
(Saladin	   et	   al.,	   2003).	   They	   only	   found	   an	   interaction	   effect	   between	   PTSD	   severity	   and	   trauma	   cued	  
craving.	   This	   difference	   might	   be	   explained	   by	   the	   fact	   that	   we	   did	   our	   measurements	   on	   different	  
assessment	  days	  while	  patients	  were	  unaware	  of	  the	  type	  of	  cue	  to	  which	  they	  would	  be	  exposed	  that	  
day.	   This	   uncertainty	   might	   have	   induced	   feelings	   of	   craving.	   Also,	   Brady	   (2003)	   found	   no	   group	  
differences	  (Alcohol	  +	  PTSD	  vs.	  Alcohol	  only)	  in	  craving	  after	  patients	  were	  subjected	  to	  a	  Cold	  Pressor	  
Task,	  though	  this	  might	  be	  attributed	  to	  the	  use	  of	  a	  general	  stress	  test	  in	  Brady’s	  study	  while	  we	  used	  
personalized	  scripts.	  
Next,	   not	   only	  was	   there	  more	   craving	   in	   patients	  with	   high	   PTSD	   scores,	   our	   study	   showed	   that	  
these	  patients	  also	  reported	  more	  tension	  in	  all	  conditions	  of	  the	  experiment.	  This	  is	  not	  very	  surprising	  
since	  PTSD	  is	  characterized	  by	  the	  experience	  of	  negative	  mood	  and	  increased	  arousal	  (5th	  ed.;	  DSM-­‐5	  
APA,	   2013)	   and	   our	   results	   thus	   merely	   reflect	   the	   symptomatology	   of	   PTSD.	   It	   is	   possible	   that	   this	  
increased	   level	   of	   tension	   precedes	   the	   craving	   because	   SUD	   patients	   with	   high	   PTSD	   severity	   have	  
limited	   coping	   mechanisms	   available	   besides	   using	   substances	   to	   dampen	   their	   negative	   affect.	   Our	  
correlation	  analysis	  partly	  confirms	  this	  hypothesis.	  This	  is	  in	  accordance	  with	  previous	  studies	  (Gielen	  et	  
al.,	   2015a;	   Gielen,	   Krumeich,	   Tekelenburg,	   Nederkoorn,	   &	   Havermans,	   2015b;	   Ouimette,	   Finney	   &,	  
Moos,	  1999;	  Staiger,	  Melville,	  Hides,	  Kambouropoulos	  &,	  Lubman,	  2009).	  Other	  cue	  reactivity	  studies	  in	  
which	  tension	  was	  measured	  as	  a	  dependent	  variable	  found	  more	  specific	  cue	  reactivity	  results.	  Coffey	  
(2006,	  2010)	  and	  Nosen	  (2014)	  only	  found	  increased	  distress	  levels	  after	  trauma	  cue	  exposure	  but	  not	  
after	  the	  neutral	  cue	  exposure.	  In	  Brady’s	  study	  (2006)	  no	  group	  differences	  were	  found	  with	  regard	  to	  
tension	  or	  distress.	  Again,	  the	  different	  experimental	  procedure	  might	  explain	  these	  different	  outcomes.	  
More	  interestingly,	  besides	  the	  main	  effects	  of	  PTSD	  severity,	  a	  significant	  three-­‐way	  interaction	  was	  
detected.	   Patients	   with	   high	   levels	   of	   PTSD	   craved	  more	   after	   exposure	   to	   both	   the	   trauma	   and	   the	  
stress	  cue,	  compared	  to	   the	  neutral	  cue.	  This	   finding	  was	  specific	   for	  craving,	  no	  such	   interaction	  was	  
found	   for	   tension.	  Not	   only	   exposure	   to	   traumatic	   triggers,	   but	   also	  more	   general	   stress	   cues	   appear	  
especially	  risky	  for	  relapse	  in	  patients	  with	  high	  PTSD	  scores.	  	  
Finally,	  we	   found	  that	  patients	   scoring	  high	  on	  PTSD	  also	  craved	  significantly	  more	   than	   low	  PTSD	  
scorers	   after	   being	   exposed	   to	   a	   personalized	   stress	   script.	   As	   to	   our	   knowledge,	   previous	   SUD/PTSD	  
studies	   never	   included	   a	   personalized	   stress	   cue	   in	   the	   paradigm.	   The	   finding	  means	   that	   SUD/PTSD	  
patients	  are	  more	  vulnerable	  for	  craving,	  and	  possibly	  relapse	  after	  stress	   induction	  than	  SUD	  patients	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with	  less	  PTSD	  severity.	  It	  is	  likely	  that	  patients	  who	  suffered	  from	  a	  past	  trauma	  and	  who	  learned	  that	  
substance	  use	  can	  ease	  the	  pain	  never	  really	  learned	  to	  cope	  in	  a	  different	  way	  with	  negative	  feelings	  or	  
cognitions.	   If	   this	   is	   indeed	   the	   case,	   this	   has	   important	   treatment	   implications.	   SUD/PTSD	   patients	  
should	  receive	  extensive	  skill	  training,	  probably	  even	  before	  a	  past-­‐focused	  therapy	  takes	  place.	  This	  is	  
exactly	   what	   is	   suggested	   in	   a	   phase-­‐oriented	   treatment	   for	   complex	   PTSD	   (Cloitre,	   Courtois,	  
Charuvastra,	  Carapezza,	  Stolbach,	  &	  Green,	  2011).	  	  
We	  acknowledge	  that	  the	  cue	  elicited	  craving,	  though	  it	  was	  significant,	  was	  still	  limited.	  This	  is	  not	  a	  
unique	   phenomenon;	   other	   researches	  who	  measured	   craving	   in	   the	   lab	   observed	   small	   increases	   in	  
craving	   as	   well	   (Avants,	   Margolin,	   Kosten,	   &	   Cooney,	   1995;	   Coffey,	   Saladin,	   Libet,	   Drobes,	   Brady,	   &	  
Dansky,	  1999;	  Coffey	  et	  al.,	  2006).	  It	  might	  be	  that	  stronger	  craving	  could	  be	  elicited	  with	  the	  addition	  of	  
an	  in	  vivo	  drug	  cue	  or	  in	  the	  drug	  use	  context	  (Coffey	  et	  al.,	  2002;	  2006;	  2010;	  Nosen	  et	  al.,	  2012;	  2014;	  
Saladin	  et	  al.,	  2003).	  Nonetheless,	  it	  is	  important	  to	  notice	  that	  patients	  in	  our	  study	  were	  abstinent	  for	  
some	  time	  (mean	  abstinence	  was	  around	  3	  months)	  and	  that	  the	  majority	  of	  our	  participants	  denied	  any	  
craving	   in	   the	   last	  month.	  With	   these	   facts	   in	  mind,	   it	   seems	   remarkable	   and	   clinically	   relevant	   that	  
relatively	  stable	  SUD	  patients	  with	  high	  PTSD	  scores	  still	  report	  an	  increase	  in	  craving	  after	  exposure	  to	  
stress	  or	  trauma	  cues.	  	  
	   In	  sum,	  the	  results	  from	  the	  current	  study	  show	  that	  SUD	  patients	  with	  high	  PTSD	  severity	  have	  
an	  overall	  higher	  tendency	  to	  crave	  and	  to	  feel	  tensed,	  even	  in	  neutral	  situations.	  Furthermore,	  we	  
demonstrated	  that	  SUD/PTSD	  patients	  crave	  not	  only	  significantly	  more	  after	  being	  exposed	  to	  a	  
traumatic	  trigger,	  which	  has	  been	  found	  before	  (Coffey	  et	  al.,	  2002;	  2010;	  Nosen	  et	  al.,	  2012;	  Saladin	  et	  
al.,	  2003),	  but	  also	  after	  more	  general	  stress	  cues,	  unrelated	  to	  the	  trauma.	  The	  increased	  craving	  after	  
trauma	  cue	  exposure	  is	  a	  replication	  of	  previous	  research	  by	  Coffey	  (2002,	  2010),	  Saladin	  (2003),	  and	  
Nosen	  (2012)	  and	  our	  study	  adds	  that	  this	  effect	  endures	  even	  in	  a	  more	  heterogeneous	  sample	  and	  
even	  without	  exposing	  patients	  to	  an	  in	  vivo	  drug	  cue.	  When	  translating	  the	  results	  to	  the	  life	  of	  
SUD/PTSD	  patients,	  this	  finding	  means	  that	  a	  significant	  increase	  in	  craving	  can	  occur	  just	  by	  being	  
triggered	  to	  a	  past	  trauma	  or	  general	  stress	  cues,	  even	  in	  the	  absence	  of	  drugs	  or	  alcohol.	  These	  results	  
suggest	  how	  vulnerable	  SUD/PTSD	  patients	  are	  for	  relapse	  when	  PTSD	  is	  left	  untreated.	  Our	  findings	  
thus	  suggest	  the	  importance	  of	  integrating	  PTSD	  treatment	  and	  SUD	  treatment.	  Moreover,	  it	  adds	  up	  to	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Nine	  Inch	  Nails	  -­‐	  Hurt	  	  
I	  hurt	  myself	  today	  	  
To	  see	  if	  I	  still	  feel	  	  
I	  focus	  on	  the	  pain	  	  
The	  only	  thing	  that's	  real	  	  
The	  needle	  tears	  a	  hole	  
The	  old	  familiar	  sting	  	  
Try	  to	  kill	  it	  all	  away	  	  




Healthcare	   providers	   working	   in	   addiction	   facilities	   do	   not	   often	   implement	   integrated	   treatment	   of	  
comorbid	  substance	  use	  disorder	  (SUD)	  and	  posttraumatic	  stress	  disorder	  (PTSD)	  while	  there	  is	  empirical	  
evidence	  to	  do	  so.	  This	  study	  aims	  to	  get	  insight	  into	  the	  views	  of	  clinicians	  with	  regard	  to	  the	  diagnosis	  
and	  treatment	  of	  PTSD	  in	  SUD	  patients.	  A	  qualitative	  research	  method	  was	  chosen.	  Fourteen	  treatment	  
staff	   members	   of	   different	   wards	   of	   an	   addiction	   care	   facility	   were	   interviewed	   by	   an	   independent	  
interviewer.	   Despite	   acknowledging	   adverse	   consequences	   of	   trauma	   exposure	   on	   SUD,	   severe	  
underdiagnosis	   of	   PTSD	   was	   mentioned	   and	   treatment	   of	   PTSD	   during	   SUD	   treatment	   was	   not	  
supported.	   Obstacles	   related	   to	   the	   underestimation	   of	   PTSD	   among	   SUD	   patients	   and	   to	   the	  
perceptions	   of	   SUD	   clinicians	   concerning	   the	   treatment	   of	   comorbid	   SUD/PTSD	   were	   reported.	   It	   is	  
concluded	   that	   SUD	   treatment	   centers	   should	   train	   their	   clinicians	   to	   enable	   them	   to	   provide	   for	  





Post-­‐Traumatic	   Stress	   Disorder	   (PTSD)	   is	   a	   frequent	   co-­‐occurring	   disorder	   in	   patients	   who	   seek	  
treatment	   for	   their	   Substance	   Use	   Disorder	   (SUD).	   Prevalence	   rates	   around	   35%	   are	   mentioned	   in	  
previous	  studies	  (Bonin,	  Norton,	  Asmundson,	  Dicurzio	  &	  Pidlubney,	  2000;	  Driessen	  et	  al.,	  2008;	  Gielen,	  
Havermans,	  Tekelenburg,	  &	  Jansen,	  2012,	  Ouimette,	  Coolhart,	  Funderburk,	  Wade	  &	  Brown,	  2007;	  Read,	  
Brown	  &	  Kahler,	   2004;	  Reynolds,	  Mezey,	  Chapman,	  Wheeler,	  Drummond	  &	  Baldacchino,	  2005),	  while	  
trauma	  exposure	  was	   found	   to	  be	  prevalent	   in	  89	   -­‐	  97.4%	  of	  SUD	  patients	   (Dansky,	   Saladin,	  Coffey	  &	  
Brady,	   1997;	   Farley,	  Golding,	   Young,	  Mulligan	  &	  Minkoff,	   2004;	  Gielen	  et	   al.,	   2012;	  Read	  et	   al.,	   2004;	  
Reynolds	   et	   al.,	   2005).	   SUD	  patients	  with	   PTSD	  often	  use	   substances	   to	   deal	  with	   the	   emotional	   pain	  
caused	   by	   their	   trauma	   (Khantzian,	   1997;	   Leeies,	   Pagura,	   Sareen,	   &	   Bolton,	   2010;	   Ouimette,	   Read,	  
Wade,	   &	   Tirone,	   2010).	   Treatment	   prognosis	   is	   relatively	   poor	   in	   these	   patients	   (Najt,	   Fusar-­‐Poli,	   &	  
Brambilla,	   2010;	   Read	   et	   al.,	   2004).	   In	   comparison	   with	   SUD	   patients	   without	   PTSD,	   the	   comorbid	  
diagnosis	   of	   SUD/PTSD	   is	   related	  with	   a	   higher	   percentage	   of	   overdoses,	   suicide	   attempts	   and	  more	  
treatment	  days	  (Mills,	  Teesson,	  Ross,	  Darke,	  &	  Shanahan,	  2005).	  
Over	   the	   last	   decade	   a	   large	   body	   of	   research	   on	   the	   treatment	   of	   SUD	   patients	   with	   PTSD	   has	  
accumulated	  (e.g.,	  Henslee	  &	  Coffey,	  2010;	  Hien,	  Cohen,	  Miele,	  Litt,	  &	  Capstick,	  2004;	  Najavits,	  Gallop,	  &	  
Weiss,	  2006;	  Mills	  et	  al.,	  2012).	  Integrated	  treatment	  focusing	  on	  both	  disorders	  simultaneously	  seems	  
to	  provide	  a	  better	  outcome	  than	  treatment	  that	  focuses	  on	  one	  disorder	  at	  a	  time	  (Dass-­‐Brailsford	  &	  
Myrick,	  2010;	  Mills	  et	  al.,	  2012;	  Zatzick	  et	  al.,	  2004).	  In	  addition	  to	  the	  importance	  to	  treat	  SUD	  and	  PTSD	  
simultaneously,	  previous	  research	  also	  documents	  the	  need	  for	  structural	  assessment	  of	  PTSD	  in	  every	  
new	  SUD	  patient	  who	  enters	  treatment	  (Back,	  Waldrop,	  Brady	  &	  Hien,	  2006;	  Gielen	  et	  al.,	  2012;	  Ruzek,	  
Polusny	  &	  Abueg,	  1998).	  Guidelines,	  focusing	  on	  the	  PTSD/	  SUD	  comorbidity	  and	  aimed	  to	  improve	  the	  
quality	  of	  healthcare,	  have	  been	  developed	   to	   inform	  clinicians	  about	   these	   research	   findings,	   in	   that	  
way	  bridging	  the	  gap	  between	  theory	  and	  practice	  (Kivlahan	  &	  Kaysen,	  2012;	  Ruzek,	  Polusny,	  &	  Abueg,	  
1998).	  These	  guidelines	  were	  also	  recently	  developed	  in	  the	  Netherlands	  (Snoek,	  Wits,	  Meulders	  &	  van	  
de	  Mheen,	  2012).	  	  
Despite	   the	   bulk	   of	   evidence	   and	   the	   development	   of	   guidelines,	   relatively	   few	   substance	  
dependence	   treatment	   centres	  have	   implemented	  an	   integrated	   treatment	  approach,	   leaving	  PTSD	   in	  
most	  cases	  untreated	  during	  SUD	  treatment	  (Glover-­‐Graf	  &	  Janikowski,	  2001;	  Najavits,	  Sullivan,	  Schmitz,	  
Weiss	  &	   Lee,	   2004;	   Young,	   Rosen	  &	   Finney,	   2005).	   Furthermore,	   assessment	   for	   PTSD	   does	   not	   take	  
place	  in	  every	  new	  patient	  and	  underdiagnosis	  is	  fairly	  common	  (Gielen	  et	  al.,	  2012;	  Young	  et	  al.,	  2005).	  
Although	  it	  is	  not	  clear	  what	  the	  specific	  reasons	  are	  for	  this	  contradiction	  between	  theory	  and	  practice,	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we	   do	   know	   that,	   in	   general,	   translation	   of	   research	   into	   practice	   is	   difficult	   (Forsner,	   Hansson,	  
Brommels,	  Wistedt	  &	  Forsell,	  2010;	  Rothrauff	  &	  Eby,	  2011).	  	  
One	   of	   the	   reasons	   why	   implementation	   of	   research	   findings	   is	   difficult	   to	   accomplish	   is	   that	  
individual	  clinicians	  hold	  different	  opinions	  about	  how	  to	  manage	   their	  patients	   (Leentjens	  &	  Burgers,	  
2008;	   Sorensen	   &	   Kosten,	   2011).	   This	   explanation	   is	   related	   to	   Arthur	   Kleinman’s	   theory	   (Kleinman,	  
1980).	  According	   to	  Kleinman’s	   explanatory	  model	   (EM)	   approach,	   every	   individual,	   professionals	   and	  
patients	  alike,	  holds	  different	  beliefs	  about	  a	  particular	  illness.	  These	  beliefs,	  or	  “EMs”	  are	  shaped	  by	  an	  
individual’s	   beliefs	   and	   impact	   how	   this	   individual	   applies	   these	   beliefs	   in	   particular	   illness	   episodes.	  
Kleinman	   (1980)	   identified	   5	   constructs	   that	   determine	   how	   an	   individual	   defines	   and	   approaches	   a	  
(health)	  problem	  and	  that	  constitute	  an	  individual’s	  EM.	  These	  constructs	  include:	  (1)	  notions	  about	  the	  
aetiology	   of	   the	   illness,	   (2)	   ideas	   about	   symptom	   onset,	   (3)	   views	   about	   the	   pathophysiology	   of	   the	  
illness,	  (4)	  perceptions	  about	  the	  course	  of	  illness	  and	  (5)	  the	  recommended	  treatment.	  Kleinman	  states	  
that	  how	  an	   individual	  defines	  a	  certain	   illness	   influences	  how	  this	   illness	  will	  be	  dealt	  with	   (i.e.	  what	  
kind	  of	  treatment	  one	  thinks	  appropriate	  and	  by	  whom	  and	  what	  kind	  of	  assessment	  criteria	  one	  applies	  
to	   these	   actions,	   including	   notions	   of	   what	   can	   be	   expected	   of	   professionals	   in	   terms	   of	   practices,	  
attitude	   and	   responsibilities).	   Kleinman	   focuses	   on	   the	   distinction	   between	   EMs	   of	   professionals	   and	  
EMs	  of	  patients	  and	  how	  the	  discrepant	  beliefs	  influence	  the	  treatment	  of	  a	  certain	  disease.	  His	  model	  
can	   also	   be	   used	   to	   study	   the	   perception	   of	   professionals	   of	   a	   particular	   health	   problem	   such	   as	  
SUD/PTSD,	   their	   attitude	   regarding	   existing	   or	   new	   treatment	   protocols	   and	   procedures,	   the	   kind	   of	  
criteria	   they	  use	   to	  assess	  effectiveness	  and	  quality	  of	  existing	  or	  new	  practices	  and	  procedures,	   their	  
actual	  evaluation	  of	  procedures	  and	  protocols	  and	  the	  preparedness	  to	  adopt	  new	  treatment	  regimes.	  	  
This	   article	   focuses	   on	   clinicians’	   EMs	   of	   comorbid	   SUD	   and	   PTSD.	   To	   understand	  why	   substance	  
abuse	  clinicians	  do	  not	  implement	  evidence	  based	  integrated	  treatment	  for	  patients	  with	  SUD/PTSD	  it	  is	  
useful	   to	   get	   insight	   into	   their	   views.	   The	   goal	   of	   this	   study	   is	   to	   explore	   why	   healthcare	   providers	  
working	   in	   the	   addiction	   field	   do	  not	   offer	   integrated	   treatment	   for	   SUD/PTSD.	  We	  also	   aim	  at	   being	  
able	   to	   formulate	   implementation	   guidelines	   for	   addiction	   facilities.	   Since	   this	   is	   a	   field	   study	   of	  
clinician’s	  perceptions	  a	  qualitative	  research	  method	  is	  the	  most	  suitable.	  The	  EM	  approach	  will	  be	  used	  
as	  a	  tool	  to	  identify	  points	  of	  improvement.	  	  
To	  our	  knowledge,	  this	   is	  the	  first	  qualitative	  study	  that	  explores	  the	  perceptions	  of	  SUD	  clinicians	  
about	  how	  to	  treat	  patients	  with	  comorbid	  SUD/PTSD	  patients.	  Some	  researchers	  have	  previously	  used	  
surveys	   with	   the	   same	   goal.	   Glover-­‐Graf	   and	   Janikowski	   (2001,	   2003)	   used	   the	   SACSCIH	   to	   survey	  
substance	   abuse	   clinicians	   who	   work	   with	   victims	   of	   incest.	   Najavits,	   Norman,	   Kivlahan	   and	   Kosten	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(2010)	  and	  Young	  et	  al.	   (2005)	  used	  surveys	  (resp.	  the	  VA	  version	  of	  the	  Clinician	  Survey	  on	  PTSD	  and	  
Substance	  Abuse	  and	  a	  survey	  developed	  by	  the	  authors)	  in	  VA	  (Veterans	  Affairs)	  settings	  to	  learn	  more	  
about	   the	   screening,	   treatment	   and	   referral	   of	   SUD/PTSD	   patients.	   While	   these	   studies	   focused	   on	  
different	   subjects	   (clinicians	   in	   VA	   settings	   and	   SUD	   clinicians	  working	  with	   victims	   of	   incest),	   in	   two	  
other	  studies	  clinicians	  were	  surveyed	  about	  the	  treatment	  of	  SUD/PTSD.	  Najavits	  (2002)	  surveyed	  147	  
clinicians	  using	  the	  Clinical	  Survey	  on	  PTSD	  and	  Substance	  Abuse	  and	  concluded	  that	  the	  treatment	  of	  
SUD/PTSD	  was	  rated	  as	  more	  difficult	  to	  treat	  than	  either	  disorder	  alone.	   Interestingly,	  she	  also	  found	  
that	   clinicians	   perceived	   more	   gratification	   than	   difficulty	   in	   working	   with	   this	   subgroup	   of	   patients.	  
Back,	  Waldrop	   and	  Brady	   (2009)	   tested	   423	   clinicians	   using	   the	   same	   survey	   as	  Najavits	   (2002).	   They	  
found	   that	   the	   issue	  on	  when	  and	  how	  to	   integrate	   the	   treatment	  of	  SUD	  and	   the	   treatment	  of	  PTSD	  
was	  perceived	  as	  the	  most	  challenging.	  
In	  this	  exploratory	  study	  we	  made	  use	  of	  a	  topic	  list	  and	  specifically	  addressed	  the	  following	  themes:	  
assessment	  of	  trauma,	  diagnosis	  of	  PTSD	  and	  treatment	  of	  PTSD.	  By	  use	  of	  semi-­‐structured	  qualitative	  
interviews,	  clinicians	  were	  asked	  about	  these	  topics	   in	  order	  to	  gauge	  the	  clinician’s	  EM	  of	  SUD/PTSD.	  
We	  questioned	  the	  current	  procedures,	  the	  responsibilities	  and	  the	  possible	  obstacles.	  
	  
Methods	  
Design	  and	  justification	  
Since	   this	  study	  aimed	  to	  explore	   the	   individual	  perceptions	  of	  substance	  abuse	  therapists,	  we	  used	  a	  
qualitative	   research	   method.	   Semi-­‐structured	   in-­‐depth	   interviews	   with	   open-­‐ended	   questions	   were	  
used.	  This	  research	  method	  best	  fitted	  the	  current	  exploratory	  research	  questions.	  
	  
Data	  collection	  and	  sampling	  
The	   current	   research	   took	   place	   in	   the	   addiction	   care	   division	   of	   Mondriaan.	   Mondriaan	   is	   a	   large	  
institution	  with	   different	   certified	   treatment	   centres	   in	   the	  whole	   region	   of	   southern	   Limburg	   in	   the	  
southern	  part	  of	  the	  Netherlands	  (total	  population	  currently	  estimated	  at	  607000).	  One	  of	  these	  centres	  
is	  a	  large	  substance/behavioral	  dependence	  treatment	  facility.	  Staff	  members	  of	  different	  wards	  of	  this	  
facility	  were	  included	  in	  this	  study.	  A	  purposeful	  sampling	  strategy	  was	  used	  to	  achieve	  a	  representative	  
sample	   with	   work	   setting,	   position	   and	   years	   of	   experience	   as	   selection	   criteria.	   These	   criteria	   were	  
chosen	  because	  of	  their	  assumed	  influence	  on	  a	  clinician’s	  EM.	  A	  profile	   list	  of	  possible	  participants	   in	  
terms	  of	  these	  selection	  criteria	  was	  made,	  and	  each	  ward	  was	  contacted	  to	  find	  participants	  with	  the	  
desired	  profile.	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A	  total	  of	  20	  candidate	  participants	  received	  an	  email	  explaining	  the	  goals	  and	  procedure	  of	  the	  
study.	  Two	  persons	  declined	  participation	  due	  to	  time	  restrictions	  and	  3	  were	  non-­‐responders,	   leaving	  
15	  staff	  members	  who	  were	  eventually	   interviewed.	  Owing	  to	  technical	  problems	  one	   interview	  could	  
not	   be	   transcribed.	   Since	   a	   suitable	   saturation	   level	   was	   reached	   after	   14	   interviews	   non-­‐responders	  
were	  not	  replaced	  in	  this	  study.	  The	  characteristics	  of	  the	  sample	  are	  outlined	  in	  Table	  1.	  
	  
Table	  1.	  Sample	  characteristics.	  	  
	   Work	  setting	   Position	   Experience	  
1	   MC	  /FPAC	  /DDW	   Psychotherapist	   	   >	  5	  years	  
2	   CCW	   Family	  system	  therapist	   >	  5	  years	  
3	   FPAC	   Psychiatric	  nurse	   <	  5	  years	  
4	   IT	   Social	  worker	   <	  5	  years	  
5	   DDW/	  MC	   Psychologist	   <	  5	  years	  
6	   CCW/	  MC	   Psychiatrist	   >	  5	  years	  
7	   AT	   Psychologist	   >	  5	  years	  
8	   IT/	  AT	   Psychiatrist	   <	  5	  years	  
9	   CCW	   Psychiatric	  nurse	   <	  5	  years	  
10	   IT,	  AT	   	   Social	  worker	   >	  5	  years	  
11	   CCW	   Psychologist	   >	  5	  years	  
12	   AT	   Social	  worker	   >	  5	  years	  
13	   DDW	   Psychologist	   <	  5	  years	  
14	   CCW/	  MC	   Unit	  manager	   >	  5	  years	  
	   	   	   	  
Work	  setting:	  intake	  team	  (IT),	  clinical	  continuation	  ward	  (CCW),	  forensic	  psychiatric	  addiction	  care	  
(FPAC),	  double	  diagnosis	  ward	  (DDW),	  motivational	  centre	  (MC)	  and	  ambulatory	  treatment	  (AT).	  
	  
Procedure	  
From	  October	  2008	  until	  January	  2009,	  the	  selected	  staff	  members	  were	  interviewed.	  To	  prevent	  bias,	  
an	   independent	   trained	   interviewer	   questioned	   the	   participants	   (investigator	   triangulation).	   All	  
participants	   provided	   informed	   consent	   and	   agreed	   that	   the	   interviews	   would	   be	   recorded	   on	  
audiotape.	   After	   an	   ice-­‐breaker	   opening	   question	   (“Can	   you	   tell	   me	   something	   about	   the	   procedure	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when	   a	   new	   patient	   enters	   treatment?”)	   a	   topic-­‐list	   was	   used	   to	   cover	   the	   formulated	   themes:	  
assessment	   of	   trauma,	   diagnosis	   of	   PTSD	   and	   treatment	   of	   PTSD.	  We	  were	   interested	   in	   the	   current	  
procedure,	   the	   responsibilities	   and	   possible	   obstacles.	   The	   interviewer,	   who	   was	   familiar	   with	   the	  
organization,	   was	   instructed	   to	   ask	   open-­‐ended	   questions	   and	   to	   approach	   the	   respondents	   with	   a	  
natural	  curiosity	  and	  respect	  to	  ensure	  honest	  and	  frank	  answers.	  Further	  instructions	  included	  holding	  
a	  natural	  fluency	  in	  the	  questions	  and	  to	  communicate	  clearly.	  When	  a	  participant	  gave	  answers	  outside	  
the	  scope	  of	  the	   interview,	  the	   interviewer	  brought	  the	  conversation	  back	  to	  the	  subject.	  Examples	  of	  
questions	   were:	   (1)	   At	   what	   moment	   in	   the	   treatment	   process	   do	   you	   refer	   patients	   for	   PTSD	  
treatment?	  (2)	  What	  treatment	  do	  you	  judge	  to	  be	  ideal	  for	  patients	  with	  SUD	  and	  PTSD?,	  (3)	  What	  kind	  
of	  tools	  do	  you	  use	  to	  diagnose	  PTSD?	  or	  (4)	  Who	  is,	  according	  to	  you,	  responsible	  to	  question	  patients	  
about	  past	  trauma?	  
Frequent	   debriefing	   sessions	  were	  organized	   to	   optimize	   the	  quality	   of	   the	   interviews.	   To	   further	  
improve	   the	   reliability	   of	   the	   results	   we	   used	   member	   checking:	   the	   interviewer	   was	   instructed	   to	  
restate	  or	  summarize	  the	  answers	  of	  the	  respondent	  and	  then	  to	  question	  the	  respondent	  to	  determine	  
accuracy.	  Each	  interview	  lasted	  between	  15	  and	  30	  minutes.	  An	  independent	  coworker	  made	  transcripts	  
of	  each	  interview.	  
	  
Data	  analysis	  
The	   transcripts	  were	  analysed	  using	   content	   analysis.	  We	   chose	   to	   categorize	   the	  data	  with	   inductive	  
analysis.	   Pope,	   Ziebland	   and	  Mays	   (2000)	   describe	   this	   procedure	   in	   their	   article.	  We	  will	   now	   give	   a	  
detailed	  description	  of	  how	  we	  analysed	  our	  data.	  The	  transcriptions	  of	   the	   interviews	  were	  read	  and	  
first	  marginal	  notes	  were	  added.	  Initially,	  these	  were	  open	  codes.	  Whatever	  came	  up	  and	  suited	  the	  text	  
segment	  was	  written	  in	  the	  margin.	  When	  this	  was	  done	  for	  all	  the	  interviews,	  sensitizing	  concepts	  were	  
chosen,	  reflecting	  associations	  of	  marginal	  notes	  between	  the	  interviews.	  The	  following	  selective	  codes	  
were	   created:	   (1)	   definition	   of	   comorbid	   SUD/PTSD	   and	   assumptions	   about	   the	   underlying	   cause,	   (2)	  
suitable	   treatments,	   (3)	   responsibilities,	   (4)	   anamnestic	   phase,	   (5)	   diagnosis	   process	   and	   (6)	  
preconditions.	  	  
For	  each	  interview,	  a	  new	  document	  was	  composed	  with	  the	  six	  concepts	  as	  headings,	  and	  the	  
exact	  copies	  of	  the	  respective	  text	  fragments	  were	  copy-­‐pasted	  below.	  Summaries	  of	  the	  text	  fragments	  
were	  made,	  each	   fragment	   resulting	   in	  a	  one	  or	   two	  sentence	  summary.	  These	  summaries	  were	   then	  
combined	   for	   all	   interviews,	   resulting	   in	   six	   documents	   with	   all	   summaries	   for	   each	   theme.	   The	  
summaries	  were	  carefully	  checked	  for	  connections	  and	  a	  higher	   level	  of	  abstraction	  was	  reached	  with	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new	  categories.	  After	  that,	  a	  fluent	  text	  was	  written	  for	  each	  category	  with	  the	  short	  summaries	  serving	  
as	  illustrations.	  When	  this	  was	  done	  for	  the	  six	  concepts,	  a	  presentation	  was	  prepared	  and	  by	  doing	  so,	  
we	  came	  up	  with	  a	  new	  and	  clearer	  way	  to	  organize	  the	  results.	  	  
Concept	  3	   (responsibilities)	  and	  6	   (preconditions)	  could	  be	  merged	   in	   the	  other	  four	  concepts.	  
Furthermore,	   it	   became	   clear	   that,	   besides	   the	   first	   concept	   (definition	  of	   illness),	   a	   subdivision	   in	   (a)	  
‘current	  situation’,	  (b)	  ‘ideal/	  desired	  situation’	  and	  (c)	  ‘needs	  to	  achieve	  the	  desired	  goals’	  was	  suitable	  
for	  the	  remaining	  3	  themes.	  Finally,	  during	  analysis,	  subdivision	  (b)	  and	  (c)	  were	  combined	  since	  these	  
constructs	  were	  closely	  connected	  with	  each	  other.	  The	  final	  categories	  thus	  emerged	  as	  (1)	  definition	  
and	   aetiology	   of	   comorbid	   SUD/PTSD,	   (2)	   anamnestic	   phase,	   (3)	   diagnosis	   process	   and	   (4)	   suitable	  
treatments.	   These	   categories	   match	   with	   Kleinman’s	   EM	   constructs,	   with	   the	   first	   category	  
corresponding	   to	   Kleinman’s	   aetiology/	   course	   of	   illness/	   symptom	   onset	   and	   pathophysiology	   EM	  
constructs	  and	  categories	  2-­‐4	  belonging	  to	  Kleinman’s	  recommended	  treatment	  EM	  domain.	  	  
To	   account	   for	   a	   potential	   researcher	   effect,	   the	   transcribed	   interviews	   were	   independently	  
analysed	   by	   two	   different	   investigators	   (investigator	   triangulation).	   Besides	   the	   analysis	   which	   is	  
outlined	  in	  detail	  in	  this	  section,	  the	  fourth	  author	  analysed	  the	  information	  in	  another	  way:	  she	  sorted	  
the	   interviews	  by	   treatment	   facility	  and	  made	   four	   subcategories:	  diagnostics,	   treatment,	   referral	  and	  
other	   relevant	   notions.	   The	  main	   relevant	   topics	   for	   each	   facility	   were	   selected	   and	   final	   summaries	  
were	   compared	   between	   treatment	   units	   to	   identify	   issues	   that	   pertained	   to	   the	   entire	   organisation.	  
Although	  the	  two	  investigators	  used	  different	  analysing	  techniques,	  they	  did	  come	  up	  with	  comparable	  
results	  and	  conclusions	  (Smeets,	  2009).	  	  
	  
Results	  
Definition	  and	  aetiology	  of	  comorbid	  SUD/PTSD	  	  
When	  we	  asked	  the	  interviewees	  to	  estimate	  the	  prevalence	  of	  trauma	  exposure	  and	  PTSD	  in	  their	  SUD	  
caseload,	  the	  opinions	  differed	  quite	  a	  lot,	  with	  estimates	  of	  trauma	  exposure	  ranging	  between	  0.5	  and	  
100%.	  	  
‘Trauma,	  as	  in	  PTSD	  in	  the	  DSM,	  is	  rare.	  Maybe	  only	  1%	  or	  even	  less.’	  




Only	   one	   interviewee	   (a	   psychologist)	   mentioned	   an	   indirect	   estimate	   of	   PTSD	   in	   SUD	   patients	   and	  
stated	  to	  have	  never	  met	  a	  SUD	  patient	  with	  PTSD.	  No	  other	  interviewees	  reported	  specific	  estimations	  
about	  PTSD	  prevalence.	  
	  ‘I’ve	  never	  seen	  real	  PTSD.	  So,	  its	  prevalence	  is	  quite	  low.’	  	  
Holding	   the	   literature	   findings	   on	   prevalence	   rates	   of	   PTSD	   and	   trauma	   exposure	   in	   SUD	   patients	   in	  
mind,	   we	   can	   conclude	   that	   the	   estimated	   prevalence	   rates	   (despite	   the	   wide	   range)	   in	   this	   study	  
suggest	  a	  severe	  underestimation	  of	  the	  problem.	  	  
An	   important	   issue	   was	   how	   participants	   interpreted	   comorbid	   SUD/PTSD.	   Among	   the	  
interviewees	  many	  views	  came	  up.	  One	  of	  these	  corroborated	  the	  self-­‐medication	  theory.	  According	  to	  
the	   clinicians	   that	   referred	   to	   this	   theory	   traumatized	   individuals	   use	   substances	   to	   numb	   negative	  
feelings	   or	   to	   suppress	   intrusions.	   As	   a	   consequence,	   these	   patients	   never	   learn	   to	   handle	   their	  
problems	   and	   their	   symptoms	   become	   chronic.	   In	   this	   interpretation	   PTSD	   symptoms	   are,	   in	   other	  
words,	  understood	  as	  a	  mediating	  factor	  leading	  to	  craving	  and	  possible	  relapse.	  	  
Other	   interpretations	   were	   offered.	   One	   of	   these	   suggested	   that	   SUD	   patients	   often	   expose	  
themselves	  to	  dangerous	  or	  trauma-­‐prone	  environments	  (high	  risk	  hypothesis;	  Stewart	  &	  Conrod,	  2008).	  
It	   was	   assumed	   that	   when	   this	   trauma	   exposure	   happens	   after	   initial	   substance	   use,	   substance	   use	  
aggravates.	  
‘And,	   indeed,	   you	   meet	   severely	   addicted	   people	   who	   often	   expose	   themselves	   to	   dangerous	  
situations	  which	  increases	  the	  risk	  for	  trauma.’	  
Another	   interpretation	   referred	   to	   the	   neurobiological	   dimension	   of	   substance	   dependence.	   This	  
interpretation	   referred	   to	   a	   pre-­‐programmed	   biological	   vulnerability	   to	   develop	   a	   mental	   disorder	  
(diathesis	   stress	   model;	   Roberts,	   Moore	   &	   Beckham,	   2007).	   In	   interpretations	   referring	   to	   the	  
neurobiological	  model	   it	  was	   asserted	   that	   early	   trauma	   can	   disturb	   neurobiological	   systems	   (reward	  
system,	   neurotransmitters,	   and	   sleep	   pattern),	   leading	   to	   different	   effects	   after	   substance	   intake	   and	  
putting	  someone	  at	  risk	  for	  the	  development	  of	  a	  SUD	  (disturbed	  stress	  reaction	  hypothesis).	  	  
A	  final	   interpretation	  focused	  on	  an	  interaction	  between	  trauma,	  SUD	  and	  personality.	  Trauma	  
exposure,	  it	  was	  asserted,	  results	  in	  a	  change	  in	  personality	  or	  even	  in	  the	  development	  of	  a	  personality	  
disorder	   and	   this	   can	   make	   a	   person	   vulnerable	   for	   the	   development	   of	   an	   SUD.	   Personality	   in	   this	  
definition	  can	  be	  understood	  as	  a	  mediating	  factor.	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These	  definitions	  have	  in	  common	  a	  presumed	  relationship	  between	  PTSD	  and	  SUD.	  No	  matter	  
how	  they	  perceived	  the	  causality,	  participants	  agree	  that	   it	   is	   important	  to	  have	  knowledge	  about	  the	  
trauma	   as	   it	   can	   increase	   understanding	   the	   patient’s	   motivations	   contributing	   to	   his/her	   SUD.	   The	  
clinicians	  also	  agree	  that	  PTSD	  symptoms	  make	  it	  particularly	  difficult	  for	  the	  SUD	  patient	  to	  get	  clean	  or	  
sober.	  	  
The	   first	   main	   finding	   is	   that	   the	   majority	   of	   clinicians	   seem	   to	   have	   a	   reasonably	   good	  
understanding	   about	   the	   interrelatedness	   between	   SUD	   and	   PTSD.	   Although	   the	   clinicians	   severely	  
underestimate	  the	  prevalence	  of	  PTSD	  in	  their	  patients	  (Gielen	  et	  al.,	  2012;	  Reynolds	  et	  al.,	  2005),	  their	  
ideas	  about	  the	  aetiology,	  symptom	  onset,	  pathophysiology	  and	  course	  of	  illness	  are	  in	  accordance	  with	  
the	   literature	   (Langeland,	  2009;	  Roberts,	  Moore	  &	  Beckham,	  2007;	  Stewart	  &	  Conrod,	  2008).	  The	   fact	  
that	   clinicians	   refer	   to	   existing	   theoretical	  models,	   including	   the	   self-­‐medication	   theory,	   the	   high-­‐risk	  
hypothesis,	   the	   diathesis	   stress	   model	   and	   the	   disturbed	   stress	   reaction	   hypothesis,	   adds	   to	   the	  
conclusion	  that	  the	  interviewed	  clinicians	  are	  well	  aware	  of	  the	  negative	  influences	  of	  trauma	  exposure	  
and	  PTSD	  symptoms	  on	  SUD.	  One	  would	  thus	  expect	  that	  clinicians	  will	  take	  PTSD	  into	  account	  during	  
SUD	  treatment.	  But	  that	  is	  clearly	  not	  the	  case.	  Why	  not?	  
	  
Trauma	  anamnesis	  in	  SUD	  patients	  
Current	  situation	  
According	  to	  the	   interviewees	  there	   is	  a	  more	  or	   less	  standard	  screening	  at	   intake	  of	  any	  patient.	  This	  
screening	   interview	   typically	   includes	   questions	   about	   current	   symptomatology,	   family	   history,	   life	  
history,	   et	   cetera.	   Although	   trauma	   exposure	   is	   not	   specifically	   enquired	   in	   this	   anamnesis,	   it	   does,	  
however,	   often	   suggest	   itself	   to	   the	   attentive	   intaker.	   The	   clinicians	   notice	   that	   sometimes	   patients	  
spontaneously	   report	   trauma	   exposure.	   When	   trauma	   is	   considered	   by	   the	   clinician,	   it	   is	   done	   very	  
carefully	  and	  only	  superficially.	  	  
‘But	  to	  really	  ask	  deeper	  about	  the	  trauma	  is	  of	  course	  not	  done.’	  
When	   a	   patient	   enters	   treatment,	   clinicians	   usually	   rely	   on	   intake	   reports	   (and/or	   on	   existing	   patient	  
files)	  and	  do	  not	  ask	  about	  possible	  trauma.	  It	  is	  noted	  that	  patients	  who	  are	  known	  for	  years	  sometimes	  
have	   an	  unknown	   case-­‐history.	   Furthermore,	   the	   interviewed	   intake	   clinicians	   agreed	   that	   sometimes	  
they	  decide	  not	  to	  enquire	  about	  trauma	  because	  of	  the	  delicacy	  of	  the	  matter.	  The	  trauma	  anamnesis	  
is	  implicitly	  expected	  to	  be	  continued	  during	  later	  treatment.	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‘When	   I	   notice	   that	   they	   (the	  patients)	   find	   it	   (the	   trauma	  anamnesis)	   very	  hard,	   then	   I	   find	   it	  
quite	  a	  challenge	  to	  ask	  about	  trauma.	  They	  often	  don’t	  see	  me	  anymore	  after	  the	  intake.	  So,	  I	  
then	  decide	  not	  to	  go	  into	  it	  and	  leave	  it	  for	  the	  treatment	  phase.’	  	  	  
The	  opinions	  on	  the	  responsibility	  to	  ask	  about	  trauma	  history	  are	  mixed.	  The	  trauma	  anamnesis	  should	  
be	  done	  by	  the	  intake	  clinician,	  by	  the	  psychologist	  concerned,	  by	  the	  case	  manager	  or	  by	  the	  individual	  
mentor	  (in	  case	  of	  hospitalization).	  Another	  view	  is	  that	  anyone	  should	  do	  it.	  	  	  
With	  regard	  to	  the	  anamnesis	  of	  trauma	  exposure	  we	  can	  conclude	  that	  (1)	  trauma	  exposure	  is	  
not	  directly	  questioned	   in	  new	  patients	  and	   intake	  clinicians	  do	  not	  use	   specific	   validated	  assessment	  
tools,	  (2)	  clinicians	  seem	  to	  favour	  a	  very	  careful	  approach	  with	  regard	  to	  the	  trauma	  anamnesis,	  (3)	  in	  
case	  of	  already	  known	  patients	  clinicians	  rely	  on	  former	  and	  possibly	  outdated	  patient	  files	  and	  finally,	  
(4)	  the	  responsibility	  to	  enquire	  about	  trauma	  is	  indistinct.	  So	  it	  is	  clear	  that	  there	  is	  a	  lack	  of	  a	  protocol	  
concerning	   the	   trauma	   anamnesis	   in	   SUD	   patients.	   It	   is	   possible	   that	   the	   previously	   mentioned	  
underestimation	   of	   trauma	   exposure	   prevalence	   is	   related	   with	   this	   absence	   of	   trauma	   anamnesis	  
protocol.	  Since	  most	  clinicians	  believe	  that	  PTSD	   is	  not	  a	   frequent	  problem	  in	  SUD	  treatment,	   they	  do	  
not	  experience	  a	  need	  for	  a	  protocol	   to	  assess	   trauma.	  The	  cautious	  approach	  toward	  trauma,	  on	  the	  
other	   hand,	   may	   reflect	   the	   supposed	   association	   between	   talking	   about	   trauma,	   increase	   of	   PTSD	  
symptoms	   and	   consequently	   an	   increase	   in	   craving	   and	   possible	   relapse	   of	   addictive	   behavior.	   This	  
thinking	   contrasts	   clinical	   guidelines	   (e.g.,	   Gielen	   et	   al.,	   2012;	   Ruzek	   et	   al.,	   1998)	   and	   the	   scientific	  
literature.	  McHugo	  and	  colleagues	  (2005)	  interviewed	  over	  2700	  SUD	  patients	  with	  co-­‐occurring	  mental	  
disorders	  about	  how	  trauma	  assessment	  was	  tolerated.	  The	  results	  of	  McHugo’s	  study	  indicated	  that	  the	  
assessment	   was	   not	   only	   well	   tolerated,	   but	   was	   even	   regarded	   as	   a	   positive	   experience	   by	   most	  
patients.	  	  
	  
Ideal	  –	  desired	  situation	  
When	  the	  interviewer	  specifically	  asked	  for	  the	  need	  to	  assess	  trauma	  during	   intake	  or	  treatment,	  the	  
clinicians	  do	  agree	  that	  trauma	  anamnesis	  is	  essential	  and	  they	  add	  that	  every	  patient	  should	  be	  directly	  
questioned	  about	  possible	  trauma.	  They	  also	  state	  that	  is	  very	  important	  to	  clearly	  report	  these	  facts	  in	  
their	   patient	   files	   and	   to	   be	   aware	   that	   already	   known	   patients	  may	   have	   incomplete	   or	   out-­‐of-­‐date	  
patient	  files.	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‘But	  there	  are	  people	  who	  are	  for	  instance	  on	  methadone	  and	  have	  been	  in	  and	  out	  of	  treatment	  
for	  over	  10	  years.	  Not	  a	  lot	  of	  attention	  is	  paid	  to	  their	  history	  and	  who	  knows	  what	  further	  lurks	  
beneath	  the	  surface.’	  	  
Interviewees	  state	  that	  when	  trauma	  is	  not	  questioned	  during	  intake,	  the	  intake	  clinician	  should	  clearly	  
communicate	  this	  with	  the	  responsible	  substance	  abuse	  clinician.	  	  
In	  contrast	   to	  current	  practice	  the	  desired	   ideal	  situation	   is	   in	   line	  with	  the	  guidelines	  and	  can	  
lead	   to	   a	   better	   assessment	   of	   trauma	   exposure.	   Interviewees	   provide	   some	   suggestions	   on	   how	   to	  
reach	  this	  goal.	  The	  responsibility	  to	  assess	  trauma	  should	  be	  defined	  more	  clearly	  and	  training	  on	  how	  
to	  assess	  trauma	  is	  needed	  for	  the	  intake	  clinicians.	  	  
	  
Diagnosing	  PTSD	  in	  SUD	  patients	  
Current	  situation	  	  
Clinicians	   emphasize	   that	   it	   is	   important	   to	   diagnose	   PTSD.	   The	   following	   procedure	   in	   the	   diagnosis	  
process	   of	   a	   new	  patient	   is	   reported.	   First,	   the	   intake	   clinician,	   often	   a	   social	  worker	   or	   a	   psychiatric	  
nurse,	  makes	  a	   temporary	  diagnosis	  based	  on	  an	   interview.	   In	  case	  of	  uncertainty,	   the	  patient	   is	   then	  
referred	   to	   a	   psychiatrist.	   This	   psychiatrist	   only	   sees	   a	  minority	   of	   the	  patients	   and	  does	   not	   use	   any	  
standardized	  assessment	  tools	  in	  reaching	  a	  diagnosis.	  	  
‘They	  (the	  patients)	  rarely	  end	  up	  with	  me	  (the	  psychiatrist)…I	  have	  12	  hours	  for	  the	  treatment	  of	  
1000	   patients.	   I	   expect	   there	   are	   a	   lot	   of	   patients	   among	   them	   that	   have	   a	   whole	   lot	   of	  
(psychiatric)	  problems	  of	  which	  I’m	  not	  aware.’	  
When	   the	   temporary	   diagnosis	   does	   seem	   clear,	   the	   patient	   is	   discussed	   in	   a	   multidisciplinary	   team	  
meeting,	  including	  a	  psychologist	  and	  a	  psychiatrist.	  During	  this	  discussion	  a	  final	  diagnosis	  is	  made.	  The	  
psychiatrist	  holds	  the	  end	  responsibility	  to	  make	  a	  diagnosis.	  	  
	   It	   is	  acknowledged	  that,	   in	  case	  of	  previously	  known	  patients,	   the	  diagnoses	  of	   the	  old	  patient	  
files	  are	  often	  used	  without	  further	  inquiry.	  	  
The	   interviewees	   indicate	   that	   during	   treatment	   the	   diagnosis	   is	   malleable.	   Team	   members	  
sometimes	   signal	   trauma	   related	   symptoms	   in	   a	   patient	   and	   then	   refer	   the	   patient	   for	   further	  
consultation	   to	   the	   psychiatrist	   or	   resident	   psychologist.	   This	  may	   result	   in	   a	   change	   in	   the	   patient’s	  
diagnosis.	   Again,	   both	   the	   resident	   psychiatrist	   and	   psychologist	   rarely	   use	   standardized	   assessment	  
tools	   to	   reach	   a	   specific	   diagnosis.	   As	   for	   PTSD	   specifically,	   the	   interviewees	  mention	   that	   no	   specific	  
PTSD	   questionnaires	   or	   interviews	   are	   available	   or	   known	   to	   them.	   This	   of	   course	   may	   result	   in	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misdiagnosis	  or	  as	  in	  the	  case	  of	  PTSD,	  severe	  underdiagnosis.	  Indeed,	  the	  interviewed	  clinicians	  are	  in	  
agreement	  with	  regard	  to	  the	  severe	  underdiagnosis	  of	  PTSD	  in	  their	  patient	  group.	  
	  ‘I	  think	  our	  patient	  group	  is	  heavily	  under	  diagnosed.’	  
Finally,	   the	   interviewees	   state	   that	  diagnosis	   can	  be	  difficult	   in	   SUD	  patients	  because	  of	   the	   similarity	  
between	  PTSD	  symptoms	  and	  addiction	  related	  symptoms	  (e.g.,	  intoxication	  and	  withdrawal).	  	  	  
‘It	  is	  difficult	  to	  disentangle	  PTSD	  and	  addiction	  symptoms.	  What	  is	  what?’	  
	  
Ideal	  –	  desired	  situation	  
The	  necessity	  to	  screen	  for	  PTSD	  in	  every	  patient	  at	  different	  times	  (since	  a	  diagnosis	  can	  change	  over	  
time)	  during	  treatment	  is	  stressed.	  Furthermore,	  clinicians	  are	  aware	  that	  they	  should	  be	  more	  alert	  for	  
PTSD	   symptoms.	   Although	   the	   importance	   of	   diagnosing	   PTSD	   in	   SUD	   patients	   is	   recognized,	   three	  
important	  difficulties	   can	  be	   indicated.	   Firstly,	   the	   clinicians	  describe	  only	   two	  evaluation	  moments	   in	  
which	   PTSD	   can	   be	   evaluated	   and	   report	   that	   in	   already	   known	   patients	   their	   previous	   diagnosis	   is	  
copied,	  not	  re-­‐assessed.	  Different	  existing	  clinical	  guidelines	  suggest	  at	   least	  three	  separate	  evaluation	  
moments	   in	   all	   patients	   and	   a	   continuous	   monitoring	   of	   symptoms	   (Schatzberg,	   Weiss,	   Brady	   &	  
Culpepper,	  2008;	  Snoek	  et	  al.,	  2012).	  	  
A	  second	  problem	  is	  that	  clinicians	  at	   intake	  reach	  a	  diagnosis	  relying	  solely	  on	  an	  interview	  in	  
which	   PTSD	   or	   trauma	   exposure	   is	   not	   explicitly	   questioned.	   Clinicians	   seem	   to	   rely	   heavily	   on	   their	  
clinical	   judgment	   when	   diagnosing	   PTSD	   in	   SUD	   patients.	   The	   combination	   of	   the	   reported	  
underestimation	  of	  PTSD	  prevalence	  and	  the	  inherent	  bias	  of	  clinical	  judgement	  (Dawes,	  Faust	  &	  Meehl,	  
1989;	  Garb;	  2005)	  make	  for	  a	  plausible	  explanation	  of	  the	  underdiagnosis	  of	  PTSD.	  	  
The	   third	   difficulty	   is	   that	   PTSD	   symptoms	   can	   be	   confused	  with	   intoxication	   and	  withdrawal	  
symptoms.	   Although	   some	   SUD	   related	   symptoms	  mimic	   or	   overlap	  with	   PTSD	   symptoms	   (e.g.	   sleep	  
disturbance,	   difficulty	   concentrating,	   feelings	   of	   detachment,	   irritability),	   PTSD	   is	   characterized	   by	  
unique	  criteria:	  the	  exposure	  to	  a	  criterion	  A	  event	  and	  intrusive	  trauma	  related	  symptoms	  (4th	  ed.,	  text	  
rev.;	   DSM–IV–TR;	   American	   Psychiatric	   Association,	   2000).	   To	   overcome	   this	   problem	   of	   symptom	  
confusion,	  the	  assessment	  of	  PTSD	  is	  best	  done	  after	  a	  period	  of	  abstinence	  (Snoek	  et	  al.,	  2012).	  	  	  
	  




The	   interviews	   with	   the	   clinicians	   make	   it	   clear	   that	   the	   treatment	   facility	   promotes	   sequential	  
treatment	  in	  which	  SUD	  is	  treated	  before	  PTSD.	  The	  focus	  should	  be	  on	  SUD	  and	  patients	  are	  sometimes	  
advised	  not	  to	  go	  into	  trauma	  therapy	  during	  SUD	  treatment.	  	  
‘I	  usually	  gave	  the	  advice	  that	  trauma	  therapy	  was	  not	  an	  option	  on	  that	  moment.’	  	  
	  ‘Doing	  that,	  you	  may	  cause	  more	  misery	  than	  necessary.	  In	  cases	  like	  that	  I’m	  more	  inclined	  to	  
cover	   the	   trauma	   with	   sand,	   a	   concrete	   layer,	   and	   to	   continue	   work	   upon	   that	   rotten	  
foundation.’	  
Although	  the	  sequential	  view	  on	  treatment	  of	  comorbid	  SUD	  and	  PTSD	  is	  seen	  as	  outmoded	  by	  different	  
interviewees,	   quite	   a	   few	   interviewees	   strongly	   argue	   against	   simultaneous	   treatment.	   To	   treat	   PTSD	  
during	  SUD	  treatment	  is	  seen	  as	  too	  soon,	  harmful,	  counterproductive,	  unwise	  and	  distracting.	   	  
	  ‘Sometimes	  doing	  nothing	  is	  less	  harmful.’	  
‘The	  real	  trauma	  therapy	  is	  not	  done	  here	  because	  it	  usually	  impedes	  addiction	  treatment.’	  	  
In	  contrast	  with	  this	  current	  practice	  and	  thinking,	  the	  guidelines	  are	  very	  clear:	  integrated	  treatment	  is	  
the	  standard	  of	  care	  (Kivlahan	  &	  Kaysen,	  2012;	  Mueser,	  Noordsy,	  Drake	  &	  Fox,	  2003;	  Snoek	  et	  al.,	  2012).	  	  
Despite	  the	  fact	  that	  guidelines	  emphasize	  using	  pharmacotherapy	  only	  as	  an	  additional	  form	  of	  
therapy	  (Snoek	  et	  al.,	  2012),	  the	  interviewed	  clinicians	  indicate	  that	  pharmacotherapeutic	  treatment	  is	  
the	   current	   treatment	   of	   choice	   for	   PTSD	   in	   SUD	   patients.	   Interviewees	   state	   that	   neuroleptica	   and	  
Selective	   serotonin	   Reuptake	   Inhibitors	   (SSRI’s)	   are	   prescribed	   for	   PTSD	   in	   SUD	   patients,	   leading	   to	   a	  
decrease	  of	   intrusions	  and	  other	  PTSD	  symptoms.	  Psychopharmaceuticals	  are	  also	  advised	  for	  trauma-­‐
related	  sleeping	  disorders.	  	  
Clinicians	   favour	   a	   present-­‐focused	   approach	   for	   PTSD	   treatment	   above	   a	   trauma-­‐	   or	   past-­‐
focused	   treatment.	   This	   approach	   involves	   carefully	   exploring	   the	   impact	   of	   trauma,	   developing	   new	  
coping	   techniques,	   focusing	   on	   the	   future,	   psycho-­‐education,	   symptom	   reduction	   and	   increasing	  
stability.	   Interviewees	   state	   the	   importance	   of	   not	   talking	   about	   the	   trauma	  with	   the	   patient	   and	   to	  
restrict	  or	  refer	  patients	  when	  they	  do.	  	  
‘In	  essence,	  you	  don’t	  discuss	  the	  trauma.’	  
The	   interviewees	   note	   that	   in	   patients	   with	   more	   introspective	   skills	   the	   psycho-­‐education	   can	   be	  
further	   deepened	   to	   increase	   the	   understanding	   and	   to	   link	   trauma-­‐related	   patterns	   with	   addiction.	  
Therapy	  can	  then	  include	  social	  skills	  training	  or	  rational	  emotive	  therapy.	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According	   to	   the	   interviewees,	   the	   above-­‐mentioned	   approach	   can	   be	   applied	   by	   all	   team	  
members,	   under	   supervision	   of	   a	   psychologist	   or	   psychiatrist.	   There	   should,	   however,	   be	   a	   match	  
between	  psychopathology	  and	  expertise.	  
Current	  research	  suggests	  that	  past-­‐focused	  therapies,	  not	  present-­‐focused	  therapies,	  should	  –	  
even	  in	  SUD	  patients	  –	  be	  the	  treatment	  of	  choice	  (Berenz	  &	  Coffey,	  2012;	  van	  Dam	  et	  al.,	  2012).	  	  
The	   arguments	   that	   are	   given	   against	   trauma	   therapy	   during	   SUD	   treatment	   suggest	   that	  
clinicians	  favour	  a	  sequential,	  pharmacotherapeutical,	  or	  present-­‐focused	  treatment	  approach	  for	  PTSD	  
because	   they	   believe	   that	   a	   past-­‐focused	   integrated	   approach	   might	   exacerbate	   PTSD	   symptoms	  
promoting	  drug	  or	  alcohol	  craving	  and	  possible	  addictive	  behaviour	  relapse.	  
	  
Ideal	  –	  desired	  situation	  
Although	  sequential	   treatment	  seems	  to	  be	   the	  current	  way	  of	  handling	  SUD/PTSD	  patients,	  clinicians	  
do	   report	   that	  dividing	   the	   treatment	  of	   SUD	  and	  PTSD	   is	   artificial	   and	  difficult	   to	  bring	   into	  practice.	  
Because	  of	   the	  high	   suffering	  of	   the	  patient	   and	   the	   close	   link	  between	  PTSD	   symptoms	  and	   relapse,	  
both	  disorders	  should	  be	  treated	  simultaneously.	  The	   interviewees	  recognize	   the	  ethical	   responsibility	  
to	  do	  a	  co-­‐treatment	  of	  SUD	  and	  PTSD.	  	  
‘…so	  we	  have	  the	  responsibility	  to	  treat	  everything.’	  	  
According	   to	   the	   interviewees,	   this	   simultaneous	   treatment	   should,	   ideally,	   be	   given	   intramurally	   in	   a	  
double	  diagnosis	  ward	  where	  a	  long	  enough	  admission	  time	  is	  possible.	  	  
‘But,	   of	   course,	   it’s	   not	  always	   relevant.	   It	   depends	  on	  where,	   on	  which	  department,	   and	  with	  
what	  goal,	  someone	  is	  hospitalized.’	  	  
If	  PTSD	   treatment	   takes	  place	  on	  an	  ambulatory	  basis,	   an	  emergency	  admission	   should	  be	  possible	   in	  
case	  of	  severe	  psychological	  deterioration	  of	  the	  patient.	  Clinicians	  further	  express	  the	  need	  to	  have	  a	  
treatment	  protocol	  for	  comorbid	  SUD/PTSD.	   In	  this	  protocol,	  special	  attention	  should	  be	  given	  to	  a	  no	  
show	  procedure	  as	  it	  is	  expected	  that	  no	  shows	  may	  occur	  more	  often	  with	  this	  subgroup	  of	  patients.	  A	  
clear	   and	   uniform	   view	   of	   the	   institution	   about	   how	   to	   deal	   with	   comorbid	   SUD/PTSD	   is	   another	  
important	   condition	   that	   is	   highlighted.	   If	   the	   institution	   stimulates	   PTSD	   treatment	   during	   SUD	  
treatment,	  more	  time	  and	  money	  should	  be	  reserved	  for	  this	  aim.	  	  
‘Not	  much	  is	  done	  with	  that	  information	  (PTSD	  diagnosis)	  because	  we	  can’t	  do	  so	  much	  with	  it,	  
because	  we	  don’t	  have	  the	  means.’	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Training	  and	  supervision	  is	  needed	  in	  order	  to	  increase	  the	  knowledge	  about	  PTSD	  and	  about	  the	  impact	  
of	  PTSD	  treatment.	  Intervision	  is	  suggested	  to	  prevent	  clinicians	  from	  developing	  secondary	  PTSD.	  
	  ‘We	  can’t	  actually	  do	  that	  much	  with	  trauma	  within	  our	  departments	  of	  addiction	  care.	  We	  do	  
not	  have	  the	  time	  or	  the	  expertise.’	  
As	  in	  the	  previous	  sections,	  there	  is	  an	  explicit	  contrast	  between	  the	  current	  practice	  and	  the	  situation	  
that	  is	  described	  as	  ideal.	  The	  suggestions	  that	  are	  provided	  offer	  good	  possibilities	  to	  alter	  the	  current	  
practices	  towards	  a	  more	  evidence-­‐based	  treatment.	  Lack	  of	  time,	  money	  and	  expertise	  are	  mentioned	  
as	  reasons	  why	  integrated	  treatment	  is	  currently	  not	  offered	  to	  SUD/PTSD	  patients.	  	  
	  
Gap	  between	  theory	  and	  practice	  
Almost	  every	  interviewee	  (12	  out	  of	  14)	  believes	  that	  trauma	  and	  SUD	  are	  interrelated.	  Most	  clinicians	  
report	   that	   substance	   use	   is	   negatively	   influenced	   by	   PTSD	   symptoms	   or	   that	   substance	   use	   follows	  
trauma	   exposure.	   According	   to	   Kleinman’s	  model	   these	   statements	   should	   predict	   that	   treatment	   of	  
PTSD	  takes	  place	  during	  SUD	  treatment.	  However,	  nearly	  all	  clinicians	  admit	  that	  PTSD	  treatment	  does	  
not	  occur	  during	  SUD	  treatment.	  	  
Interviewee	  1:	   	   ‘It	  (trauma/PTSD)	  can	  be	  a	  maintaining	  factor	  (for	  addiction).’	  
	   	   	   ‘Sometimes	  doing	  nothing	  is	  less	  harmful.’	  	  	  
Interviewee	  2:	  	  	   ‘Trauma	  is	  always	  of	  influence.’	  
‘I	  don’t	  think	  you	  should	  work	  on	  trauma	  processing	  here.	  That’s	  more	  something	  
for	  after	  the	  treatment	  (of	  addiction).’	  	  
Interviewee	  4:	  	   ‘The	  real	  problems	  start	  when	  someone	  is	  going	  to	  detoxify…then	  the	  sorrow,	  the	  
pain	  and	  the	  grief	  emerge.’	  
	   ‘We	   can’t	   do	   that	  much	  with	   trauma…During	   treatment	  we	   thus	  only	   focus	  on	  
substance	  use.’	   	  
	  
Discussion	  	  
In	   order	   to	   understand	  why	   substance	   abuse	   clinicians	   do	   not	   implement	   evidence	   based	   integrated	  
treatment	  for	  patients	  with	  SUD/PTSD,	  the	  current	  report	  explored	  how	  healthcare	  providers	  define	  the	  
comorbid	  disorders	  and	  how	  their	  perceptions	  influence	  clinical	  practice.	  The	  purpose	  of	  this	  study	  was	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to	  unearth	  perceptions	  and	  practices	  regarding	  SUD/PTSD	  in	  order	  to	   improve	   implementation	  of	  best	  
practice	  guidelines	  concerning	  the	  comorbidity	  of	  SUD	  and	  PTSD	  for	  addiction	  facilities.	  	  
This	  study	  suggests	  that	  two	  factors	  affect	  the	  underdiagnosis	  and	  under	  treatment	  of	  PTSD	  in	  
SUD	   facilities,	   which	   is	   also	   reported	   in	   the	   literature	   (Gielen	   et	   al.,	   2012;	   Glover-­‐Graf	   &	   Janikowski,	  
2001;	   Najavits	   et	   al.,	   2004;	   Young	   et	   al.,	   2005).	   (1)	   Although	   most	   clinicians	   are	   well	   aware	   of	   the	  
adverse	  consequences	  of	  trauma	  exposure	  and	  PTSD	  on	  SUD,	  in	  general,	  SUD	  clinicians	  are	  not	  aware	  of	  
the	  high	  prevalence	  rates	  of	  trauma	  exposure	  and	  PTSD	  among	  their	  patients.	  As	  a	  consequence,	  PTSD	  is	  
not	   a	   priority	   and	   adequate	   treatment	   protocols,	   specific	   diagnostic	   tools	   and	   even	   the	   clinical	  
guidelines	  are	  not	  well	  known.	  (2)	  Clinicians	  believe	  that	  talking	  about	  past	  traumas	  elicits	  craving	  and	  
possible	  relapse.	  This	  belief	  leads	  to	  a	  too	  careful	  or	  no	  approach	  of	  past	  trauma.	  	  
The	   fact	   that	   the	   interviewees	   advised	   specific	   improvements	   about	   the	   trauma	   anamnesis,	  
PTSD	   diagnosis	   and	   PTSD	   treatment	   which	   resembled	   the	   SUD/PTSD	   guidelines,	   suggests	   that	   their	  
theoretical	  knowledge	  might	  not	  be	  the	  most	  important	  reason	  for	  not	  following	  the	  clinical	  guidelines.	  
The	  main	  hurdles	  appear	  to	  be	  practical:	  lack	  of	  time,	  money	  and	  expertise.	  It	  should	  be	  noted	  though	  
that	  the	  interviews	  forced	  the	  clinicians	  to	  think	  about	  PTSD	  in	  SUD	  patients.	  This	  impromptu	  awareness	  
of	  PTSD	  in	  their	  patients	  may	  have	  lead	  them	  to	  stress	  the	  importance	  of	  diagnosing	  and	  treating	  PTSD	  
in	  SUD	  patients.	  Nonetheless,	  with	  regard	  to	  Kleinman’s	  EM	  approach	  we	  can	  conclude	  that	  the	  views	  
SUD	  clinicians	  hold	  about	  PTSD	  prevalence	  and	  the	  supposed	  negative	  influence	  of	  discussing	  traumata	  
certainly	  affect	  how	  the	  clinician	  handles	  comorbid	  PTSD	  in	  SUD	  patients.	  The	  matter	  is	  however	  further	  
complicated	  by	  the	  lack	  of	  means.	  	  
Unfortunately,	   we	   could	   not	   ask	   participants	   to	   determine	   the	   accuracy	   of	   the	   conclusions	  
because	   too	   much	   time	   passed	   between	   the	   interviews	   and	   the	   analysis.	   Nonetheless,	   the	   present	  
findings	  might	  provide	  important	  implications	  for	  SUD	  treatment	  facilities.	  	  
	  
Conclusions	  
The	  results	  of	  this	  study	  confirm	  that	  PTSD	  treatment	  was	  not	  a	  focus	  during	  SUD	  treatment.	  Although	  
clinicians	   were	   well	   aware	   of	   the	   adverse	   consequences	   of	   trauma	   exposure	   and	   PTSD	   on	   SUD,	  
hindrances	  related	  to	  the	  underestimation	  of	  PTSD	  in	  SUD	  patients,	  a	  too	  careful	  approach	  and	  lack	  of	  
time	   and	   money	   prevented	   an	   adequate	   diagnosis	   and	   treatment	   of	   PTSD.	   SUD	   facilities	   should	  
therefore	  invest	   in	  the	  evidence	  based	  integrated	  approach	  of	  comorbid	  SUD/PTSD.	  The	  results	  of	  this	  
study	   corroborate	   previous	   findings	   that	   indicate	   that	   SUD	   treatment	   facilities	   have	   a	   lot	   to	   gain	  
investing	  in	  integrated/simultaneous	  SUD/PTSD	  treatment.	  Clinicians	  should	  be	  educated	  and	  trained	  to	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be	   able	   to	   assess	   PTSD/trauma,	   using	   reliable	   and	   valid	   measures,	   and	   to	   provide	   evidence-­‐based	  
SUD/PTSD	  treatment.	  Since	  successful	  implementation	  is	  also	  dependent	  on	  the	  perceptions	  SUD/PTSD	  
patients	  hold,	  future	  research	  might	  focus	  on	  this	  topic.	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Morphine	  –	  Cure	  for	  Pain 
Where	  is	  the	  ritual	  
And	  tell	  me	  where	  where	  is	  the	  taste	  
Where	  is	  the	  sacrifice	  
And	  tell	  me	  where	  where	  is	  the	  faith	  
Someday	  there'll	  be	  a	  cure	  for	  pain	  
That's	  the	  day	  I	  throw	  my	  drugs	  away	  






Despite	   empirical	   support,	   integrated	   treatment	   of	   Substance	   Use	   Disorder	   (SUD)	   and	   Posttraumatic	  
Stress	  Disorder	   (PTSD)	   is	  not	   sufficiently	   implemented	   in	  SUD	   facilities.	  To	  understand	   the	   reasons	   for	  
this	  gap	  between	  theory	  and	  practice,	  in	  this	  study	  the	  perceptions	  of	  SUD/PTSD	  patients	  about	  the	  co-­‐
occurrence	  and	  the	  symptom	  interplay	  of	  the	  two	  disorders	  were	  explored.	  Seventy-­‐two	  SUD	  patients	  
with	  differing	  levels	  of	  PTSD	  severity	  filled	  out	  a	  survey	  and	  three	  self-­‐report	  questionnaires	  pertaining	  
to	  their	  perceptions.	  Regression	  analysis	  was	  used	  to	  test	  whether	  PTSD	  severity	  accounts	  for	  possible	  
differences	  between	  perceptions	  about	   the	   link	  between	  SUD	  and	  consequences	  of	   trauma	  exposure.	  
Patients	   perceive	   that	   substance	   use	   is	   effective	   in	   diminishing	   PTSD	   symptoms,	   they	   feel	   that	  
abstinence	  does	  not	  improve	  PTSD	  symptomatology,	  and	  they	  hold	  positive	  expectancies	  regarding	  the	  
effect	   of	   the	   substance	   on	   their	   PTSD	   symptoms.	   Considering	   these	   patients’	   perceptions,	   it	   is	   hardly	  
surprising	  that	  SUD/PTSD	  patients	  are	  reluctant	  to	  start	  an	  integrated	  SUD/PTSD	  treatment.	  Treatment	  
implications	  are	  discussed.	  
	  




Substance	  Use	  Disorder	  (SUD)	  and	  post-­‐traumatic	  stress	  disorder	  (PTSD)	  are	  two	  severe	  and	  often	  long-­‐
lasting	   psychiatric	   disorders	   that	   frequently	   co-­‐occur	   (Driessen	   et	   al.,	   2008;	   Gielen,	   Havermans,	  
Tekelenburg,	  &	   Jansen,	   2012;	   Read,	   Brown,	  &	  Kahler,	   2004).	   Patients	  with	   this	   particular	   comorbidity	  
have	  a	  higher	   risk	   for	   relapse	  of	   addictive	  behavior	  when	   their	  PTSD	   is	   left	  untreated	   (Mills,	   Teesson,	  
Ross,	  Darke,	  &	  Shanahan,	  2005;	  Read	  et	  al.,	  2004).	  
There	  is	  a	  strong	  rationale	  and	  empirical	  support	  for	  integrated	  SUD/PTSD	  treatment	  (van	  Dam,	  
Vedel,	   Ehring,	   &	   Emmelkamp,	   2012;	   Torchalla,	   Nosen,	   Rostam,	   &	   Allen,	   2012).	   In	   spite	   of	   this,	   SUD	  
clinicians	   still	   seem	   to	   favor	   a	   sequential	   treatment,	   treating	   SUD	   first	   and	   leaving	   the	   PTSD	   to	   other	  
trauma	   treatment	   specialists	   (Gielen,	  Krumeich,	  Havermans,	   Smeets,	  &	   Jansen,	  2014;	  Young,	  Rosen	  &	  
Finney,	  2005).	  There	  is	  a	  gap	  between	  clinical	  science	  and	  practice	  here.	  To	  bridge	  this	  gap,	  one	  needs	  to	  
understand	  why	  research	  findings	  are	  not	  implemented	  in	  SUD	  facilities.	  	  
Three	   possible	   barriers	   hindering	   implementation	   of	   integrated	   SUD/PTSD	   treatment	   can	   be	  
identified:	   (1)	   obstacles	   related	   to	   the	   clinician	   (e.g.,	   lack	   of	   expertise),	   (2)	   obstacles	   related	   to	   the	  
institution	   (e.g.,	   institution	   gives	   priority	   to	   SUD	   treatment),	   and	   (3)	   obstacles	   related	   to	   the	   patients	  
(e.g.,	  shame,	  anxiety).	  Implementation	  of	  integrated	  SUD/PTSD	  treatment	  is	  likely	  to	  fail	  if	  not	  all	  three	  
barriers	   are	   removed.	   Previously	   researchers	   surveyed	   and	   interviewed	   clinicians,	   thereby	   identifying	  
different	   factors	   preventing	   implementation	   of	   integrated	   SUD/PTSD	   treatment.	  One	   particular	   factor	  
appears	   to	   be	   the	   anxiety	   on	   the	   part	   of	   the	   clinician	   that	   SUD	  patients	  with	   comorbid	   PTSD	   are	   too	  
unstable	  to	  handle	  both	  treatment	  for	  SUD	  and	  PTSD.	  Indeed,	  one	  seems	  afraid	  that	  discussing	  trauma	  
with	  the	  patient	  may	  put	  him/her	  in	  jeopardy	  for	  a	  (re-­‐)lapse	  (Back,	  Waldrop,	  &	  Brady,	  2009;	  Gielen	  et	  
al.,	  2014;	  Najavits,	  2002).	  
Although	  there	  are	  studies	  suggesting	  that	  discussing	  trauma	  will	  increase	  the	  patient’s	  craving	  
for	   alcohol	   or	   drugs	   (Coffey	   et	   al.,	   2002;	   Saladin	   et	   al.,	   2003),	   this	   does	   not	   compromise	   treatment	  
outcome.	   Indeed,	   as	   mentioned	   above,	   there	   are	   several	   studies	   showing	   better	   overall	   treatment	  
outcome	  with	  integrated	  SUD/PTSD	  treatment,	  compared	  to	  SUD	  treatment	  only	  (van	  Dam	  et	  al.,	  2012;	  
Torchalla	  et	  al.,	   2012).	  Therapists	  appear	  wary	  not	   to	  harm	   their	  patients,	   as	   they	   should,	  but	  a	  good	  
therapist	  should	  not	  be	  so	  cautious	  as	  not	  to	  provide	  treatment	  at	  all.	  But	  what	  do	  SUD	  patients	  with	  
comorbid	  PTSD	  think	  on	  this	  issue?	  How	  do	  they	  view	  the	  role	  of	  PTSD	  in	  their	  SUD?	  And	  is	   it	  possible	  
that	  the	  patients	  feed	  the	  concerns	  of	  the	  therapist	  by	  showing	  resistance	  in	  discussing	  their	  trauma?	  
Janikowski	   and	   Glover	   (1994)	   and	   Janikowski,	   Bordieri,	   and	   Glover	   (1997)	   studied	   the	  
relationship	  between	  incest	  and	  substance	  abuse.	  They	  surveyed	  patients	  and	  concluded	  that	  patients	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perceive	  incest	  and	  SUD	  to	  be	  interrelated.	  Furthermore,	  most	  patients	  preferred	  individual	  treatment	  
and	   were	   willing	   to	   talk	   about	   their	   incest	   past	   if	   their	   counselor	   would	   only	   ask	   about	   it.	   Opinions	  
regarding	   integrated	   treatment	  were	  mixed.	   Patient	   barriers	   that	   could	  be	   identified	  were	   feelings	   of	  
shame	   and	   concerns	   about	   confidentiality.	   In	   1998,	   a	   survey	   was	   conducted	   by	   Brown,	   Stout,	   and	  
Gannon-­‐Rowley,	   investigating	   the	   relationship	   between	   comorbid	   SUD/PTSD	   and	   patient	   treatment	  
preferences.	  The	  results	  of	  the	  study	  showed	  that	  patients	  perceive	  the	  two	  disorders	  to	  be	  functionally	  
related	  and	  that	  patients	  prefer	  a	  simultaneous	  treatment	  of	  SUD	  and	  PTSD.	  Patients	   in	  this	  study	  too	  
were	  concerned	  about	  feelings	  of	  shame,	  blame,	  and	  about	  the	  painfulness	  of	  talking	  about	  their	  past	  
trauma.	   Together,	   this	   suggest	   that	   some	  patients	  might	   indeed	  give	   signals	   to	   the	   therapist	   that	   the	  
trauma	  is	  not	  discussed	  easily,	  but	  also	  that	  if	  they	  feel	  secure,	  they	  are	  willing	  to	  start	  a	  trauma-­‐focused	  
treatment.	  	  
But	   even	   if	   patients	   are	   willing	   to	   talk	   about	   their	   trauma,	   do	   patients	   feel	   it	   is	   relevant	   to	  
integrate	  SUD	  and	  PTSD	  treatment?	  How	  do	  patients	  perceive	  the	  interplay	  between	  trauma,	  PTSD	  and	  
substance	  use?	  
Some	   important	   questions	   are	   relevant	   in	   the	   perspective.	   The	   self-­‐medication	   theory,	  which	  
implies	  that	  substances	  are	  used	  as	  a	  way	  to	  cope	  with	  the	  PTSD	  symptoms	  (Khantzian,	  1997),	  does	  not	  
seem	   to	   offer	   a	   full	   explanation	   of	   the	   link	   between	   PTSD	   and	   SUD	   (Berenz	   &	   Coffey,	   2012;	   Dass-­‐
Braisford	  &	  Myrick,	  2010;	  Jacobsen,	  Southwick,	  &	  Kosten,	  2001).	  Researchers	  seem	  to	  agree	  that	  a	  more	  
complex	  relationship	  is	  more	  likely	  to	  explain	  the	  frequent	  comorbidity	  between	  SUD	  and	  PTSD	  (Berenz	  
&	  Coffey,	  2012;	  Dass-­‐Braisford	  &	  Myrick,	  2010;	  Torchalla	  et	  al.,	  2012).	   Furthermore,	   researchers	  have	  
never	   asked	   SUD/PTSD	   patients	   to	   elaborate	   upon	   the	   issue	   of	   first	   substance	   use.	  What	   were	   their	  
reasons	   to	   start	   using	   drugs	   or	   alcohol?	   Did	   trauma	   experience	   play	   a	   role	   in	   this?	  What	   is	   the	   link	  
between	  PTSD	  symptoms	  and	  craving	  (and	  possibly	  relapse)	  according	  to	  SUD/PTSD	  patients?	  Finally,	  so	  
far,	   it	  has	  not	  been	   tested	  whether	  SUD	  patients	  with	  and	  without	  PTSD	  differ	  on	  how	   they	  view	   the	  
relation	  between	  past	  trauma	  and	  substance	  use.	  It	  would	  be	  interesting	  and	  relevant	  to	  know	  whether	  
it	  is	  PTSD	  or	  mere	  trauma	  exposure	  that	  is	  responsible	  for	  a	  possible	  distinction	  in	  results.	  
The	  present	   study	   focuses	  on	   the	   ideas	  of	   SUD/PTSD	  patients	  by	  asking	   them:	   (1)	  what	   is	   the	  
relation	  between	  your	  past	  trauma	  and	  the	  start	  of	  your	  addiction,	  and	  what	  are	  your	  motives	  to	  keep	  
using	  the	  substance?	  And	  (2)	  how	  is	  your	  PTSD	  related	  to	  craving	  and	  relapse	  (defining	  relapse	  as	  first	  
substance	  use	  after	  a	  period	  of	  abstinence,	  regardless	  of	  whether	  patients	  resume	  abstinence	  after	  this	  
substance	  use)?	  In	  the	  current	  study,	  SUD	  patients	  with	  different	  levels	  of	  PTSD	  severity	  (all	  with	  trauma	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exposure)	   filled	   out	   a	   brief	   survey	   and	   three	   questionnaires	   pertaining	   to	   their	   motives	   for	   drug	   or	  
alcohol	  use.	  	  
To	   reach	   a	   complete	   understanding	   of	   the	   perceptions	   of	   patients	   with	   the	   SUD-­‐PTSD	  
comorbidity,	  another	   study	  was	  conducted,	   focusing	  on	   the	  perceptions	  of	  SUD/PTSD	  patients	  as	  well	  
but	   using	   a	   qualitative	   design.	   This	   study	   is	   published	   elsewhere	   (Gielen,	   Krumeich,	   Tekelenburg,	  
Nederkoorn	  &	  Havermans,	  2015b).	  	  
	  
Methods	  
Data	  collection	  and	  sampling	  
The	  patients	  who	  participated	   in	   this	   study,	   also	   took	  part	   in	   a	   larger	  experimental	   study	   (concerning	  
trauma	   cue	   induced	   cravings;	   Gielen,	   Nederkoorn,	   Havermans	   &	   Jansen,	   2015c)	   in	   which	   91	   SUD	  
patients	   with	   trauma	   exposure	   in	   their	   past	   were	   included.	   General	   information	   about	   participant	  
enrolment	  is	  described	  in	  Gielen	  et	  al.	  (2015c).	  Since	  not	  all	  patients	  completed	  the	  full	  study,	  data	  of	  72	  
SUD	  patients	  were	  used	  for	  the	  current	  study.	  Participants	  were	  all	   in	  clinical	  treatment	  for	  SUD.	  PTSD	  
was	   diagnosed	   with	   the	   use	   of	   a	   validated	   self-­‐report	   questionnaire	   (self-­‐rating	   inventory	   for	   PTSD	  
[SRIP];	  Hovens,	  Van	  der	  Ploeg,	  Bramsen,	  Klaarenbeek,	  Schreuder	  &	  Rivero,	  1994)	  and	  a	  clinical	  interview	  
(MINI-­‐The	   International	   Neuropsychiatric	   Interview;	   Overbeek,	   Schruers	   &	   Griez,	   1999).	   With	   the	  
combination	  of	  scores	  on	  both	  diagnostic	  tools	  three	  groups	  were	  formed:	  38	  patients	  scoring	  negative	  
for	  PTSD	  on	  both	  the	  MINI	  and	  the	  SRIP	  (SUD/	  no	  PTSD	  group),	  23	  patients	  scoring	  positive	  for	  PTSD	  on	  
the	  MINI	  or	  the	  SRIP	  (SUD/	  probable	  PTSD	  group),	  and	  11	  patients	  scoring	  positive	  for	  PTSD	  on	  both	  the	  
MINI	  and	  the	  SRIP	  (SUD/PTSD	  group).	  After	  patients	  provided	  informed	  consent,	  they	  were	  asked	  to	  fill	  
out	  a	  survey	  and	  self-­‐report	  questionnaires.	  Patients	  received	  a	  voucher	  of	  20	  euro	  for	  participating	  in	  
the	  experimental	  study	  and	  completing	  the	  questionnaires	  for	  this	  study.	  	  
Patients	   experienced	   different	   types	   of	   trauma	   in	   their	   past.	   They	   experienced	   at	   least	   two	  
different	   types	  of	   traumatic	  exposures.	  The	   included	  patients	  were	  between	  4	  and	  30	  years	  old	  when	  
they	  first	  encountered	  a	  traumatic	  experience	  and	  mean	  age	  was	  13	  (SD	  =	  7.26).	  Their	  primary	  preferred	  
psychotropic	   substance	   of	  misuse	  was	   first	   used	   at	   a	  mean	   age	   of	   22	   (SD	   =	   8.31),	   with	   ages	   ranging	  







Table	  1.	  Sample	  characteristics.	  
Note:	  Degrees	  of	  freedom	  vary	  depending	  on	  which	  questionnaires/	  items	  were	  filled	  out	  by	  the	  patients.	  	  
Not	  Possible:	  Chi-­‐square	  could	  not	  be	  calculated	  since	  minimum	  1	  cell	  had	  expected	  count	  less	  than	  5.	  
	  
Materials	  
All	  patients	   filled	  out	  a	  survey	  and	   three	  self-­‐report	  questionnaires	   to	  gain	  more	  understanding	  about	  
the	  perceived	   link	  between	  SUD	  and	  PTSD.	  The	   self-­‐report	  questionnaires	   focused	  on	   the	  motives	   for	  
substance	  use,	  the	  strategies	  for	  handling	  negative	  emotions,	  and	  expectancies	  regarding	  the	  effect	  of	  
substances	  upon	  PTSD	  symptoms.	  
	  
Survey	  
A	  survey	  was	  composed	  with	  questions	  concerning	  the	  link	  between	  traumatic	  past	  and	  substance	  use.	  
Specific	   questions	  were	   asked	  about	  onset	  of	   SUD,	   craving,	   relapse,	   and	   self-­‐medicating	   to	   cope	  with	  
trauma	   intrusions.	   For	   each	  of	   these	  questions	  multiple-­‐choice	   answers	  were	  provided.	   The	   following	  
main	  questions	  (translated	  form	  Dutch)	  were	  used	  in	  this	  study:	  
	  
	   SUD/PTSD	   SUD/probable	  PTSD	   SUD/no	  PTSD	   Statistics	   Sign.	  









F	  (2)	  =	  .80	  
	  
NS	  
Gender	  (%)	   (n=11)	   (n=23)	   (n=38)	   	   	  
	  	  Male	   63.6	   73.9	   81.6	   NP	   NP	  
	  	  Female	   36.4	   26.1	   18.4	   NP	   NP	  
Primary	  
substance	  (%)	  
(n=11)	   (n=22)	   (n=36)	   	   	  
	  	  Alcohol	   72.7	   59.1	   41.7	   Χ2	  (2)	  =	  3.88	   NS	  
	  	  Heroin	   0	   18.2	   16.7	   NP	   NP	  
	  	  Cocaine	   0	   13.6	   22.2	   NP	   NP	  
	  	  Cannabis	   9.1	   4.5	   13.9	   NP	   NP	  
	  	  Speed	   9.1	   0	   2.8	   NP	   NP	  
	  	  Poly	  	   9.1	   0	   2.8	   NP	   NP	  
	  	  Benzo’s	   0	   4.5	   0	   NP	   NP	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- According	  to	  your	  experience,	  is	  there	  a	  connection	  between	  your	  traumatic	  past	  and	  the	  start	  
of	  your	  addiction?	  (0,	  no	  ,	  or	  1,	  yes)	  
- According	   to	   your	   experience,	   is	   there	   a	   connection	   between	   your	   traumatic	   intrusions	   and	  
craving?	  (possible	  scores	  ranging	  from	  1,	  no	  connection	  at	  all	  to	  5,	  a	  very	  clear	  connection)	  
- According	  to	  your	  experience,	  is	  there	  a	  connection	  between	  your	  traumatic	  past	  and	  relapse?	  
(possible	  scores	  ranging	  from	  1,	  no	  connection	  at	  all	  to	  5,	  a	  very	  clear	  connection)	  
	  
Three	   final	   questions	   were	   asked	   about	   patients’	   experiences	   with	   the	   use	   of	   substances	   to	  
dampen	  traumatic	  intrusions	  (0,	  no,	  or	  1,	  yes),	  the	  effectiveness	  of	  this	  self-­‐medication	  (0,	  no,	  or	  1,	  yes),	  
and	   about	   the	   relationship	   between	   PTSD	   symptoms	   and	   abstinence	   (more,	   less,	   same	   amount	   of	  
symptoms	  during	  abstinence).	  
	  
Modified	  Drinking	  Motives	  Questionnaire	  -­‐	  Revised	  (DMQ-­‐R)	  	  
We	  used	  an	  adjusted	  version	  of	   the	  Modified	  DMQ-­‐R	  (Grant,	  Stewart,	  O’Connor,	  Blackwell,	  &	  Conrod,	  
2007)	   to	   incorporate	   a	   complete	   range	   of	  motives	   patients	  might	   have	   to	   use	   substances.	   Five	   items	  
were	  added	  from	  the	  Marijuana	  Motives	  Measure	  (Simons,	  Correia,	  Carey,	  &	  Borsari,	  1998)	  and	  7	  more	  
items	  were	   added	   from	   the	   Amsterdam	  Motives	   for	   Drinking	   Scale-­‐short	   (Ooteman,	   Koeter,	   Verheul,	  
Schippers,	   &	   van	   den	   Brink,	   2006).	   Patients	   were	   asked	   to	   rate	   a	   list	   of	   34	   items	   with	   reasons	   for	  
substance	  use	  on	  a	  5-­‐point	  scale	  (1,	  [almost]	  never	  –	  5,	  [almost]	  always).	  Every	  item	  belonged	  to	  one	  of	  
seven	  possible	  categories	   (enhancement	  motives,	  expansion	  motives,	   social	  motives,	   somatic	  motives,	  
coping-­‐anxiety	  motives,	  coping-­‐depression	  motives,	  and	  coping-­‐general	  motives).	  
	  
Cognitive	  Emotion	  Regulation	  Questionnaire	  –	  short	  (CERQ-­‐short)	  	  
To	  assess	  the	  cognitive	  emotion	  regulation	  strategies	  SUD/PTSD	  patients	  use,	  the	  CERQ-­‐short	  (Garnefski	  
&	  Kraaij,	  2005)	  was	  administered	  to	  the	  patients.	  The	  questionnaire	  consists	  of	  36	  items,	  each	  belonging	  
to	   one	   of	   9	   scales	   (self-­‐blame,	   other-­‐blame,	   acceptance,	   refocus	   on	   planning,	   positive	   refocusing,	  
rumination,	   positive	   reappraisal,	   putting	   into	   perspective,	   and	   catastrophizing).	   Patients	   are	   asked	   to	  
rate	  each	  item	  on	  a	  5-­‐point	  scale	  (1,	  (almost)	  never	  –	  5,	  (almost)	  always).	  To	   interpret	  scores	  we	  used	  
the	  norm	  table	  representing	  psychiatric	  patients.	  The	  CERQ-­‐short	  has	  proven	  to	  have	  a	  good	  reliability	  
and	  validity	  (Garnefski	  &	  Kraaij,	  2006).	  
	  
PTSD	  Alcohol	  Expectancy	  Questionnaire	  (P-­‐AEQ)	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The	  P-­‐AEQ	  (Norman,	   Inaba,	  Smith,	  &	  Brown,	  2008)	   is	  a	  27	  item	  self-­‐report	  questionnaire	  to	  assess	  the	  
beliefs	  SUD/PTSD	  patients	  hold	  about	  the	  effects	  of	  substances	  with	  regard	  to	  their	  PTSD	  symptoms.	  The	  
P-­‐AEQ	  measures	   two	   dimensions:	   a	   positive	   factor,	   reflecting	   beliefs	   that	   substances	   have	   a	   positive	  
effect	  on	  PTSD	  symptoms,	  and	  a	  negative	  factor,	  reflecting	  beliefs	  that	  substances	  have	  a	  negative	  effect	  
on	  PTSD	  symptoms.	  Scores	  may	  range	  between	  1	   (totally	  disagree)	  and	  5	   (totally	  agree).	  We	  adjusted	  
the	  P-­‐AEQ	  to	  include	  other	  substances	  besides	  alcohol.	  
	  
Data	  management	  and	  analyses	  
All	   analyses	  were	   conducted	  using	   SPSS	  21.0	   for	  Windows.	  We	  used	  backward	   regression	   analyses	   to	  
test	   whether	   PTSD	   severity	   accounts	   for	   possible	   differences	   between	   perceptions	   about	   the	   link	  
between	   SUD	   and	   consequences	   of	   trauma	   exposure.	  Other	   possible	   predictors	  were	   included	   in	   the	  
regression	  model	  as	  well	  (current	  age,	  type	  of	  substance	  [depressant	  or	  stimulant],	  and	  gender).	  	  
Logistical	   regression	   tests	   were	   used	   to	   analyze	   categorical	   data	   (binomial	   or	   multinomial	  
depending	  on	  the	  levels	  of	  the	  dependent	  variable).	  Several	  participants	  had	  one	  or	  more	  missing	  values	  
for	   items	   of	   the	   different	  measures	   described	   above.	   Due	   to	   these	  missing	   values,	   sample	   sizes	   vary	  
slightly	  between	  the	  analyses.	  
Tables	  of	  full	  models	  are	  revealed	  only	  when	  a	  significant	  effect	  of	  PTSD	  severity	  was	  found.	  	  
	  
Results	  
Beginning	  of	  addiction	  
In	   the	   survey,	   SUD	   patients	   indicated	   whether	   their	   traumatic	   past	   relates	   to	   what	   they	   believe	  
represents	   the	   origin	   of	   their	   addiction.	  Most	   SUD/PTSD	   patients	   responded	   that	   their	   trauma	  was	   a	  
cause	  of	  their	  addiction.	  Likewise,	  the	  same	  belief	  that	  trauma	  caused	  substance	  abuse	  and	  dependence	  
was	   reported	   by	  most	   SUD/probable	   PTSD	   and	   SUD/no	   PTSD	   patients.	   A	   logistical	   regression	   analysis	  
was	  conducted	  to	  predict	  the	  perception	  that	  addiction	  was	  caused	  by	  a	  traumatic	  exposure	  using	  PTSD	  
severity,	   current	  age,	   type	  of	   substance	   [depressant	  or	   stimulant],	  and	  gender	  as	  predictors.	  A	   test	  of	  
the	  full	  model	  against	  a	  constant	  only	  model	  was	  not	  significant,	  indicating	  that	  the	  predictors	  could	  not	  
distinguish	   between	   patients	   who	   felt	   that	   trauma	   caused	   their	   addiction	   and	   patients	   who	   felt	   that	  
trauma	  and	  start	  of	  addiction	  were	  two	  independent	  factors	  (Χ	  2	  =	  3.99,	  p	  >	  .05).	  	  
All	  descriptives	  of	  this	  study	  are	  displayed	  in	  Table	  2.	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Table	  2.	  Descriptives.	  
	   SUD/PTSD	   SUD/prob.	  PTSD	   SUD/no	  PTSD	  








Motives	  (Mean	  +	  SD)	  
	  	  Enhancement	  	  
	  
	  	  Expansion	  	  
	  
	  	  Social	  	  
	  
	  	  Somatic	  	  
	  
	  	  Coping-­‐anxiety	  	  
	  
	  	  Coping-­‐depression	  	  
	  






















































Trauma	  -­‐	  relapse	  	  








strategies	  (Mean	  +	  SD)	  
	  	  Self-­‐blame	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Note	  n	  varies	  depending	  on	  which	  questionnaires/items	  were	  filled	  out	  by	  the	  patients.	  	  
	  
Motives	  for	  continued	  substance	  use	  
Results	   from	  the	  DMQ-­‐R	   indicated	  that	  coping	  motives	   (sum	  of	  coping-­‐anxiety,	  coping-­‐depression	  and	  
coping-­‐general)	  were	  mentioned	  most	  frequently	  as	  the	  primary	  motive	  for	  substance	  use,	  irrespective	  
of	  having	  PTSD.	  However,	  as	  can	  be	  seen	  in	  Table	  3,	  SUD	  patients	  use	  drugs	  or	  alcohol	  significantly	  more	  
because	   of	   social	   motives	   when	   they	   score	   higher	   on	   PTSD	   severity.	   There	   were	   no	   significant	  
differences	  between	   the	  PTSD	  groups	  with	   regard	   to	  other	  motives.	  Other	  predictors	  were,	   however,	  
responsible	  for	  outcome	  differences	  in	  coping-­‐anxiety	  motives	  (gender:	  B	  =	  .73,	  SE	  B	  =	  .34,	  t	  =	  2.11,	  p	  =	  
.039,	  and	  type	  of	  main	  substance:	  B	  =	  -­‐.94,	  SE	  B	  =	  .37,	  t	  =	  -­‐2.51,	  p	  =	  .014)	  somatic	  motives	  (type	  of	  main	  
substance:	  B	  =	  -­‐1.09,	  SE	  B	  =	  .36,	  t	  =	  -­‐3.01,	  p	  =	  .004)	  and	  enhancement	  motives	  (current	  age:	  B	  =	  -­‐.04,	  SE	  B	  
=	  .01,	  t	  =	  -­‐2.92,	  p	  =	  .005).	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Table	  3.	  Regression	  table	  with	  PTSD	  severity	  as	  significant	  predictor.	  
	   B	   SE	  B	   β	  
Social	  motives	  -­‐	  use	   .40	   .17	   .27*	  
Relapse	  -­‐	  trauma	   .58	   .23	   .31*	  
Rumination	   1.19	   .31	   .43**	  
Positive	  reappraisal	   -­‐.63	   .27	   -­‐.27*	  
Catastrophizing	   .90	   .28	   .36**	  
Other-­‐blame	   .58	   .29	   .24*	  
*	  p	  <	  .05	   	   **	  p	  <	  .005	  
	  
Opinions	  regarding	  the	  link	  between	  craving	  and	  relapse	  and	  trauma	  
We	  asked	  the	  included	  patients	  the	  following	  two	  questions:	  (1)	  According	  to	  your	  experience,	  what	  is	  
the	  connection	  between	  traumatic	  intrusions	  and	  craving?	  (2)	  According	  to	  you,	  what	  is	  the	  connection	  
between	   a	   traumatic	   past	   and	   relapse?	  No	   significant	   differences	   between	   the	   groups	  were	  detected	  
with	  regard	  to	  craving	  (B	  =	  .27,	  SE	  B	  =	  .22,	  t	  =	  1.20,	  p	  =	  .234).	  On	  average,	  SUD/PTSD	  patients	  felt	  that	  
relapse	   followed	   traumatic	  memories	  very	  often.	  This	  differed	   significantly	   from	  SUD/	  probable	  PTSD,	  
and	   SUD/no	   PTSD	   patients.	   As	   shown	   in	   Table	   3,	   PTSD	   severity	   was	   responsible	   for	   predicting	   this	  
difference.	  
Most	  SUD/PTSD	  patients	  (90.9%)	  stated	  that	  craving	  or	  a	  relapse	  happened	  always	  or	  often	  as	  a	  
consequence	  of	  their	  traumatic	  past	  as	  compared	  to	  63.6%	  of	  SUD/probable	  PTSD	  patients	  and	  57.9%	  of	  
SUD/no	  PTSD	  patients.	  A	  logistical	  regression	  analysis	  showed	  however	  that	  these	  differences	  were	  not	  
significant,	   indicating	   that	   the	   predictors	   could	   not	   distinguish	   between	   patients	   who	   perceived	   that	  
craving	  or	  relapse	  happened	  as	  a	  consequence	  of	  trauma	  and	  patients	  who	  perceived	  the	  two	  factors	  as	  
independent	  (Χ	  2	  =	  5.29,	  p	  =	  .381).	  	  
	  
Perceived	  relationship	  between	  SUD	  and	  PTSD	  	  
We	  asked	  the	  patients	  whether	  they	  ever	  used	  a	  substance	  after	  experiencing	  traumatic	  intrusions.	  We	  
found	  that	  90.9%	  of	  the	  SUD/PTSD	  patients	  reported	  having	  used	  drugs	  or	  alcohol	  after	  an	  intrusion	  (vs.	  
87.5%	   in	   the	   SUD/probable	   PTSD	   group	   and	   75%	   in	   the	   SUD/no	   PTSD	   group).	   Logistical	   regression	  
analysis	  showed	  that	  these	  results	  did	  not	  depend	  on	  PTSD	  severity	  or	  any	  of	  the	  other	  predictors	  (i.e.,	  
current	  age,	  type	  of	  substance	  [depressant	  or	  stimulant],	  and	  gender)	  (Χ	  2	  =	  3.45,	  p	  =	  .063).	  
90%	  of	  the	  SUD/PTSD	  patients	  with	  this	  experience	  added	  that	  their	  substance	  use	  was,	  at	  that	  
moment,	  effective	  in	  diminishing	  the	  intrusion.	  This	  percentage	  was	  lower	  in	  the	  other	  groups	  (76.5%	  in	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the	  SUD/probable	  group	  and	  77.3%	  in	  the	  SUD/no	  PTSD	  group),	  but	  this	  outcome	  was	  not	  predicted	  by	  
PTSD	  severity	  or	  any	  of	  the	  other	  predictor	  variables	  	  (Χ	  2	  =	  -­‐1.37,	  p	  =	  .242).	  	  
We	  further	  asked	  the	  patients	  to	  state	  whether	  they	  experience	  more,	  less,	  or	  the	  same	  amount	  
of	  PTSD	  symptoms	  during	  substance	  use	  and	  abstinence.	  We	  found	  that	  in	  the	  SUD/PTSD	  group,	  36.4%	  
reported	  fewer	  symptoms	  during	  substance	  use,	  45.5%	  experienced	  more	  PTSD	  symptoms,	  and	  in	  18.2%	  
of	   the	   SUD/PTSD	  patients,	   the	   symptoms	  did	   not	   change	  during	   substance	  use.	  Multinomial	   logistical	  
regression	   analysis	   showed	   that	   this	   outcome	   did	   not	   depend	   on	   one	   of	   the	   predictor	   variables	   (i.e.,	  
PTSD	  severity,	  current	  age,	  type	  of	  substance	  [depressant	  or	  stimulant],	  and	  gender;	  with	  all	  Χ2’s	  ≤	  3.65,	  
all	  p’s	  >	  .05.	  
	  
Cognitive	  emotion	  regulating	  strategies	  
Data	  analysis	  of	   the	  answers	  on	   the	  CERQ-­‐short	   indicated	   that	  SUD/PTSD	  patients	   scored	   significantly	  
higher	   on	   rumination,	   other-­‐blame	   and	   catastrophizing	   than	   SUD/no	   PTSD	   patients.	   Furthermore,	  
SUD/PTSD	  patients	   scored	   significantly	   lower	  on	  positive	   reappraisal.	  As	   can	  be	   seen	   in	  Table	  3	   these	  
differences	  were	  all	  predicted	  by	  PTSD	  severity.	  “Positive	  reappraisal”	  was	  also	  predicted	  by	  current	  age	  
(B	  =	  -­‐.05,	  SE	  B	  =	  .02,	  t	  =	  -­‐2.49,	  p	  =	  .015).	  	  Differences	  on	  “Positive	  Refocusing”	  were	  predicted	  by	  type	  of	  
main	  substance	  (B	  =	  -­‐1.48,	  SE	  B	  =	  .63,	  t	  =	  -­‐.28,	  p	  =	  .023).	  	  
	  
Expectancies	  of	  effect	  of	  substances	  on	  PTSD	  symptoms	  
Data	  on	  the	  P-­‐AEQ	  indicated	  that	  SUD	  patients	  with	  trauma	  exposure	   in	  their	  past	  have	  more	  positive	  
than	  negative	  expectancies	  about	   the	  effect	  of	   their	   favorite	   substance	  on	   trauma	   related	   symptoms.	  
None	  of	  the	  predictor	  variables	  predicted	  this	  relationship	  with	  all	  B’s	  ≤	  .46,	  all	  SE	  B’s	  ≤.28,	  all	  t’s	  ≤	  1.18,	  
and	  all	  p’s	  >	  .05.	  
	  
Discussion	  
This	  exploratory	  study	  aimed	  to	  get	  more	  insight	  into	  the	  perceptions	  of	  SUD/PTSD	  patients	  concerning	  
their	  SUD	  and	  PTSD	  symptoms.	  SUD	  patients	  with	  different	  levels	  of	  PTSD	  severity	  were	  asked	  to	  fill	  out	  
a	   survey	   and	   self-­‐report	   questionnaires.	   Two	   research	   questions	   were	   formulated.	   The	   first	   research	  
question	  in	  the	  present	  study	  concerned	  the	  perceived	  relation	  between	  SUD	  and	  past	  trauma.	  Although	  
the	  majority	  of	  SUD/PTSD	  patients	  claimed	  that	  their	  traumatic	  past	  is	  a	  cause	  of	  their	  SUD,	  this	  finding	  
was	  not	  specific.	  SUD	  patients	  with	  lower	  levels	  of	  PTSD	  severity	  reported	  likewise	  that	  their	  traumatic	  
past	  was	   a	   cause	   of	   their	   excessive	   substance	   use.	   SUD	   patients	  with	   a	   traumatic	   past	   thus	   consider	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trauma	   to	   be	   a	   causal	   factor	   in	   their	   addiction,	   regardless	   if	   the	   trauma	   led	   to	   PTSD.	   Almost	   all	  
SUD/PTSD	  patients	   in	  the	  study	  reported	  using	  substances	  to	  cope	  with	  the	  negative	  consequences	  of	  
their	   traumatic	   past.	   This	   self-­‐medicating	   behavior	   is	   deemed	   effective	   by	   a	   large	   majority	   of	   the	  
patients.	  The	  same	  holds,	  however,	  for	  SUD	  patients	  with	  lower	  levels	  of	  PTSD	  severity.	  	  
Comparing	   the	   results	   between	   groups	   we	   found	   that	   SUD/PTSD	   patients	   used	   substances	  
significantly	  more	  because	  of	  social	  motives.	  This	  finding	  can	  be	  explained	  by	  the	  detachment,	  distrust,	  
hyperarousal	  and	  anxiety	  PTSD	  patients	  often	  report.	  It	  seems	  that	  SUD/PTSD	  patients	  use	  substances	  to	  
feel	  more	  at	  ease	  in	  social	  environments.	  	  
Furthermore,	   SUD/PTSD	   patients	   have	   less	   adaptive	   cognitive	   emotion	   regulation	   strategies,	  
hold	   positive	   expectancies	   regarding	   the	   effect	   of	   the	   substance	   on	   their	   PTSD	   symptoms,	   and	  
abstinence	   does	   not	   improve	   PTSD	   symptomatology.	   It	   is	   therefore	   hardly	   surprising	   that	   SUD/PTSD	  
patients	  find	  it	  hard	  to	  stop	  using	  substances.	  	  
Our	  second	  research	  question	  concerned	  craving	  and	  relapse	  as	  a	  consequence	  of	  a	   traumatic	  
past.	  A	  clear	  link	  exists	  between	  craving,	  relapse,	  and	  PTSD	  symptoms	  but	  also	  SUD	  patients	  without	  (or	  
with	   less	   severe	  symptoms	  of)	  PTSD	  experience	  craving	  when	  being	   reminded	  of	   their	   traumatic	  past.	  
The	  link	  between	  relapse	  and	  PTSD	  related	  symptoms	  on	  the	  other	  hand,	  is	  specific	  for	  patients	  with	  the	  
comorbidity.	  	  
Important	  treatment	  implications	  can	  be	  drawn	  from	  this	  study.	  Since	  SUD	  patients	  experience	  a	  
clear	   link	   between	   their	   SUD	   and	   their	   traumatic	   past,	   it	   seems	   fit	   to	   introduce	   a	   trauma-­‐focused	  
component	   in	   their	   SUD	   treatment,	   even	   for	   patients	   with	   lower	   levels	   of	   PTSD	   severity.	   Psycho-­‐
education	  about	  the	  link	  between	  SUD	  and	  past	  trauma	  can	  be	  a	  first	  and	  non-­‐invasive	  step	  towards	  a	  
better	   understanding	   of	   symptom	   interplay.	   Furthermore,	   although	   almost	   all	   SUD	   patients	   with	   a	  
traumatic	   past	   reported	   the	   effective	   use	   of	   substances	   to	   cope	   with	   intrusions,	   the	   inadequacy	   of	  
coping	   skills	   was	   very	   specific	   for	   SUD	   patients	   with	   high	   PTSD	   severity,	   implying	   that	   coping	   skills	  
training	  should	  be	  an	  essential	  part	  of	  SUD	  treatment,	  especially	   for	  SUD/PTSD	  patients.	  From	  this	  we	  
can	  deduce	  that	  a	  phase-­‐oriented	  PTSD	  treatment	  seems	  most	  appropriate	  for	  SUD/PTSD	  patients.	  The	  
first	   phase	   of	   this	   treatment	   consists	   of	   improving	   coping	   skills	   and	   ameliorating	   emotion	   regulation	  
strategies	  (see	  Cloitre,	  et	  al.,	  2011).	  	  
To	  summarize,	  early	  trauma	  may	  engender	  individuals	  to	  develop	  an	  SUD	  (Brady,	  Back,	  &	  Coffey,	  
2004).	  In	  line	  with	  self-­‐medication	  theory,	  patients	  with	  comorbid	  SUD/PTSD	  report	  that	  substance	  use	  
is	  a	  maladaptive	  though	  effective	  way	  to	  cope	  with	  negative	  emotions,	   intrusive	  memories,	  and	  other	  
PTSD	  symptoms	   in	   that	   it	  decreases	  or	  dampens	  these	  symptoms.	  This	  of	  course	  reinforces	  substance	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use	  and	  raises	  the	  risk	  of	  developing	  dependence.	  When	  PTSD	  is	  left	  untreated,	  PTSD	  symptoms	  pose	  a	  
heightened	  risk	  for	  relapse	  of	  addictive	  behavior.	  Like	  other	  SUD	  patients	  (see	  Sinha,	  2000),	  SUD/PTSD	  
patients	  do	  not	  seem	  to	  have	  learned	  alternative	  ways	  of	  coping	  with	  negative	  emotions	  and	  cognitions.	  
The	   efficacy	   of	   addiction	   treatment	   programs	  would	   likely	   benefit	   from	   including	   some	   form	  of	   PTSD	  
treatment	   for	  SUD	  patients	  with	  clear	   (and	  sometimes	  debilitating)	   trauma	  exposure.	  The	   finding	   that	  
SUD/PTSD	   patients	   perceive	   a	   strong	   interrelatedness	   between	   trauma	   exposure,	   SUD	   and	   PTSD	  
symptoms,	  suggests	  that	  they	  would	  identify	  this	  additional	  PTSD	  therapy	  as	  useful	  and	  relevant.	  Based	  
on	   this	   study,	   we	   can	   thus	   conclude	   that	   possible	   barriers	   for	   the	   implementation	   of	   an	   integrated	  


















Gielen,	  N.,	  Krumeich,	  A.,	  Tekelenburg,	  M.,	  Nederkoorn,	  C.,	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  Havermans,	  R.	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  How	  
patients	  perceive	  the	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  craving,	  and	  relapse;	  a	  
qualitative	  study.	  Journal	  of	  Substance	  Use.	   	  
Chapter	  6
Patients	  speaking:	  how	  they	  perceive	  the	  
relationship	  between	  trauma,	  substance	  
abuse,	  craving,	  and	  relapse	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Pink	  Floyd	  –	  Comfortably	  Numb	  
There	  is	  no	  pain	  you	  are	  receding.	  
A	  distant	  ship,	  smoke	  on	  the	  horizon.	  
You	  are	  only	  coming	  through	  in	  waves.	  
Your	  lips	  move	  but	  I	  can't	  hear	  what	  you're	  saying.	  
When	  I	  was	  a	  child	  I	  caught	  a	  fleeting	  glimpse	  
Out	  of	  the	  corner	  of	  my	  eye.	  
I	  turned	  to	  look	  but	  it	  was	  gone	  
I	  cannot	  put	  my	  finger	  on	  it	  now	  
The	  child	  is	  grown,	  the	  dream	  is	  gone.	  




In	  this	  qualitative	  study,	  patients	  with	  comorbid	  substance	  use	  disorder	  (SUD)	  and	  post-­‐traumatic	  stress	  
disorder	  (PTSD)	  were	  interviewed	  on	  their	   ideas	  about	  the	  link	  between	  SUD	  and	  PTSD.	  Although	  they	  
clearly	   reported	  self-­‐medication,	   they	  also	  gave	  a	  more	  complex	  description	  of	  how	  they	  believe	  their	  
PTSD	  influences	  their	  SUD.	  The	  results	  suggest	  that	  SUD/PTSD	  patients	  believe	  they	  did	  not	  start	  using	  
substances	   because	   of	   their	   experienced	   traumas	   or	   PTSD,	   but	   that	   PTSD	   symptoms	   are	   nonetheless	  
important	  in	  the	  maintenance	  of	  their	  addictions.	  A	  clear	  link	  exists	  between	  craving,	  relapse,	  and	  PTSD	  
symptoms.	   SUD/PTSD	  patients	  would	  prefer	   a	   “whole-­‐person	  approach”	  when	  being	   treated	   for	   their	  
PTSD.	  It	   is	  suggested	  that	  the	  integration	  of	  skills	  training	  and	  attention	  for	  patients	  who	  are	  fearful	  of	  






LaCoursiere,	   Godfrey,	   and	   Ruby	   (1980)	   were	   probably	   the	   first	   authors	   to	   describe	   the	   link	   between	  
substance	   use	   disorder	   (SUD)	   and	   post-­‐traumatic	   stress	   disorder	   (PTSD).	   Starting	   in	   the	   early	   1980s,	  
many	  authors	  published	  articles	  that	  described	  the	  heightened	  prevalence	  of	  PTSD	  and	  trauma	  exposure	  
among	   SUD	   patients	   and	   emphasized	   the	   vulnerability	   of	   this	   patient	   subgroup	   (Bonin,	   Norton,	  
Asmundson,	  Dicurzio,	  &	  Pidlubney,	  2000;	  Gielen,	  Havermans,	  Tekelenburg,	  &	   Jansen,	  2012;	  Ouimette,	  
Brown,	  &	  Najavits,	  1998;	  Taber,	  McCormick,	  &	  Ramirez,	  1987).	  
Recent	  years	  have	  seen	  the	  publication	  of	  review	  articles	  that	  once	  again	  emphasize	  the	  need	  to	  
treat	  SUD	  and	  PTSD	  in	  a	  simultaneous	  and	  integrated	  manner	  (Dass-­‐Brailsford	  &	  Myrick,	  2010;	  Torchalla,	  
Nosen,	   Rostam,	   &	   Allen,	   2012;	   van	   Dam,	   Vedel,	   Ehring,	   &	   Emmelkamp,	   2012).	   Despite	   that	  
recommendation,	   addiction	   treatment	   facilities	   still	   do	   not	   seem	   to	   offer	   integrated	   treatment	   for	  
SUD/PTSD	   patients	   (Gielen,	   Krumeich,	   Havermans,	   Smeets,	   &	   Jansen,	   2014;	   Young,	   Rosen,	   &	   Finney,	  
2005).	  Why	  does	  this	  gap	  between	  science	  and	  clinical	  practice	  exist?	  And,	  even	  more	  importantly,	  what	  
should	  be	  done	  to	  bridge	  this	  gap?	  	  
It	   is	   relevant	   to	   learn	   more	   about	   how	   SUD/PTSD	   patients	   perceive	   the	   link	   between	   their	  
traumatic	  pasts	  and	  their	  SUD.	  How	  do	  patients	  feel	  about	  receiving	  integrated	  SUD/PTSD	  treatment?	  It	  
is	  clear	  from	  previous	  studies	  that	  we	  can	  learn	  a	  lot	  about	  the	  relationship	  between	  trauma	  exposure	  
and	  addiction	  by	  listening	  to	  patients’	  narratives	  (Larrabee	  &	  Bolden,	  2001;	  Sofaer	  &	  Firminger,	  2005).	  	  
Some	  researchers	  have	  queried	  the	  views	  of	  SUD	  patients	  with	  a	  traumatic	  past.	  For	  example,	  
the	  perceptions	   of	   patients	  who	   suffered	   sexual	   abuse	   as	   children	   and	  now	  have	   SUD	  have	  been	   the	  
focus	  of	  a	  qualitative	  study	  by	  Jarvis,	  Copeland,	  and	  Walton	  (1998)	  and	  a	  case	  study	  by	  Teusch	  (2001).	  
Both	   research	   teams	   noted	   the	   important	   role	   of	   self-­‐medication	   and	   coping	   for	   SUD	   patients	   with	  
comorbid	   PTSD,	   and	   both	   emphasized	   the	   complexity	   of	   this	   subgroup	   of	   patients.	   They	   noted	   that	  
feelings	   of	   impaired	   self-­‐esteem,	   hopelessness,	   shame,	   and	   guilt	   were	   possible	   barriers	   to	   PTSD	  
treatment.	  	  
Hall	  (2000)	  and	  Harris,	  Fallot,	  and	  Berley	  (2005)	  conducted	  qualitative	  studies	  that	  only	  included	  
traumatized	   women	   with	   SUD.	   Hall	   interviewed	   20	   women	   who	   had	   been	   abused	   as	   children	   and	  
concluded	  that	  the	  abuse	  was	  relevant	  to	  their	  current	  life	  difficulties.	  Negative	  ideas	  about	  self	  and	  the	  
future	  were	  manifested	  as	  possible	  barriers	  for	  treatment.	  The	  study	  by	  Harris	  et	  al.	  focused	  on	  recovery	  
and	  relapse	  prevention.	  They	  stressed	  the	  importance	  of	   interpersonal	  connectedness	  to	  sustaining	  an	  
abstinent	  lifestyle.	  This	  study	  found	  that	  depression	  and	  a	  lack	  of	  personal	  control	  were	  possible	  barriers	  
to	  successful	  treatment	  of	  these	  patients.	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We	   recently	   conducted	   a	   survey	   study	   in	   which	  we	   asked	   SUD	   patients	   with	   traumatic	   pasts	  
about	   how	   they	   perceive	   the	   interrelatedness	   between	   their	   traumatic	   pasts	   and	   SUD	   (Gielen,	  
Nederkoorn,	  &	  Havermans,	   2015b).	   This	   study	   included	  72	   SUD	  patients	  with	  different	   levels	  of	   PTSD	  
severity.	  We	  found	  that	  the	  SUD	  patients	  with	  severe	  PTSD	  used	  substances	  to	  cope	  with	  general	  stress	  
and	  had	   less	   adequate	   coping	   skills	   than	  SUD	  patients	  with	   less	   severe	  PTSD.	   Furthermore,	   this	   study	  
found	   that	   SUD/PTSD	   patients	   perceive	   a	   clear	   link	   between	   their	   past	   traumas	   and	   previous	   relapse	  
experiences.	  	  
Some	  questions	  still	   remain.	  Not	  much	  is	  known	  about	  what	  patients	  actually	  expect	  or	  prefer	  
during	   their	   treatment	   (Dass-­‐Brailsford	  &	  Myrick,	   2010).	   Furthermore,	   patient	   surveys	   and	   interviews	  
have	   shown	   that	   while	   some	   patients	   favor	   integrated	   treatment,	   other	   patients	   mainly	   mention	  
obstacles	  and	  barriers	  related	  to	  PTSD	  treatment	  during	  their	  SUD	  treatment	  (Brown,	  Stout,	  &	  Gannon-­‐
Rowley,	  1998;	  Hall,	  2000;	  Harris	  et	  al.,	  2005;	  Janikowski,	  Bordieri,	  &	  Glover,	  1997;	  Janikowski	  &	  Glover,	  
1994;	   Jarvis	   et	   al.,	   1998;	   Teusch,	   2001).	   It	   is	   not	   clear	  what	   determines	   this	   distinction.	  Furthermore,	  
although	   previous	   studies	   have	   found	   that	   SUD/PTSD	   patients	   perceive	   a	   link	   between	   their	   past	  
traumas	  and	   their	  SUD	   (Brown	  et	  al.,	  1998;	  Gielen	  et	  al.,	  2015b;	   Janikowski	  et	  al.,	  1997;	   Janikowski	  &	  
Glover,	  1994),	  we	  have	  no	  in-­‐depth	  understanding	  of	  how	  SUD/PTSD	  patients	  evaluate	  the	  role	  of	  PTSD	  
in	   the	   development	   and	   continuation	   of	   their	   substance	   dependency.	   Do	   patients	   think	   PTSD	   was	  
involved	   in	   the	   onset	   of	   their	   drug	   use,	   the	   transition	   into	   an	   addiction	   or	   the	   continuation	   of	   the	  
addiction	  and	  relapses?	  These	  missing	  factors	  could	  be	   important	  to	  the	  successful	   implementation	  of	  
integrated	  SUD/PTSD	  treatment.	  	  
We	   determined	   that	   a	   qualitative	   research	   design	   was	   most	   suitable	   to	   reach	   this	   in-­‐depth	  
understanding	  of	   the	  perceptions	  of	  SUD/PTSD	  patients.	  We	  then	   formulated	   two	  research	  questions:	  
(1)	  According	  to	  SUD/PTSD	  patients,	  why	  did	  they	  start	  using	  drugs/alcohol	  and	  why	  did	  they	  keep	  using	  
the	   substance?	   and	   (2)	  What	   types	   of	   treatment	  would	   SUD/PTSD	   patients	   prefer	   and	  why?	   To	   help	  
answer	   these	   questions,	   an	   independent	   researcher	   conducted	   semi-­‐structured	   interviews	   with	  
SUD/PTSD	  patients.	  	  
	  
Methods	  
Data	  collection	  and	  sampling	  
We	  recruited	  432	  SUD	  patients	  for	  a	  prevalence	  study.	  These	  patients	  were	  all	  in	  treatment	  for	  SUD	  and	  
were	  asked	  to	  fill	  out	  a	  PTSD	  questionnaire;	  36.6%	  of	  them	  had	  a	  positive	  diagnosis	  for	  PTSD	  (Gielen	  et	  
al.,	  2012).	  From	  this	  group,	  we	  selected	  10	  patients	  using	  the	  following	  selection	  criteria:	  main	  product	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(i.e.,	   previously	   preferred	   psychotropic	   substance	   for	   misuse),	   age,	   and	   treatment	   facility.	   This	  
purposeful	   sampling	   strategy	   was	   used	   to	   achieve	   a	   heterogeneous	   sample	   of	   treatment-­‐seeking	  
SUD/PTSD	   patients	   with	   differing	   characteristics.	   One	   patient	   was	   excluded	   from	   further	   analysis	  
because	   that	   patient	   showed	   psychotic	   symptoms	   during	   the	   interview.	   All	   interviewed	   patients	   had	  
experienced	   type	   II	   trauma	  with	  multiple,	   prolonged,	   or	   chronic	   traumas	   happening	   throughout	   their	  
lives;	   these	   included	   emotional	   neglect/abuse,	   sexual	   abuse,	   physical	   abuse,	   imprisonment,	   and/or	  
being	   confronted	   by	   or	   witnessing	   death.	   Most	   patients	   had	   experienced	   a	   traumatic	   event	   in	   their	  
childhoods	  and	  started	  using	  drugs	  and/or	  alcohol	  as	  teenagers.	  	  
The	   SUD/PTSD	   patients	   we	   interviewed	   experienced	  many	   current	   complaints	   and	   problems.	  
Most	  of	  them	  stated	  that	  their	  problems	  had	  already	  started	  in	  childhood.	  They	  went	  on	  to	  experience	  
difficulties	   in	   their	   relationships	   and	   their	   families.	   Some	   had	   legal	   problems	   and	   others	   reported	  
problems	  related	  to	  their	  social	  environments	  and	  their	  finances.	  Finally,	  the	  patients	  were	  troubled	  by	  
health-­‐related	  issues.	  Table	  1	  shows	  the	  sample	  characteristics	  of	  the	  interviewed	  individuals.	  
	  
Table	  1.	  Sample	  characteristics.	  
	   Gender	   Preferred	  
substance	  	  
Age	   Treatment	  facility	  
1	  	   Male	  	   Poly	   36	   ambulatory	  treatment	  
2	  	   Female	  	   Poly	   49	   double	  diagnosis	  ward	  
3	  	   Male	  	   Alcohol	  	   64	   outpatient	  treatment	  
4	  	   Male	  	   Poly	   29	   reintegration	  training	  
5	  	   Male	  	   Poly	   37	   forensic	  psychiatric	  addiction	  care	  
6	  	   Male	  	   Poly	   53	   double	  diagnosis	  ward	  
7	  	   Male	  	   Poly	   28	   ambulatory	  treatment	  
8	  	   Male	  	   Poly	   46	   motivational	  center	  
9	  	   Male	   Alcohol	  	   63	   clinical	  continuation	  ward	  	  
	  
Procedure	  
Patients	   were	   interviewed	   by	   an	   independent	   trained	   interviewer,	   a	   student	   working	   on	   a	   Master’s	  
degree	   in	   mental	   health	   who	   had	   frequent	   consultations	   with	   her	   supervisors.	   Interviews	   were	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audiotaped	  for	  later	  transcription.	  A	  topics	  list	  was	  used	  so	  that	  the	  following	  themes	  were	  included	  in	  
the	  interviews:	  the	  perceived	  link	  between	  SUD	  and	  PTSD,	  the	  perceived	  reasons	  for	  first	  substance	  use	  
and	   continued	   substance	   use,	   the	   perceived	   link	   between	   trauma	   and	   craving	   and	   relapse,	   and	  
preferred	   treatment.	   The	   interviewer,	   who	  was	   familiar	   with	   the	   organization,	   was	   instructed	   to	   ask	  
open-­‐ended	  questions	  and	  to	  approach	  the	  participants	  with	  a	  natural	  curiosity	  and	  respect	  to	  ensure	  
honest	  and	  frank	  answers.	  	  
Each	   semi-­‐structured	   in-­‐depth	   interview	   lasted	  approximately	  45	  minutes.	  When	  a	  participant	  
gave	  answers	  outside	  the	  scope	  of	  the	  interview,	  the	  interviewer	  brought	  the	  conversation	  back	  to	  the	  
subject.	   At	   the	   end	   of	   the	   interview,	   patients	  were	   debriefed	   and	   given	   information	   about	   PTSD	   and	  
treatment	  options.	  An	  independent	  co-­‐worker	  transcribed	  each	  interview.	  
Patients	  gave	  informed	  consent	  for	  study	  participation.	  They	  received	  gift	  vouchers	  worth	  €20	  in	  
exchange	  for	  their	  participation.	  
	  
Data	  analysis	  
We	  analyzed	  the	  data	  in	  a	  similar	  way	  as	  in	  our	  previously	  published	  study	  (Gielen	  et	  al.,	  2014).	  We	  used	  
content	  and	  inductive	  analysis	  to	  analyze	  the	  qualitative	  data	  (Pope,	  Ziebland,	  &	  Mays,	  2000).	  We	  read	  
the	   interview	   transcripts	   and	   added	   marginal	   notes	   (primarily	   open	   codes).	   Whatever	   came	   up	   and	  
fitted	  the	  text	  segment	  was	  written	   in	   the	  side-­‐line.	  When,	   for	  example,	   the	   interviewee	  talked	  about	  
the	  fact	  that	  he	  preferred	  a	  female	  therapist,	  the	  words	  “gender	  clinician”	  were	  written	  in	  the	  margin.	  
After	   we	   completed	   this	   analysis	   for	   all	   the	   interviews,	   we	   chose	   sensitizing	   concepts	   that	  
reflected	  associations	  in	  the	  marginal	  notes	  between	  the	  interviews.	  The	  sensitizing	  concepts	  were:	  (1)	  
reasons	  for	  continued	  substance	  use,	  (2)	  connection	  trauma	  –	  substance	  use,	  (3)	  craving,	  (4)	  relapse,	  (5)	  
trauma	  treatment,	  (6)	  consequences	  of	  trauma,	  (7)	  ages	  of	  trauma	  and	  first	  substance	  use,	  (8)	  reasons	  
for	  first	  substance	  use,	  (9)	  course	  of	  substance	  use,	  (10)	  type	  of	  trauma,	  (11)	  PTSD	  symptoms,	  and	  (12)	  
symptom	  decrease	  after	  substance	  use.	  	  
For	  each	  interview,	  we	  created	  a	  new	  document	  with	  the	  concepts	  as	  headings	  and	  pasted	  exact	  
copies	   of	   the	   respective	   text	   fragments	   below.	   We	   summarized	   the	   text	   fragments;	   each	   fragment	  
resulted	  in	  a	  one-­‐	  or	  two-­‐sentence	  summary.	  In	  this	  phase,	  we	  combined	  concepts	  2	  and	  12,	  as	  well	  as	  
concepts	  6	  and	  11.	  These	  summaries	  were	  then	  combined	  for	  all	  interviews,	  resulting	  in	  10	  documents	  
with	  all	   the	   summaries	   for	  each	   theme.	  The	  summaries	  were	  carefully	   checked	   for	   connections	  and	  a	  
higher	   level	   of	   abstraction	  was	   reached,	  with	   six	   new	   subcategories	   emerging.	   These	   final	   categories	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were:	  (1)	  first	  substance	  use,	  (2)	  course	  of	  SUD,	  (3)	  motives	  for	  continued	  substance	  use,	  (4)	  craving	  and	  
relapse,	  (5)	  link	  between	  SUD	  and	  PTSD,	  and	  (6)	  treatment	  preferences.	  
To	   account	   for	   a	   potential	   researcher	   effect,	   the	   transcribed	   interviews	   were	   independently	  
analyzed	   by	   two	   different	   investigators	   (i.e.,	   investigator	   triangulation).	   The	   first	   author	   analyzed	   the	  
data	  as	  outlined	  in	  this	  section,	  while	  the	  third	  author	  analyzed	  the	  data	  using	  Kleinman’s	  (1980)	  clinical	  
core	   functions	   as	   the	   guiding	   principle.	   Although	   the	   two	   investigators	   used	   different	   analysis	  
techniques,	  they	  came	  up	  with	  comparable	  results	  and	  conclusions.	  	  
	  
Results	  
First	  substance	  use	  
Analysis	   of	   the	   interviews	   showed	   that	   SUD/PTSD	   patients	   often	   started	   using	   alcohol/drugs	   as	  
teenagers.	   They	   described	   no	   stress-­‐	   or	   trauma-­‐related	   triggers;	   first	   substance	   use	   occurred	  without	  
any	  provocation	  and	  was	   seen	  as	  part	  of	   experimenting	   in	  one’s	   youth.	   Some	   stressed	   that	   their	   first	  
substance	  use	  happened	  in	  a	  social	  environment.	  For	  instance:	  “I	  started	  using	  hashish	  around	  age	  15	  or	  
16.	  …	  I	  just	  did	  it,	  I	  didn’t	  really	  think	  about	  it.”	  
	  
Course	  of	  SUD	  
SUD/PTSD	   patients	   described	   how	   their	   substance	   use	   gradually	   increased.	   They	   often	   started	   using	  
cannabis	   or	   alcohol,	   and	   then	   tried	   other	   drugs.	   This	   phenomenon	   relates	   to	   the	   gateway	   theory	   in	  
which	  less	  deleterious	  drugs	  pave	  the	  way	  for	  the	  use	  of	  more	  dangerous	  drugs	  (Vanyukov	  et	  al.,	  2012).	  
It	   is	   important	  to	  note	  that	  only	  one	  respondent	  identified	  trauma	  as	  a	  deteriorating	  factor.	  The	  other	  
patients	   described	   diverse	   factors	   that	   caused	   an	   increase	   in	   their	   substance	   use	   (e.g.,	   receiving	   the	  
monthly	   salary,	   working	   as	   a	   prostitute,	   burn-­‐out,	   change	   in	   the	   family	   situation,	   house	   parties,	  
withdrawal,	   friends	   who	   used	   substances).	   Factors	   related	   to	   improvement	   and	   abstinence	   were	  
pregnancy,	  military	  service,	  and	  health	  problems.	  	  
“It	  became	  more	  when	  I	  was	  18	  because	  of	  the	  house	  parties.	  We	  drank,	  sniffed,	  smoked,	  and	  
used	  XTC	  really	  hard.	  When	  I	  joined	  the	  army	  it	  was	  over.	  …	  After	  military	  service,	  I	  met	  a	  friend	  
who	  used	  heroin	  and	  I	  started	  using	  it	  too.”	  
	  
Motives	  for	  continued	  substance	  use	  
Patients	  were	  asked	  to	  elaborate	  upon	  their	  reasons	  or	  motives	  for	  substance	  use.	  Their	  motives	  can	  be	  
divided	   into	   social	   motives	   (e.g.,	   social	   pressure,	   belonging,	   parties,	   coziness,	   less	   social	   anxiety),	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addiction-­‐specific	  motives	   (e.g.,	  withdrawal,	   loss	   of	   control,	   substance	   cues,	   obsessive	   behavior,	   taste	  
and	  smell),	  expansion	  motives	   (e.g.,	  expanding	  one’s	  consciousness),	  enhancement	  motives	   (e.g.,	  kick,	  
reward,	   the	   feeling,	  opportunism,	  euphoria,	  boredom	  alleviation),	  and	  coping	  motives.	  Motives	   in	   this	  
last	   category	  were	  most	   frequently	   reported.	  Respondents	  used	  drugs	  or	   alcohol	   to	   forget,	   to	  escape	  
reality,	   to	   survive,	   to	   cope	   with	   difficulties,	   to	   feel	   safe,	   to	   have	   more	   self-­‐confidence,	   to	   dampen	  
negative	   emotions,	   or	   to	   be	   able	   to	   sleep,	   rest,	   or	   relax.	   Some	   of	   the	   respondents	  mentioned	   these	  
coping	   motives	   in	   specific	   relation	   to	   trauma,	   while	   others	   seemed	   to	   generalize	   it	   to	   all	   negative	  
emotions	  and	  thoughts.	  
“I	  drank	  to	  stop	  my	  negative	  feelings	  and	  to	  not	  be	  burdened	  by	  them.	  I	  don’t	  allow	  myself	  to	  
feel	  anything	  and	  I	  use	  alcohol	  as	  a	  means	  to	  get	  rid	  of	  my	  feelings.”	  
	  
Opinions	  regarding	  the	  link	  between	  craving	  and	  relapse	  and	  trauma	  
Patients	  were	  asked	  about	  their	  experiences	  with	  craving	  and	  relapse.	  They	  stated	  that	  cravings	  could	  
happen	  after	  drug	  or	  alcohol	  cue	  exposure	  or	  during	  withdrawal.	  Some	  SUD/PTSD	  patients	  specifically	  
mentioned	   that	   cravings	   occurred	   when	   they	   were	   confronted	   with	   trauma	   cues	   (e.g.,	   intrusions):	  
“Memories	  and	  nightmares	  precede	  my	  cravings.”	  
Relapse	  was	  described	  as	  a	  conscious	  choice,	  something	  that	  was	  usual	  and	  that	  could	  happen	  at	  
any	  moment	  after	  a	  period	  of	  abstinence.	  They	  described	  specific	   reasons	   for	   relapse,	  which	  matched	  
the	  motives	   for	   continued	   substance	  use	   and	  had	  a	   clear	   focus	  on	   coping	  motives.	  Other	   reasons	   for	  
relapse	  were	  the	  end	  of	  a	  pregnancy	  and	  revenge	  after	  relationship	  problems.	  Patients	  stated	  that	  the	  
chance	   of	   another	   relapse	   became	   higher	   every	   time	   they	   broke	   their	   abstinence	   rule.	   One	   patient	  
clearly	  described	  his	  negative	  thoughts	  about	  himself	  after	  a	  relapse:	  “I’m	  weak;	  I’ll	  never	  get	  rid	  of	  my	  
addiction.”	  Another	  patient	  stated:	  
“I	  continually	  relapsed	  because	  I	  couldn’t	  forget	  these	  people,	  couldn’t	  forget	  my	  problems.	  I	  got	  
stuck	  in	  using	  drugs.”	  
	  
Perceived	  relationship	  between	  SUD	  and	  PTSD	  	  
The	  interviewed	  patients	  clearly	  described	  examples	  of	  how	  they	  self-­‐medicated	  themselves	  with	  drugs	  
or	  alcohol	   to	  cope	  with	   the	  negative	  consequences	  of	   their	   traumatic	  pasts.	  Patients	  were	  aware	  that	  
the	  positive	  effects	  they	  experienced	  from	  drugs	  and	  alcohol	  are	  superficial	  and	  temporary.	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“When	  I	  use,	  I	  think	  about	  nothing,	  not	  about	  the	  negative	  things,	  the	  things	  that	  happened,	  the	  
memories...	  At	  that	  moment,	  I	  feel	  great!	  But	  it	  only	  lasts	  for	  a	  short	  time	  and	  I	  feel	  depressed	  
when	  it’s	  over.”	  
Some	  patients	  stated	  that	  PTSD	  symptoms	  do	  not	  diminish	  during	  intoxication.	  It	  is	  important	  to	  
note	   that	   some	   patients	   only	   became	   aware	   of	   the	   link	   between	   their	   traumatic	   past	   and	   their	  
substance	  use	  later	  in	  their	  lives.	  Their	  substance	  use	  typically	  increased	  after	  such	  a	  revelation.	  	  
	  
Treatment	  preferences	  
None	  of	  the	  interviewed	  patients	  had	  been	  treated	  for	  their	  PTSD.	  One	  patient	  even	  mentioned	  that	  this	  
was	  the	  first	  time	  in	  his	  life	  that	  someone	  had	  asked	  about	  his	  past	  traumatic	  experiences.	  
When	  we	  asked	  patients	  what	  they	  preferred	  with	  regard	  to	  the	  treatment	  of	  their	  PTSD,	  most	  
replied	  that	  they	  preferred	  a	  combination	  of	  individual	  and	  group	  treatments.	  Individual	  treatment	  was	  
believed	  to	  be	  easier,	  more	  emotion-­‐focused,	  safer,	  and	  more	  personal.	  Patients	  liked	  the	  attention	  they	  
received	  in	  individual	  treatment	  and	  the	  fact	  that	  they	  could	  discuss	  more	  details.	  They	  expressed	  that	  
they	  could	   learn	  more	  from	  an	   in-­‐depth	   individual	  approach.	  Patients	  had	  experienced	  that	  they	  were	  
better	   able	   to	   reflect	   during	   individual	   treatment.	   According	   to	   the	   patients,	   the	   ideal	   individual	  
treatment	  would	  take	  place	  weekly	  with	  a	  female	  therapist:	  someone	  who	  is	  strong	  and,	   if	  possible,	  a	  
“hands-­‐on”	   expert.	   There	   should	   be	   trust	   and	   a	   certain	   connection	   between	   the	   therapist	   and	   the	  
patient.	   Therapy	   should	   not	   necessarily	   be	   solution-­‐focused;	   patients	   deemed	   it	  more	   important	   that	  
the	  clinician	  listen,	  try	  to	  understand,	  confront,	  and	  keep	  on	  asking	  questions.	  	  
The	  patients	  also	  noted	  positive	  aspects	  of	   group	   therapy.	   These	   included	   the	   fact	   that	   group	  
interaction	   can	   be	   very	   enjoyable,	   that	   theoretical	   knowledge	   can	   directly	   be	   applied,	   and	   that	   other	  
patients	   often	   recognize	   problems	   and	   complaints.	   The	   patients	   pointed	   to	   the	   importance	   of	   closed	  
groups	  and	  sufficient	  profundity.	  A	  risk	  of	  group	  therapy	  is	  that	  it	  can	  be	  too	  impersonal.	  
Analysis	  of	  the	   interviews	  showed	  that	  patients	  receiving	  trauma	  treatment	  not	  only	  want	  to	  confront	  
the	  trauma,	  but	  to	  discuss	  daily	  hassles,	  like	  relationship	  and	  social	  problems.	  Some	  patients	  mentioned	  
that	  medication	  should	  be	  part	  of	  the	  treatment.	  Others	  wanted	  to	  improve	  their	  social	  and	  coping	  skills	  
during	  treatment.	  Since	  the	  patients	  believed	  that	  trauma	  treatment	  is	  hard	  and	  difficult,	  some	  of	  them	  
preferred	  treatment	  in	  a	  clinical	  setting.	  Patients	  hoped	  that	  trauma	  treatment	  could	  give	  them	  a	  new	  
start,	  teaching	  them	  how	  to	  enjoy	  life	  and	  feel	  connected	  with	  others.	  The	  patients	  mentioned	  that	  they	  
were	  not	  fully	  aware	  of	  the	  benefits	  of	  trauma	  treatment	  and	  most	  of	  them	  did	  not	  know	  what	  kind	  of	  
trauma	  treatment	  is	  possible.	  As	  one	  patient	  stated,	  “I	  don’t	  know	  what	  kind	  of	  help	  you	  can	  get.”	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Another	   important	   aspect	   patients	  mentioned	  was	   that	   they	   sometimes	   live	   in	   trauma-­‐prone	  
environments	  (e.g.,	  with	  a	  violent	  partner).	  These	  patients	  felt	  that	  trauma	  treatment	  would	  not	  help	  as	  
long	  as	  their	  surroundings	  did	  not	  change.	  
Although	  most	  patients	  favored	  integrated	  treatment	  of	  SUD	  and	  PTSD	  in	  which	  the	  person	  as	  a	  
whole	  can	  be	  treated	   instead	  of	  only	   the	  addiction,	  some	  patients	  did	  have	  hesitations.	  They	   felt	   that	  
trauma	  treatment	  would	  not	  change	  anything	  or	  they	  felt	  that	  there	  was	  no	  need	  for	  it,	  that	  life	  goes	  on.	  
One	  patient	  stated:	  “I	  want	  to	  leave	  it	  behind	  me;	  I	  don’t	  want	  to	  think	  about	  it.”	  Another	  said:	  
“I	   don’t	   know,	   I	   really	   don’t	   know.	   It’s	   so	  much…the	   enormous	   anxiety.	  On	   one	   hand,	   I	   think	  
don’t	  go	  into	  it;	  on	  the	  other	  hand,	  it	  keeps	  triggering	  me.”	  
	  
Discussion	  
In	   this	   qualitative	   study,	   we	   interviewed	   SUD/PTSD	   patients	   to	   learn	   more	   about	   their	   perceptions	  
regarding	  their	  comorbidity.	  We	  then	  attempted	  to	  answer	  two	  research	  questions.	  	  
The	   first	   research	   question	   concerned	   the	   motives	   of	   SUD/PTSD	   patients	   for	   starting	   to	   use	  
substances	  and	  continuing	  to	  do	  so.	  We	  noticed	  an	  apparent	  discrepancy	  in	  their	  answers.	  On	  the	  one	  
hand,	  patients	  reported	  that	  PTSD	  was	  not	  linked	  with	  their	  very	  first	  substance	  use	  or	  with	  aggravation	  
of	  their	  substance	  using	  pattern;	  instead,	  they	  mainly	  reported	  non-­‐trauma-­‐related	  reasons	  for	  starting	  
to	  use	  (or	  using	  more)	  substances.	  On	  the	  other	  hand,	  all	  the	  patients	  reported	  self-­‐medicating	  behavior	  
and	   craving	   after	   trauma	   intrusions.	   They	   declared	   that	   coping	   motives	   were	   the	   most	   important	  
reasons	  they	  used	  substances	  and	  that	  relapse	  often	  happened	  when	  they	  perceived	  no	  other	  means	  of	  
coping	  with	   a	   difficult	   situation.	   These	   results	   are	   in	   agreement	  with	   earlier	   findings	   from	  Ouimette,	  
Coolhart,	  Funderburk,	  Wade,	  and	  Brown	  (2007).	  	  
However,	   the	   self-­‐medicating	   behavior	   of	   SUD/PTSD	   patients	   is	   not	   limited	   to	   coping	   with	  
trauma-­‐related	   stress.	   They	   also	   reported	   using	   substances	   to	   cope	   with	   daily	   hassles	   and	   general	  
stressors	   and	   to	   feel	   more	   at	   ease	   in	   social	   environments.	   Previous	   researchers	   who	   compared	   the	  
coping	  styles	  of	  SUD	  patients	  with	  and	  without	  PTSD	  found	  that	  SUD/PTSD	  patients	  are	  characterized	  by	  
a	   maladaptive	   coping	   style	   (Gielen	   et	   al.,	   2015b;	   Ouimette,	   Finney,	   &	  Moos,	   1999;	   Staiger,	   Melville,	  
Hides,	  Kambouropoulos,	  &	  Lubman,	  2009).	  	  
Our	   second	   research	   goal	   was	   to	   explore	   which	   treatment	   options	   SUD/PTSD	   patients	   found	  
most	  feasible.	  None	  of	  the	  patients	  were	  being	  treated	  for	  PTSD	  and	  one	  patient	  even	  admitted	  that	  no	  
one	  had	  ever	  asked	  about	  his	  traumatic	  past.	  This	  confirms	  our	  earlier	  findings	  about	  under	  diagnosis	  of	  
PTSD	  in	  SUD	  patients	  (Gielen	  et	  al.,	  2012,	  2014).	  We	  further	  found	  that	  patients	  are	  well	  aware	  of	  what	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kinds	  of	  treatment	  they	  prefer.	  Most	  SUD/PTSD	  patients	  favor	  simultaneous	  treatment	  of	  SUD	  and	  PTSD	  
that	   combines	   individual	   and	   closed	   group	   treatment,	   and	   in	  which	   the	   person	   as	   a	  whole	   is	   treated	  
(they	   judged	   a	   primary	   focus	   on	   SUD	   or	   PTSD	   to	   be	   insufficient).	   The	   patients	   further	   expressed	   a	  
preference	   for	   female	   therapists.	   Ambulatory	   treatment	   was	   seen	   as	   a	   possibility	   but	   it	   should	   be	  
possible	   to	   switch	   to	   in-­‐patient	   treatment	   if	   necessary.	   Some	   patients	   were	   reluctant	   to	   start	   PTSD	  
treatment,	  which	   is	  understandable	   in	   the	   light	  of	   their	  avoidance	  symptoms.	  A	   final	   important	   result	  
was	  that	  SUD/PTSD	  patients	  knew	  very	  little	  about	  possible	  PTSD	  treatments.	  Clearly,	  these	  two	  factors	  
(avoiding	   traumatic	   memories	   and	   lack	   of	   knowledge	   about	   treatment	   options)	   form	   barriers	   to	  
implementing	  a	  standard	  integrated	  SUD/PTSD	  treatment	  for	  this	  particular	  patient	  group.	  
Although	   self-­‐medicating	   behavior	   in	   SUD/PTSD	   patients	   seems	   obvious,	   it	   appears	   more	  
appropriate	   to	  use	  a	  more	  complex	  etiological	   theory	   to	  explain	   the	   link	  between	  SUD	  and	  PTSD.	  The	  
SUD/PTSD	  patients	  said	  that	  they	  did	  not	  start	  using	  drugs	  or	  alcohol	  because	  of	  their	  PTSD.	  However,	  
the	  influence	  of	  PTSD	  on	  SUD	  is	  particularly	  important	  in	  maintaining	  any	  addictive	  behavior.	  PTSD	  has	  
to	  be	  experienced	  as	   instrumental	  before	  it	  reinforces	  further	  drug	  use.	  More	  research	  on	  this	   issue	  is	  
warranted.	  It	  would	  be	  particularly	  interesting	  to	  examine	  whether	  PTSD	  patients	  with	  and	  without	  SUD	  
report	  differences	  in	  initial	  substance	  use	  and	  in	  the	  perceived	  function	  of	  the	  substance	  use.	  	  
Finally,	   a	   clear	   link	   exists	   between	   craving,	   relapse	   and	   PTSD	   symptoms.	   SUD/PTSD	   patients	  
expect	  a	  whole-­‐person	  approach	  when	  being	  treated	  for	  their	  PTSD.	  The	  integration	  of	  skills	  training	  and	  
attention	   for	  patients	  who	  are	   fearful	   of	   PTSD	   treatment	  might	   further	   improve	   SUD/PTSD	   treatment	  
results.	  	  


































K’s	  choice	  –	  Not	  an	  Addict	  
The	  deeper	  you	  stick	  it	  in	  your	  vein	  	  
The	  deeper	  the	  thoughts	  there's	  no	  more	  pain	  	  
I'm	  in	  heaven,	  I'm	  a	  god	  	  
I'm	  everywhere,	  I	  feel	  so	  hot	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Previous	  studies	  have	  documented	  a	  strong	  link	  between	  PTSD	  and	  SUD.	  Patients	  with	  this	  comorbidity	  
bear	  the	  burden	  of	  two	  severe,	  mutually	   influencing,	  and	  often	  chronic	  disorders.	  Both	  SUD	  and	  PTSD	  
might	   push	   a	   person	   into	   social	   isolation	   and	   secrecy.	   When	   such	   a	   person	   finally	   does	   seek	   help,	  
treatment	  possibilities	  are	  limited.	  	  
When	  examining	   clinical	   guidelines	   and	   clinical	   research,	   there	   is	   a	   growing	   consensus	   that	   in	  
case	  of	  SUD/PTSD	  comorbidity	  treatment	  should	  be	  offered,	  immediately,	  and	  in	  an	  integrated	  manner	  
(Berenz	  &	  Coffey,	  2012;	  Kivlahan	  &	  Kaysen,	  2012;	  McCauley	  et	  al.,	  2012;	  Najavits	  &	  Hien,	  2013;	  Ruzek,	  
Polusny,	  &	  Abueg,	  1998;	  Snoek,	  Wits,	  Meulders	  &	  van	  de	  Mheen,	  2012;	  van	  Dam	  et	  al.,	  2012).	  Why	  is	  it	  
then	   that	   SUD	   treatment	   centers	   have	   not	   implemented	   this	   integrated	   treatment	   for	   comorbid	  
SUD/PTSD	  (Ducharme,	  Knudsen,	  &	  Roman,	  2006;	  Killeen,	  Back,	  &	  Brady,	  2015)?	  And	  what	  is	  missing	  that	  
might	   facilitate	   bridging	   the	   gap	   between	   SUD/PTSD	   research	   and	   clinical	   practice?	   In	   addition,	   the	  
precise	  interaction	  between	  the	  two	  disorders	  is	  not	  clear	  yet.	  It	  is	  often	  suggested	  that	  substances	  are	  
used	   to	   reduce	   the	  mental	  pain	   caused	  by	  PTSD,	  but	   it	   is	   also	  possible	   that	   the	  motives	  of	   SUD/PTSD	  
patients	  to	  use	  substances	  are	  related	  to	  their	  inadequacy	  to	  cope	  with	  stress	  in	  general.	  	  
The	   central	   theme	   of	   the	   present	   dissertation	   concerned	   the	   interaction	   between	   SUD	   and	  
PTSD.	  Three	  main	  aims	  were	  addressed	  in	  this	  thesis:	  (1)	  to	  study	  the	  prevalence	  and	  the	  vulnerability	  of	  
patients	  with	  SUD/PTSD	  comorbidity	  (Chapters	  2,	  3,	  5,	  and	  6),	  (2)	  to	  study	  how	  the	  craving	  response	  of	  
SUD/PTSD	  patients	  interacts	  with	  personalized	  trauma	  and	  stress	  cues	  (Chapters	  3,	  5,	  and	  6),	  and	  (3)	  to	  
examine	  why	  the	  implementation	  of	  integrated	  SUD/PTSD	  treatment	  has	  been	  unsuccessful	  (Chapters	  2,	  
4,	  5,	  and	  6).	  The	  following	  sections	  provide	  an	  overview	  and	  discussion	  of	  the	  main	  findings;	  theoretical	  
and	   clinical	   implications	   are	   put	   forward;	   limitations	   of	   the	   studies	   are	   discussed	   and	   suggestions	   for	  
future	  research	  are	  given.	  
	  
Main	  findings	  
	  	   	  
PREVALENCE	  AND	  VULNERABILITY	  OF	  PATIENTS	  WITH	  SUD	  AND	  PTSD	  
	  
The	   first	  aim	  of	   the	  dissertation	  was	   to	  examine	  both	   the	  prevalence	  and	  the	  vulnerability	  of	  patients	  
with	  SUD	  and	  PTSD.	  The	  prevalence	  of	  PTSD	  and	  trauma	  exposure	  in	  SUD	  patients	  was	  compared	  with	  
the	  prevalence	  of	  PTSD	  and	  trauma	  exposure	  in	  a	  “healthy”	  control-­‐group	  using	  the	  same	  validated	  self-­‐
report	   questionnaire	   in	   Chapter	   2.	  More	   than	   one	   third	   of	   SUD	  patients	   scored	   positive	   on	   the	   PTSD	  
questionnaire	   compared	   to	  one	   in	   ten	  of	   the	   individuals	   in	   the	   control	   group.	  And	  while	  both	   groups	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reported	  high	  rates	  of	  trauma	  exposure,	  this	  number	  was	  significantly	  higher	  in	  the	  SUD-­‐patient	  group	  
(97.4%	  vs.	  86.3%).	  
In	  the	  same	  study	  we	  investigated	  the	  vulnerability	  of	  SUD/PTSD	  patients.	  One	  finding	  was	  that	  
SUD/PTSD	  patients	  share	  substantial	  similarities	  with	  SUD	  patients	  who	  experienced	  trauma	  but	  did	  not	  
develop	   PTSD.	   Indeed,	   both	   groups	   did	   not	   differ	   in	   age,	   gender	   distribution,	   number	   of	   previous	  
treatments,	   time	   in	   treatment,	   treatment	   outcome,	   primary	   substance,	   criminal	   past,	   financial	   debts,	  
and	  relational	  status.	  Only	  two	  demographic	  factors	  were	  markedly	  different:	  SUD/PTSD	  patients	  were	  
more	   often	   unemployed	   and	   had	   a	   lower	   educational	   level.	   Moreover,	   with	   regard	   to	   psychiatric	  
comorbidity,	  SUD/PTSD	  patients	  were	  more	  likely	  to	  have	  depressive	  disorders	  and	  were	  more	  likely	  to	  
have	  another	  axis	  I	  disorder	  compared	  to	  SUD/no	  PTSD	  patients.	  
Other	  results	  pointing	  to	  the	  vulnerability	  of	  SUD/PTSD	  patients	  are	  described	   in	  Chapter	  3.	   In	  
this	  study,	  the	  sample	  consisted	  of	  SUD	  patients	  who	  had	  experienced	  trauma	  and	  who	  were	  sober	  or	  
clean	   for	   some	   time.	   The	   participants	   had	   different	   levels	   of	   PTSD	   severity.	   The	   participants	   were	  
exposed	  to	  narrative	  cues	  in	  the	  absence	  of	  in	  vivo	  drug	  cues.	  SUD/PTSD	  patients	  were	  found	  to	  crave	  
more	  and	  to	  feel	  more	  tense	  in	  all	  conditions	  of	  this	  experiment	  as	  compared	  to	  SUD	  patients	  with	  lower	  
levels	  of	  PTSD	  severity.	  Furthermore,	  SUD	  patients	  with	  high	  PTSD	  severity	  craved	  more	  after	  both	  stress	  
and	  trauma	  exposure	  compared	  to	  neutral	  exposure.	  Thus,	  not	  only	  exposure	  to	  traumatic	  triggers,	  but	  
also	   more	   general	   stress	   cues	   elicit	   strong	   craving	   in	   particularly	   SUD/PTSD	   patients	   and	   this	   makes	  
them	  more	  vulnerable	  to	  relapse	  of	  addictive	  behavior	  after	  treatment.	  	  
The	   lack	   of	   adequate	   coping	   skills	   in	   SUD/PTSD	   patients	  was	   noted	   in	   the	   study	   described	   in	  
Chapter	   5.	   In	   this	   study,	   the	   sample	   consisted	   of	   SUD	   patients	   with	   previous	   trauma	   exposure	   and	  
differing	  levels	  of	  PTSD	  severity.	  As	  PTSD	  severity	  predicted	  the	  coping	  outcome,	  it	  was	  concluded	  that	  
SUD	   patients	   with	   PTSD	   have	   inadequate	   cognitive	   emotion	   regulation	   strategies.	   Specific	   for	   the	  
SUD/PTSD	  patients	  was	  also	  the	  increased	  use	  of	  substances	  because	  of	  social	  motives,	  which	  was	  less	  
frequently	   named	   as	   a	  motive	   in	   SUD	  patients	  with	   no/less	   severe	   PTSD	   and	   that	   SUD/PTSD	  patients	  
perceived	  a	  strong	  link	  between	  relapse	  and	  traumatic	  intrusions.	  	  
The	   vulnerability	   of	   SUD/PTSD	   patients	  was	   also	   examined	   in	   a	   qualitative	   study	   described	   in	  
Chapter	  6.	  SUD/PTSD	  patients	  were	   interviewed	  and	   in	   the	   interviews,	  patients	   stressed	   that	   they	  did	  
not	  only	  struggle	  with	  the	  consequences	  of	  past	  trauma	  and	  substance	  use,	  but	  that	  they	  also	  needed	  
counseling	   for	   problems	   in	   their	   current	   social	   environment	   and	   relationships.	   Furthermore,	   the	  
interviewed	   patients	   declared	   that	   they	   mostly	   used	   substances	   to	   cope	   with	   negative	   emotions	   or	  
cognitions,	  implying	  the	  absence	  of	  adaptive	  coping	  skills.	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In	  sum,	  SUD/PTSD	  patients	  account	  for	  a	  substantial	  subgroup	  of	  patients.	  Their	  inadequacy	  to	  
cope	  with	  social	   situations,	  negative	  affect,	  general	   stressors,	  and	  traumatic	   triggers	  puts	   them	  at	   risk	  
for	  increased	  craving	  and	  relapse.	  
	  
CUED	  CRAVINGS	  TO	  TRAUMA	  AND	  STRESS	  CUES	  
	  
The	   second	   aim	  of	   this	   thesis	  was	   to	   study	   how	   the	   craving	   response	   of	   SUD/PTSD	  patients	   interacts	  
with	   personalized	   trauma	   and	   stress	   cues.	   The	   participants	   of	   the	   experiment	   described	   in	   Chapter	   3	  
were	   exposed	   to	   three	   auditory	   cues:	   a	   neutral	   script,	   their	   personalized	   trauma	   script,	   and	   a	  
personalized	   stress	   script.	   SUD	   patients	   with	   high	   PTSD	   severity	   craved	   more	   and	   felt	   more	   tense	  
throughout	   the	   experiment.	  Moreover,	   these	   patients	   craved	   significantly	  more	   after	   both	   stress	   and	  
trauma	  cue	  exposure,	  compared	  to	  neutral	  script	  exposure.	  
The	  results	  described	   in	  Chapter	  5	  demonstrated	  that	  substances	  are	  abused	  to	  cope	  with	  the	  
consequences	   of	   trauma,	   but	   equally	   to	   endure	   general	   stressors.	   However,	   this	   self-­‐medicating	  
behavior	  did	  not	   seem	  to	  be	  specific	   for	  SUD/PTSD	  patients.	   Indeed,	  SUD	  patients	  who	  experienced	  a	  
past	  trauma	  but	  did	  not	  develop	  PTSD	  reported	  that	  they	  too	  use	  substances	  in	  response	  to	  trauma	  and	  
stress.	  When	  SUD	  patients	  with	  and	  without	  PTSD	  were	  asked	  about	   their	  experiences	  of	   relapse	  as	  a	  
consequence	  of	  PTSD	  symptoms,	  PTSD	  severity	  did	  predict	   the	  outcome.	  SUD	  patients	  with	  high	  PTSD	  
scores	  reported	  to	  relapse	  significantly	  more	  often	  as	  a	  consequence	  of	  their	  traumatic	  past.	  
The	  qualitative	  patient	  study	  (Chapter	  6)	  showed	  that	  SUD/PTSD	  patients	  view	  craving,	  relapse,	  
and	  trauma	  cues	  as	  interrelated,	  but	  also	  report	  that	  they	  use	  substances	  to	  cope	  with	  stress.	  	  
In	  sum,	  it	  appears	  that	  SUD/PTSD	  patients	  experience	  not	  solely	  a	  link	  between	  trauma	  cues	  and	  
craving,	   but	   equally	   between	   stress	   cues	   and	   craving.	   Although,	   subjectively,	   SUD	   patients	   with	   low	  
levels	  of	  PTSD	  severity	  also	  report	  to	  crave	  substances	  when	  remembering	  trauma	  or	  when	  experiencing	  
stress,	   an	   experimental	   manipulation	   showed	   that	   this	   trauma/stress	   elicited	   craving	   is	   particularly	  
strong	  in	  SUD/PTSD	  patients.	  
	  
UNSUCCESFUL	  IMPLEMENTATION	  OF	  INTEGRATED	  SUD/PTSD	  TREATMENT	  
	  
The	   third	   aim	   of	   this	   dissertation	   was	   to	   examine	   why	   the	   implementation	   of	   integrated	   SUD/PTSD	  
treatment	  was	  not	  established.	  Chapter	  2	  revealed	  some	  important	  aspects	  with	  regard	  to	  this	  matter.	  It	  
was	   found	   that	   structural	   screening	   of	   PTSD	   in	   SUD	  patients	   did	   not	   take	   place,	   resulting	   in	   a	   severe	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underdiagnosis	  of	  PTSD.	  Despite	   the	   fact	   that	  almost	   four	  out	  of	   ten	  SUD	  patients	  mentioned	   trauma	  
exposure	  and	  one-­‐fifth	  described	  PTSD	  symptoms	  during	  their	  intake	  interview,	  only	  in	  less	  than	  5%	  of	  
cases	   possible	   PTSD	   was	   reported	   by	   the	   clinicians	   who	   interviewed	   the	   patients	   during	   the	   intake	  
procedure.	  When	  examining	   the	   final	  diagnosis	   in	   the	  patient	   files,	   this	  number	   further	  dropped;	  only	  
2.1%	   of	   the	   SUD	   patients	   was	   diagnosed	   with	   PTSD	   as	   compared	   to	   36.6%	   when	   a	   validated	  
questionnaire	  was	  used.	  
Addiction	  therapists,	  though	  well	  aware	  of	  the	  negative	  consequences	  of	  trauma	  on	  SUD,	  were	  
not	  aware	  of	  the	  heightened	  prevalence	  score	  of	  PTSD	  (Chapter	  4).	  It	  is	  conceivable	  that	  because	  of	  this	  
underestimation	   PTSD	   treatment	   does	   not	   receive	   priority	   in	   SUD	   treatment	   and	   clinicians	   do	   not	  
examine	   new	   treatment	   protocols,	   or	   specific	   diagnostic	   tools.	   Besides	   this	   underestimation,	   the	  
interviewed	  clinicians	  reported	  that	  they	  were	  careful,	  even	  avoidant	  to	  discuss	  trauma	  with	  their	  SUD	  
patients.	  This	  careful	  approach	  was	  fed	  by	  the	  perception	  that	  asking	  for	  and	  talking	  about	  trauma	  elicits	  
craving,	   and	   possibly	   relapse.	   Furthermore,	   clinicians	   clearly	   stated	   that	   PTSD	   is	   not	   a	   focus	   in	   SUD	  
treatment	   because	   the	   institution	   they	   work	   for	   does	   not	   support	   PTSD	   treatment	   during	   SUD	  
treatment.	   In	  other	  words,	   clinicians	  neither	   receive	   training	   for	  PTSD	  diagnosis	  or	   treatment,	  nor	  are	  
they	   allowed	   spending	   too	  much	   time	   on	   other	   problems	   besides	   SUD.	   As	   a	   result	   PTSD	   is	   not	   well	  
assessed	  or	  treated	  during	  SUD	  treatment.	  
Chapter	  5	  describes	  some	  patient	  factors	  that	  might	  explain	  the	  unsuccessful	  implementation	  of	  
the	  advised	  integrated	  treatment.	  Patients	  perceive	  that	  substance	  use	  is	  effective	  in	  diminishing	  PTSD	  
symptoms,	   they	   feel	   that	   abstinence	  does	  not	   improve	  PTSD	   symptomatology,	   and	   they	  hold	  positive	  
expectancies	   regarding	   the	   effect	   of	   the	   substance	   on	   their	   PTSD	   symptoms.	   It	   is	   therefore	   hardly	  
surprising	  that	  SUD/PTSD	  patients	  are	  reluctant	  to	  start	  an	  integrated	  SUD/PTSD	  treatment.	  
Chapter	  6	  describes	  some	  last	  factors	  that	  might	  hinder	  successful	  implementation	  of	  integrated	  
SUD/PTSD	   treatment.	   Since	   SUD/PTSD	   patients	   are	   anxious	   or	   reluctant	   to	   start	   PTSD	   treatment	   this	  
might	  further	  discourage	  clinicians	  to	  implement	  PTSD	  treatment	  during	  SUD	  treatment.	  Also,	  patients	  
are	   often	   not	   aware	   of	   possible	   PTSD	   treatments	   and	   this	   lack	   of	   knowledge	  might	   prevent	   them	   of	  
discussing	  trauma	  treatment	  with	  their	  clinicians.	  The	  fact	  that	  all	  of	  the	  interviewed	  SUD/PTSD	  patients	  
never	  received	  PTSD	  treatment	  confirms	  previous	  research	  findings	  that	  integrated	  SUD/PTSD	  treatment	  
is	  not	  implemented.	  
Thus,	   it	   was	   found	   that	   the	   unsuccessful	   implementation	   integrated	   SUD/PTSD	   treatment	   is	  
explained	   by	   a	   combination	   of	   factors:	   the	   severe	   underdiagnosis	   and	   underestimation	   of	   PTSD,	   the	  
avoidance	  of	  both	  patients	  and	  clinicians,	  the	  absence	  of	  facilitation	  to	  diagnose	  and	  treat	  PTSD	  patients	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properly,	   the	   lack	   of	   knowledge	   of	   patients	   about	   PTSD	   treatment	   possibilities,	   and	   the	   efficiency	   of	  
substances	  to	  diminish	  PTSD	  symptoms.	  	  
	  
Discussion	  of	  research	  findings	  
	  
PREVALENCE	  AND	  VULNERABILITY	  OF	  PATIENTS	  WITH	  SUD	  AND	  PTSD	  
	  
It	  was	  found	  that	  36.6%	  of	  SUD	  patients	  scored	  positive	  on	  PTSD	  and	  that	  almost	  every	  SUD	  patient	  had	  
encountered	  at	  least	  one	  traumatic	  experience	  in	  his/her	  lifetime.	  These	  numbers	  are	  significantly	  lower	  
in	   individuals	   without	   substance	   dependence.	   The	   results	   of	   some	   comparable	   studies	   (measuring	  
current	  PTSD	  in	  a	  heterogeneous	  SUD	  population)	  are	  consistent	  with	  my	  prevalence	  data	  described	  in	  
Chapter	  2.	  In	  prior	  studies	  in	  SUD	  populations,	  current	  PTSD	  was	  found	  to	  be	  prevalent	  in	  25.3	  –	  41%	  of	  
cases	  (Bonin	  et	  al.,	  2000;	  Driessen	  et	  al.,	  2008;	  Ouimette	  et	  al.,	  2007;	  Read	  et	  al.,	  2004;	  Reynolds	  et	  al.,	  
2005).	   Studies	   in	   SUD	   populations	   that	   assessed	   incidence	   of	   trauma	   exposure	   typically	   report	  
percentages	   between	   89%	   and	   95%	   (Dansky,	   Saladin,	   Coffey,	   &	   Brady,	   1997;	   Farley,	   Golding,	   Young,	  
Mulligan,	  &	  Minkoff,	  2004;	  Read	  et	  al.,	  2004;	  Reynolds	  et	  al.,	  2005),	  which	  also	  concurs	  with	  the	  present	  
results	  in	  this	  dissertation.	  	  
With	  regard	  to	  the	  vulnerability	  of	  the	  SUD/PTSD	  patient	  subgroup	  we	  found	  that	  these	  patients	  
are	  comparable	  to	  SUD	  patients	  with	  lower	  or	  no	  PTSD	  severity	  on	  most	  measured	  characteristics	  (age,	  
gender	   distribution,	   number	   of	   previous	   treatments,	   time	   in	   treatment,	   treatment	   outcome,	   primary	  
substance,	   criminal	   past,	   financial	   debts,	   relational	   status,	   and	   axis	   two	   comorbidity).	   There	   were	  
however,	  seven	  characteristics	  that	  were	  specific	  for	  SUD/PTSD	  patients.	  	  
(1) SUD/PTSD	   patients	   are	   less	   educated	   and	   are	   more	   often	   unemployed,	   compared	   to	   SUD	  
patients	   with	   no	   PTSD	   (Chapter	   2).	   As	   educational	   level	   is	   a	   strong	   predictor	   for	   future	  
opportunities	   on	   the	   labor	   market	   (Gesthuizen	   &	   Scheepers,	   2010)	   it	   is	   not	   surprising	   that	  
SUD/PTSD	   patients	   are	   more	   often	   unemployed.	   There	   are	   different	   possible	   pathways	   that	  
might	  explain	   the	   lower	  educational	   level	  of	   SUD/PTSD	  patients.	   Firstly,	   it	   is	   known	   that	  early	  
trauma	   exposure	   affects	   the	   developing	   brain.	   (Klaassens,	   van	   Noorden,	   Giltay,	   van	   Pelt,	   van	  
Veen,	  &	   Zitman,	   2009)	   and	   that	   PTSD	   patients	   have	   shown	   to	   experience	  more	   difficulties	   in	  
executive	   functioning	   tasks	   (Aupperle,	  Melrose,	   Stein,	  &	  Paulus,	  2012;	   Leskin	  &	  White,	  2007).	  
Therefore,	  they	  might	  experience	  more	  troubles	  during	  their	  primary	  and	  secondary	  education,	  
affecting	   school	   performances,	   educational	   opportunities	   or	   school	   absenteeism.	   Secondly,	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peers	  and	  family	  also	  hold	  a	  crucial	  role	  in	  educational	  choice	  (Davis-­‐Kean,	  2005;	  Palmer,	  Hayek,	  
Hossler,	  Jacob,	  Cummings,	  &	  Kinzie,	  2004)	  and	  when	  a	  child	  does	  not	  grow	  up	  in	  an	  aspirational	  
environment	   chances	   are	   that	   this	   child	   ends	   up	  with	   a	   lower	   educational	   level	   compared	   to	  
children	  who	  are	  raised	   in	  more	  stimulating	  environments	   (Ferry,	  Fouad,	  &	  Smith,	  2000;	  Flint,	  
1992;	  Sewell	  &	  Shah,	  1968).	  Thirdly,	  the	  symptomatology	  of	  both	  disorders	  further	  shows	  that	  
education	  and	  employment	  are	  negatively	  affected	  by	  PTSD	  and	  SUD.	  The	  diminished	  interest	  or	  
participation	   in	   important	  activities	  and	   the	  experience	  of	   significant	   impairment	   in	   important	  
areas	   of	   functioning	   are	   two	   important	   PTSD	   symptoms	   that	   directly	   influence	   education	   and	  
employment.	   SUD	   equally	   implies	   a	   failure	   to	   fulfill	   major	   role	   obligations	   at	   school	   or	   that	  
important	  occupational	   activities	   are	   given	  up	  or	   reduced	  because	  of	   substance	  use	   (DSM	   IV-­‐
TR).	  As	  unemployment	   is	   related	  with	  mental	   health	  problems	   (Paul	  &	  Moser,	   2009),	   poverty	  
(Gallie,	  Paugam,	  &	  Jacobs,	  2003),	  and	  high	  society	  costs	  (Liem	  &	  Rayman,	  1982),	  it	  is	  clear	  that	  
unemployment	  is	  an	  important	  vulnerability	  factor	  for	  SUD/PTSD	  patients.	  
(2) SUD	  patients	  with	  PTSD	  are	  more	  likely	  to	  have	  depressive	  disorders	  and	  are	  more	  likely	  to	  have	  
another	  axis	  I	  disorder	  (Chapter	  2).	  In	  a	  prospective	  study	  by	  Shalev	  and	  colleagues	  (1998)	  it	  was	  
found	  that	  PTSD	  and	  major	  depression	  are	  independent	  consequences	  of	  trauma	  exposure	  and	  
that,	   when	   comorbidity	   occurs,	   this	   is	   associated	   with	   more	   symptom	   severity.	   This	   again	  
underlines	  the	  vulnerability	  of	  patients	  with	  comorbid	  SUD	  and	  PTSD.	  The	  fact	   that	  SUD/PTSD	  
patients	   are	  more	   often	   diagnosed	   with	   depression	   and	   other	   axis	   I	   disorders	   might	   also	   be	  
explained	  by	  the	  underdiagnosis	  or	  symptom	  entanglement	  of	  PTSD	  in	  SUD	  patients	  (Chapters	  2	  
and	  4).	  The	  finding	  that	  SUD	  clinicians	  are	  not	  trauma-­‐focused,	  might	  lead	  to	  the	  underdiagnosis	  
of	   PTSD	   (Chapter	   4),	   but	   also	   to	   a	  misdiagnosis.	   As	   such,	   a	   patient	  who	   experiences	   trauma-­‐
related	   hallucinations	   or	   dissociative	   reactions	   can	   end	   up	   being	   diagnosed	   with	   a	   psychotic	  
disorder.	  	  
(3) SUD/PTSD	  patients	  are	  more	  tensed	  in	  general	  (Chapter	  3).	  This	  is	  not	  very	  surprising	  since	  PTSD	  
is	  characterized	  by	  the	  experience	  of	  negative	  mood	  and	  increased	  arousal	  (5th	  ed.,	  DSM-­‐5	  APA,	  
2013)	   and	   our	   results	   might	   thus	   merely	   reflect	   the	   symptomatology	   of	   PTSD.	   As	   chronic	  
feelings	  of	  tension	  put	  individuals	  at	  risk	  for	  physical	  health	  problems	  (Allostatic	  load:	  McEwen,	  
1999),	   including	   diabetes,	   obesity,	   hypertension,	   heart	   disease,	   dermatological	   problems	  
(Dallman	   et	   al.,	   2003;	   ),	   the	   increased	   and	   generalized	   level	   of	   tension	   in	   SUD/PTSD	   patients	  
clearly	  demands	  immediate	  attention	  in	  treatment.	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(4) SUD/PTSD	  patients	  experience	  a	  higher	   level	  of	  craving	  in	  general	  (Chapter	  3).	  As	  craving	  is	  an	  
important	  predictor	  for	  relapse	  (Back	  et	  al.,	  2010;	  Schneekloth	  et	  al.,	  2012),	  this	  further	  suggests	  
that	   SUD	   patients	   with	   high	   PTSD	   severity	   belong	   to	   an	   especially	   vulnerable	   subgroup	   of	  
patients.	   It	   is	   possible	   that	   the	   increased	   level	   of	   tension	   precedes	   feelings	   of	   craving.	   The	  
correlation	   analysis	   in	   Chapter	   3	   showed	   that	   tension	   ratings	   and	   craving	   ratings	  were	   highly	  
correlated.	  In	  all	  three	  sessions	  baseline	  tension	  was	  highly	  correlated	  with	  craving	  ratings	  both	  
before	   and	   after	   cue	   exposure.	   However,	   when	   observing	   the	   correlations	   between	   baseline	  
craving	   rates	   and	   tension	   rates	   both	   before	   and	   after	   cue	   exposure,	   we	   found	   that	   the	  
significance	  levels	  dropped,	  suggesting	  that	  tension	  precedes	  craving.	  
(5) SUD/PTSD	  patients	  abuse	  substances	   to	   feel	  more	  at	  ease	   in	   social	  environments	   (Chapter	  5).	  
This	   finding	   can	  be	  explained	  by	   the	  detachment,	  distrust,	   hyperarousal,	   and	  anxiety	   typically	  
reported	  by	  PTSD	  patients.	  Our	  findings	  thus	  suggest	  that	  SUD/PTSD	  patients	  suffer	  discomfort	  
in	  social	  company	  when	  abstinent.	  As	  a	  result	  they	  either	  avoid	  social	  interaction	  or	  endure	  the	  
company	  while	  being	  intoxicated.	  In	  the	  long	  term,	  this	  probably	  leads	  to	  either	  social	  isolation	  
or	  to	  selective	  interaction	  with	  other	  substance	  users.	  	  
(6) SUD	   patients	   with	   high	   PTSD	   scores	   report	   an	   increase	   in	   craving	   after	   exposure	   to	   both	  
personalized	  stress	  cues	  and	  personalized	  trauma	  cues	  (Chapter	  3)	  and	  report	  to	  relapse	  more	  
often	  after	  being	   triggered	  by	  a	   traumatic	  cue	   (Chapters	  5	  and	  6).	  The	   increased	  craving	  after	  
trauma	  cue	  exposure	  is	  a	  replication	  of	  previous	  research	  by	  Coffey	  and	  colleagues	  (2002,	  2010),	  
Nosen	  and	   colleagues	   (2012),	   and	   Saladin	   and	   colleagues	   (2003)	   and	  our	   study	  adds	   that	   this	  
effect	  endures	  in	  a	  more	  heterogeneous	  sample	  of	  patients	  who	  were	  abstinent	  for	  some	  time	  
(mean	  abstinence	  was	  around	  3	  months)	  and	  even	  without	  concurrent	  exposure	   to	  an	   in	  vivo	  
drug	   cue.	   Prior	   research	   also	   documented	   the	   existence	   of	   stress-­‐induced	   craving	   in	   SUD	  
patients	   (Fox,	   Bergquist,	   Hong,	   &	   Sinha,	   2007;	   Sinha,	   2007;	   Sinha	   &	   Li,	   2007).	   The	   findings	  
presented	   in	  Chapter	   3	   indicate	   that	   this	   effect	   is	  magnified	  when	  patients	   suffer	   from	  PTSD.	  
When	   translating	   the	   results	   to	   the	   life	   of	   SUD/PTSD	   patients,	   this	   finding	   means	   that	   a	  
significant	   increase	   in	   craving	   can	   occur	   just	   by	   being	   triggered	   to	   a	   past	   trauma	   or	   general	  
stress	   cues,	   even	   in	   the	   absence	   of	   drugs	   or	   alcohol.	   These	   results	   further	   suggest	   how	  
vulnerable	  SUD/PTSD	  patients	  are	  for	  relapse	  when	  PTSD	  is	  left	  untreated.	  
(7) SUD/PTSD	  patients	  have	  less	  adaptive	  cognitive	  emotion	  regulating	  strategies	  compared	  to	  SUD	  
patients	  with	   lower	  PTSD	  scores	   (Chapter	  5).	  The	  protective	  role	  of	  adequate	  coping	  skills	  has	  
been	   established	   both	   in	   studies	   examining	   patients	   with	   PTSD	   (Bosmans	   &	   van	   der	   Velden,	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2015),	   SUD	   (McConnell,	  Memetovic,	  &	   Richardson,	   2014),	   as	   in	   SUD	   patients	  who	   have	   been	  
exposed	   to	   trauma	   (Anderson,	   Ramo,	   &	   Brown,	   2006;	   Bonar,	   Bohnert,	   Ilgen,	   Sanborn,	   &	  
Chermack,	   2013;	   Brady,	   Tschann,	   Pach,	   Flores,	   &	   Ozer,	   2009).	   It	   is	   plausible	   that	   when	   an	  
individual	  learns	  that	  substance	  use	  is	  an	  effective	  way	  to	  cope	  with	  trauma-­‐related	  symptoms	  
and	  to	  cope	  with	  daily	  stressors	  (Chapter	  6),	  other	  coping	  skills	  are	  not	  developed,	  leaving	  this	  
individual	  to	  rely	  on	  his/her	  established	  substance	  use	  coping	  mechanisms.	  	  
	  
CUED	  CRAVINGS	  TO	  TRAUMA	  AND	  STRESS	  CUES	  
Our	  studies	  demonstrated	  a	  perceived	  and	  experimentally	  induced	  interrelatedness	  between	  on	  the	  one	  
hand	  trauma	  and	  stress	  triggers	  and,	  on	  the	  other	  hand	  craving,	  substance	  use,	  or	  relapse	  (Chapters	  3,	  5	  
and	  6).	   In	  two	  of	  our	  studies	   (Chapters	  5	  and	  6)	  almost	  all	  SUD/PTSD	  patients	  reported	  substance	  use	  
and	  craving	  after	  stress	  and	  trauma	  triggers.	  The	  experimental	  study,	  described	  in	  Chapter	  2,	  confirmed	  
that	  SUD	  patients	  with	  high	  PTSD	  severity	  craved	  more	  after	  exposure	  to	  both	  trauma	  and	  stress	  cues,	  
relative	  to	  neutral	  cues.	  Thus,	  not	  only	  exposure	  to	  traumatic	  triggers,	  but	  also	  more	  general	  stress	  cues	  
appear	   especially	   risky	   for	   relapse	   in	   patients	   with	   high	   PTSD	   scores.	   It	   is	   likely	   that	   patients	   who	  
suffered	   from	  a	  past	   trauma	  and	  who	   learned	   that	   substance	  use	   can	  ease	   the	  pain	  never	   learned	   to	  
cope	  effectively	  with	  negative	  feelings	  or	  cognitions	  and,	  therefore,	  rely	  on	  using	  substances	  when	  being	  
confronted	  with	  trauma	  or	  stress	  cues.	  Indeed,	  the	  findings	  described	  in	  Chapter	  5	  show	  that	  SUD/PTSD	  
patients	  have	   significantly	   lower	   cognitive	  emotion	   regulating	   strategies	  as	   compared	   to	  SUD	  patients	  
with	  lower	  PTSD	  severity	  scores.	  Recently,	  Bosmans	  and	  van	  der	  Velden	  (2015)	  prospectively	  examined	  
coping	   in	   400	   adults	   who	   had	   been	   exposed	   to	   a	   potentially	   traumatic	   event.	   They	   found	   that	  
inadequate	  coping	  predicted	  the	  development	  of	  subsequent	  PTSD	  symptoms,	  but	  PTSD	  symptoms	  did	  
not	   predict	   coping.	   They	   did,	   however,	   not	   measure	   coping	   before	   the	   traumatic	   incident.	   So,	  
inadequate	  coping	  skills	  seem	  to	  form	  an	  important	  factor	  in	  the	  relation	  between	  trauma	  exposure	  and	  
PTSD	  (Bosmans	  &	  van	  der	  Velden,	  2015),	  between	  high	  life	  stress/trauma	  and	  substance	  use	  (Anderson	  
et	   al.,	   2006;	   Brady	   et	   al.,	   2009),	   and	   between	   PTSD	   and	   SUD	   (Asberg	   &	   Renk,	   2012;	   Ullman,	   Relyea,	  
Peter-­‐Hagena,	  &	  Vasquez,	  2013).	  
	  




Results	   of	   several	   studies	   provided	   more	   insight	   into	   why	   integrated	   SUD/PTSD	   treatment	   is	   not	  
implemented	   in	   SUD	   treatment	   centers.	   Three	   barriers	   hindering	   implementation	   of	   integrated	  
SUD/PTSD	  treatment	  can	  be	  identified:	  (1)	  obstacles	  related	  to	  the	  clinician,	  (2)	  obstacles	  related	  to	  the	  
institution,	  and	  (3)	  obstacles	  related	  to	  the	  patients.	  Implementation	  of	  integrated	  SUD/PTSD	  treatment	  
is	  likely	  to	  fail	  if	  not	  all	  three	  barriers	  are	  removed.	  	  
On	   the	   level	   of	   the	   clinicians	   two	  main	  obstacles	  were	  detected.	   Firstly,	   PTSD	   remains	   largely	  
undetected	   in	   SUD	   treatment	   centers	   (Chapter	   2).	   This	   happens	   as	   a	   result	   of	   not	   using	   standardized	  
PTSD	  questionnaires	  and	  as	  a	   result	  of	  not	   routinely	   screening	   for	  PTSD	  during	  different	   stages	  of	   the	  
treatment	   process.	   Consequently,	   PTSD	   prevalence	   is	   severely	   underestimated,	   leading	   to	  
undertreatment	   and	   not	   being	   familiar	   with	   integrated	   treatment	   protocols,	   specific	   guidelines,	   or	  
useful	  diagnostic	  tools.	  Secondly,	  clinicians	  seemed	  afraid	  that	  discussing	  trauma	  with	  the	  patient	  may	  
put	  him/her	  in	  jeopardy	  for	  a	  (re-­‐)lapse	  (Chapter	  4).	  This	  same	  obstacle	  has	  been	  identified	  in	  previous	  
studies	   as	   well	   (Back,	   Waldrop,	   &	   Brady,	   2009;	   Najavits,	   2002).	   Although	   our	   and	   previous	   studies	  
suggest	   that	   trauma	   cues	  will	   increase	   the	   patient’s	   craving	   for	   alcohol	   or	   drugs	   (Coffey	   et	   al.,	   2002;	  
Saladin	  et	  al.,	   2003,	  Chapter	  3),	   this	  does	  not	   compromise	   treatment	  outcome.	   Indeed,	  as	  mentioned	  
above,	   there	  are	  several	  studies	  showing	  better	  overall	   treatment	  outcome	  with	   integrated	  SUD/PTSD	  
treatment,	   compared	   to	  SUD	   treatment	  only	   (Torchalla	  et	  al.,	   2012;	   van	  Dam	  et	  al.,	   2012).	  Therapists	  
appear	  wary	  not	  to	  harm	  their	  patients,	  as	  they	  should,	  but	  a	  good	  therapist	  should	  not	  be	  so	  cautious	  
as	  not	  to	  provide	  treatment	  at	  all.	  
On	   the	   level	   of	   the	   institution	   it	   is	   found	   that	   lack	   of	   time,	   money,	   and	   expertise	   are	   main	  
hurdles	   that	   explain	   the	   unsuccessful	   implementation	   of	   the	   integrated	   treatment	   (Chapter	   4).	   SUD	  
treatment	   centers	   do	   not	   invest	   in	   the	   integrated	   approach	   of	   comorbid	   SUD/PTSD.	   The	   results	  
described	   in	   Chapter	   4	   suggest	   that	   clinicians	   are	   willing	   to	   implement	   the	   integrated	   treatment	   if	  
facilitated	  by	  the	  institution	  they	  work	  for.	  
On	   the	  patient	   level,	   three	  main	  obstacles	   are	   identified:	   (1)	   patients	   are	   anxious/avoidant	   to	  
start	  PTSD	   treatment,	  possibly	  enhancing	   the	   clinicians’	   reluctance	   to	  discuss	   trauma,	   (2)	  patients	   are	  
not	  aware	  of	  the	  treatment	  possibilities,	  which	  might	  inhibit	  them	  to	  discuss	  their	  PTSD	  symptoms	  with	  
their	  SUD	  clinicians,	  and	  (3)	  SUD/PTSD	  patients	  reported	  in	  several	  of	  our	  studies	  that	  substance	  use	  is	  
an	  effective	  way	   to	  cope	  with	  PTSD	  symptoms.	  This	   last	  point	  deserves	   some	  elaboration.	  The	   results	  
from	  the	  studies	  described	  in	  Chapters	  3,	  5,	  and	  6	  clearly	  indicate	  that	  SUD/PTSD	  patients	  crave	  and	  use	  
substances	  when	  being	  confronted	  with	  the	  consequences	  of	  their	  traumatic	  past	  (90.9%	  of	  SUD/PTSD	  
patients	   reported	  using	   substances	   after	   intrusions;	   Chapter	   5)	   and,	   similarly,	  when	  being	   confronted	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with	  daily	  stressors.	  Although	  the	  patients	  are	  aware	  that	  the	  experienced	  positive	  effects	  of	  drugs	  and	  
alcohol	  are	  superficial	  and	  temporary,	  they	  do	  experience	  them	  as	  effective	  means	  to	  dampen	  negative	  
emotions	   or	   cognitions	   (90%	   of	   SUD/PTSD	   patients	   reported	   that	   substance	   use	   is	   effective	   in	  




Based	   on	   the	   results	   presented	   in	   the	   previous	   chapters	   a	  working	  model	   is	   proposed	   explaining	   the	  
symptom	  interplay	  between	  PTSD	  and	  SUD.	  The	  key	  concept	  within	  this	  model	  is	  inadequate	  coping.	  
Individuals	   who	   develop	   comorbid	   SUD/PTSD	   commonly	   experienced	   trauma	   at	   an	   early	   age	  
(see	   e.g.	   Chapter	   2).	   In	   most	   of	   these	   patients	   trauma	   is	   not	   a	   single	   isolated	   occurrence;	   on	   the	  
contrary,	  SUD/PTSD	  patients	   typically	   report	  experiencing	  more	  than	  one	  trauma	  throughout	  their	   life	  
(Chapter	   2).	   As	   is	   illustrated	   in	   Figure	   1,	   this	   early	   and	   extensive	   trauma	   exposure	   can	   lead	   to	   the	  
development	  of	  PTSD.	  Trauma	  exposure	  can	  also	   lead	   to	   the	  development	  of	  other	  disorders,	  such	  as	  
depressive	  disorders	  (Chapter	  2)	  or	  borderline	  personality	  disorder	  (Pagura,	  Stein,	  Bolton,	  Cox,	  Grant,	  &	  
Sareen,	  2010;	  Spinhoven,	  Penninx,	  van	  Hemert,	  de	  Rooij,	  &	  Elzinga,	  2014).	  First	  substance	  use	  happens,	  
seemingly	  independent	  of	  the	  endured	  trauma	  (Chapter	  6).	  That	  is,	  patients	  report	  that	  they	  do	  not	  take	  
their	  drink	   (or	  get	  stoned	  or	  high)	   for	   the	   first	   time	  because	  of	   trauma	  or	  as	  a	  consequence	  of	  stress.	  
Rather,	   first	   substance	  use	   is	  provoked	  by	  curiosity	  and	  seen	  as	  part	  of	  experimenting	   in	  one’s	  youth.	  
This	   impulsive	  need	   to	  experiment	  however	  may	   still	   be	  a	   consequence	  of	   trauma	  exposure.	   There	   is	  
ample	   evidence	   that	   early	   life	   trauma	   exposure	   negatively	   affects	   the	   developing	   brain.	   Normal	  
development	  of	  the	  medial	  prefrontal	  cortex	  is	  impeded,	  the	  functioning	  of	  the	  amygdala	  is	  attenuated,	  
the	   volume	   of	   the	   hippocampus	   is	   reduced,	   and	   the	   hypothalamic–pituitary–adrenal	   axis	   becomes	  
hyperreactive	   (Shin,	   Rauch,	   &	   Pitman,	   2006;	   Teicher,	   Andersen,	   Polcan,	   Navalta,	   &	   Kim,	   2003;	  
Vermetten	   &	   Lanius,	   2012).	   Addictive	   behavior	   is	   associated	   with	   compromised	   functioning	   of	   the	  
medial	   prefrontal	   cortex	   (involved	   in	   cognitive	   and	   executive	   control,	   emotional	   regulation,	   memory	  
consolidation	  (Alexander	  &	  Brown,	  2011;	  Etkin,	  Egner,	  &	  Kalisch,	  2011;	  Euston,	  Gruber,	  &	  McNaughton,	  
2012)	   and	   with	   a	   reduced	   volume	   of	   the	   hippocampus	   (involved	   in	   stress	   regulation	   and	   declarative	  
memory	  processing;	  see	  Cheetham,	  Allen,	  Whittle,	  Simmons,	  Yücel,	  &	  Lubman,	  2012).	  Early	  life	  trauma	  
exposure	  might	  thus	  put	  some	  individuals	  at	  an	  increased	  risk	  for	  substance	  use	  (Langeland,	  2009).	  
A	   traumatized	   individual,	   through	  experimenting	  with	  alcohol	  or	  drugs,	   learns	   that	   substances	  
lead	  to	  a	  decline	   in	  potential	  PTSD	  symptoms	  and	  that	  substance	  use	   is	  equally	  effective	  to	  cope	  with	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general	  stress	  (Chapters	  3	  and	  5).	  The	  studies	  described	   in	  the	  current	  dissertation	  show	  that	  patients	  
with	  comorbid	  SUD/PTSD	  indeed	  perceive	  substance	  use	  to	  be	  reinforcing;	  that	  is,	  it	  is	  believed	  to	  be	  an	  
extremely	   effective	   way	   to	   deal	   with	   general	   stress	   and	   with	   PTSD	   symptoms	   (Chapters	   5	   and	   6).	  
Because	  of	  the	  positive	  and	  negative	  reinforcing	  characteristics	  of	  an	  addictive	  substance,	  substance	  use	  
culminates	   into	  abuse	  and	  ultimately	  addiction.	  Feelings	  of	  stress	  and	  specific	  PTSD	  symptoms	  such	  as	  
intrusive	  trauma	  memories	  become	  powerful	  predictors	  of	  substance	  use	  and	  –	  as	  argued	  in	  the	  General	  
Introduction	  of	  this	  dissertation	  –	  through	  Pavlovian	  learning	  become	  incentive	  cues	  triggering	  intense	  
cravings.	  This	  craving	  then	  further	  fuels	  instrumental	  substance	  use.	  Importantly	  then,	  PTSD	  is	  not	  seen	  
as	  a	  direct	  cause	  of	  substance	  abuse	  or	  SUD	  but	  as	  a	  prominent	  risk	  factor	  for	  developing	  an	  addiction.	  
This	  sequence	  is	  shown	  in	  Figure	  1.	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Throughout	  the	  described	  studies	  it	  was	  found	  that	  SUD/PTSD	  patients	  have	  inadequate	  coping	  
skills	  (Chapters	  3,	  5	  and	  6)	  and	  it	  was	  suggested	  that	  treatment	  should	  focus	  on	  coping	  skills	  training	  as	  
part	   of	   a	   stabilization	   phase	   in	   these	   patients.	   But	   this	   still	   leaves	   us	   with	   the	   question	   whether	  
SUD/PTSD	  patients	  have	  lost	  their	  capacity	  to	  adequately	  cope	  with	  stress	  somewhere	  during	  their	  life	  
(e.g.	   after	   trauma	  exposure	  or	   after	   the	  development	   of	   PTSD	  or	   SUD),	   or	  whether	   these	   inadequate	  
coping	  skills	  are	  inherent	  to	  the	  person.	  As	  the	  medial	  prefrontal	  cortex	  is	  involved	  in	  coping	  (Harmon-­‐
Jones,	  E.,	  Sigelman,	  Bohlig,	  &	  Harmon-­‐Jones,	  C.,	  2003;	  Maier	  &	  Watkins,	  2010)	  and	  this	  brain	  structure	  
shows	  dissimilarities	  in	  individuals	  who	  are	  traumatized	  at	  an	  early	  age	  (Shin	  et	  al.,	  2006;	  Teicher	  et	  al.,	  
2003;	  Vermetten	  &	   Lanius,	   2012)	   it	   is	   arguable	   that	   the	  neurobiological	   changes	   induced	  by	  early	   life	  
trauma	  exposure	  causes	   impairments	   in	  executive	  functioning,	   thereby	  affecting	  coping	  capacities	  and	  
making	  them	  more	  vulnerable	  for	  developing	  PTSD	  and	  SUD.	  The	   inadequate	  coping	  skills	  can	  thus	  be	  
seen	  as	  a	  third	  factor	  or	  a	  shared	  vulnerability	  factor	  that	  influences	  both	  PTSD	  and	  SUD.	  	  
From	  our	  findings	  it	  can	  be	  deduced	  that	  SUD/PTSD	  patients	  experience	  a	  high	  level	  of	  baseline	  
tension,	   and	   these	   SUD/PTSD	  patients	   experience	   a	   further	   increase	   in	   tension	   as	   a	   reaction	   on	   daily	  
stressors,	  social	  situations	  and	  traumatic	  triggers.	  As	  they	  have	  no	  adequate	  skills	  available	  to	  cope	  with	  
this	   increased	   tension	  and	   since	  SUD/PTSD	  patients	   learned	   that	   substance	  use	   is	   an	  effective	  way	   to	  
cope	  with	  stress	  and	  trauma	  triggers,	  craving	  and/or	  subsequent	  substance	  use	  follows.	  After	  substance	  
use	  a	  temporary	  relief	  of	  negative	  emotions	  is	  experienced	  and	  the	  substance	  is	  intrinsically	  reinforced.	  
As	   a	   consequence	   of	   this	   learning	   experience,	   there	   is	   no	   need	   for	   the	   SUD/PTSD	   patient	   to	   learn	  
alternative	  and	  healthier	  coping	  strategies.	  Why	  should	  he/she?	  As	  is	  described	  in	  Chapters	  5	  and	  6,	  the	  
substance	  use	  is	  perceived	  as	  a	  highly	  effective	  way	  of	  coping.	  So,	  the	  circle	  closes	  and	  new	  stressors	  will	  
be	   dealt	   with	   in	   exactly	   the	   same	   way,	   further	   reinforcing	   the	   connection	   between	   stress/trauma	  
triggers	  and	  substance	  use.	  From	  this	  it	  can	  be	  assumed	  that	  coping	  skills	  have	  little	  chance	  to	  improve	  
in	  SUD/PTSD	  patients.	  This	  reinforcing	  chain	  of	  events	  is	  illustrated	  in	  Figure	  2. 









Figure	  2.	  Vicious	  cycle	  starting	  from	  the	  inadequacy	  of	  coping	  skills.	  
	  
One	  of	  the	  main	  symptoms	  of	  PTSD	  is	  avoidance.	  It	  is	  clear	  that	  in	  SUD/PTSD	  patients,	  avoidance	  
plays	  a	  major	  role.	  Substance	  use	   is	  a	  way	  to	  avoid	  and/or	  escape	  from	  intrusions	  and	  emotional	  pain	  
(Chapters	  5	  and	  6,	  the	  self-­‐medication	  hypothesis).	  And	  it	  is	  precisely	  this	  avoidant	  coping	  style	  that	  in	  
the	   longer	   term	   increases	   the	   risk	   that	  PTSD	  develops	   into	  a	   chronic	   and	   long-­‐lasting	  disorder	   in	   SUD	  
patients.	  Effective	  treatment	  of	  PTSD	  requires	  some	  form	  of	  exposure	  to	  the	  memory	  of	  trauma	  (Jaycox,	  
Foa,	  &	  Morral,	  1998).	  	  
Although	   the	   presented	   theoretical	   model	   postulates	   that	   trauma	   exposure	   happens	   before	  
SUD,	  in	  some	  patients	  trauma	  can	  occur	  after	  the	  development	  of	  SUD.	  Exploratory	  analysis	  on	  the	  data	  
described	  in	  Chapter	  2	  indeed	  revealed	  that	  18.5%	  of	  SUD/PTSD	  patients	  reported	  they	  were	  exposed	  to	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(81.5%)	  trauma	  exposure	  happened	  before	  their	  substance	  abuse	  (mean	  age	  of	  13.79	  vs.	  mean	  age	  of	  
23.96).	  The	  presented	  theoretical	  model	  is	  applicable	  irrespective	  of	  the	  chronological	  order	  of	  events;	  I	  
hypothesize	   that	   the	   intrinsic	   reinforcing	   nature	   of	   a	   substance	   is	   of	   such	   strength	   that	   it	   overrules	  
previously	  learned	  coping	  mechanisms.	  This	  of	  course	  merits	  further	  investigation.	  
Taken	  together,	  the	  SUD/PTSD	  symptom	  interplay	   is	  complex	  and	  cannot	  be	  grasped	   into	  only	  
one	  of	  the	  existing	  models.	  	  
	  
Recommendations	  for	  clinical	  practice	  
	  
Based	   on	   the	   severe	   underestimation	   of	   PTSD	   in	   SUD	   patients	   (Chapter	   4)	   and	   its	   consequences	   for	  
clinical	  practice	  (Chapters	  2	  and	  4),	   it	   is	  relevant	  to	   inform	  SUD	  treatment	  centres/clinicians	  about	  the	  
finding	  that	  one	  in	  three	  of	  their	  SUD	  patients	  are	  likely	  to	  suffer	  from	  PTSD	  (Chapter	  2).	  	  
Furthermore,	  since	  clinicians	  are	  not	  familiar	  with	  the	  SUD/PTSD	  guidelines	  (Chapter	  4),	  there	  is	  
a	  missing	  link	  in	  the	  process	  between	  the	  publication	  and	  the	  actual	  implementation	  of	  the	  guideline.	  In	  
an	  attachment	  to	  the	  Dutch	  guideline	  on	  the	  treatment	  of	  comorbid	  SUD	  and	  anxiety	  disorders	  (Snoek,	  
Wits,	  Meulders,	   &	   van	   de	  Mheen,	   2012)	   a	   four-­‐page	   implementation	   plan	   is	   incorporated.	   This	   plan	  
contains	  critical	  questions	  for	  situation	  analysis	  on	  an	  organizational	  level,	  a	  summary	  of	  advancing	  and	  
impeding	   factors,	   a	   summary	  of	  possible	   implementation	   strategies,	   and	  a	   checklist	  of	   ingredients	   for	  
the	   step-­‐by-­‐step	   implementation	  plan.	  Although	   this	   implementation	  plan	  might	   be	   very	   useful	  when	  
SUD	  organizations	  decide	  to	  start	  implementing	  an	  integrated	  treatment	  for	  SUD/PTSD,	  it	  is	  of	  little	  use	  
when	  this	  information	  does	  not	  reach	  the	  SUD	  treatment	  center/clinician.	  Something	  or	  rather	  someone	  
is	   missing,	   a	   person	   that	   brings	   this	   -­‐	   and	   other	   guidelines	   -­‐	   under	   the	   attention	   of	   SUD	   treatment	  
centers/clinicians.	  This	  can	  be	  a	   function	   for	   the	  developers	  of	  guidelines.	  An	  alternative,	  or	  better	  an	  
addition,	   is	   that	  SUD	  treatment	  centers	  assign	  one	  of	   their	  clinical	  staff	  members	  with	  the	  function	  to	  
monitor	  new	  guideline	  developments	  and	  that	  this	  employee	  is	  held	  responsible	  for	  the	  implementation	  
of	  the	  new	  guideline	  in	  his/	  her	  work	  setting.	  
To	  minimalize	   the	   risk	   for	   future	  under	   diagnosis	   -­‐and	   therefore	   under	   treatment-­‐	   of	   PTSD	   in	  
SUD	  patients	  (Chapters	  2	  and	  4),	  and	  to	  optimize	  screening	  and	  accurate	  diagnosis	  of	  trauma	  and	  PTSD	  
among	  SUD	  patients,	  clinicians	  should	  also	  be	   informed	  about	  how	  and	  when	  to	  screen	  for	  PTSD.	  The	  
results	  of	   this	  dissertation	  emphasise	   the	  need	  to	   identify	   the	  SUD/PTSD	  patients	  as	  a	  substantial	  and	  
important	  subgroup	  and	  to	  systematically	  screen	  for	  PTSD	  in	  all	  SUD	  patients	  at	  intake.	  For	  this	  purpose,	  
validated	   PTSD	   assessment	   tools	   should	   be	   made	   available	   in	   addiction	   treatment	   facilities.	   As	   is	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described	   in	   the	   recently	  developed	  guidelines,	   clinicians	  ought	   to	  diagnose	  PTSD	  by	  means	  of	   clinical	  
interviews	  and	  clinical	   judgment	   (Snoek	  et	  al.,	  2012).	  Our	  results	  draw	  attention	  to	  the	   fact	   that,	  with	  
regard	   to	   the	   diagnosis	   of	   PTSD,	   SUD	   treatment	   facilities	   should	   not	   solely	   rely	   on	   the	   opinions	   of	  
clinicians	   and	   interviewers.	   Clinical	   judgement	   is	   prone	   to	   serious	   bias	   and	   therefore	   validated	  
assessment	  tools	  should	  be	  used	  (Dawes,	  Faust,	  &	  Meehl,	  1989;	  Garb,	  2005).	  Questionnaires	  like	  the	  J-­‐
PTSD	  (modified	  version	  of	  the	  PC-­‐PTSD)	  and	  the	  SRIP	  have	  shown	  to	  be	  efficient	  and	  validated	  measures	  
in	  SUD	  populations	  (Kok,	  de	  Haan,	  van	  der	  Velden,	  van	  der	  Meer,	  Najavits,	  &	  de	  Jong,	  2013;	  van	  Dam,	  
Ehring,	  Vedel	  &	  Emmelkamp,	  2010).	  The	  J-­‐PTSD	  consists	  of	  only	  4	  questions	  and	  is	  an	  ideal	  instrument	  
for	   a	   first	   screening.	   The	   SRIP	   can	   be	   administered	   as	   a	   second	   self-­‐report	   measure	   when	   a	   patient	  
scores	  positive	  on	  the	  J-­‐PTSD.	  	  
My	  results	  indicate	  that	  SUD	  clinicians	  are	  not	  properly	  trained	  in	  diagnosing	  PTSD	  (Chapter	  4).	  
We	   acknowledge	   that	   reliable	   PTSD	   diagnosis	   requires	   specific	   clinical	   skills	   and	   training	   is	   necessary.	  
The	  golden	  standard	  for	  diagnosing	  PTSD	  is	  to	  interview	  the	  patient	  with	  the	  Clinical-­‐Administered	  PTSD	  
Scale	   for	  DSM-­‐5	   (CAPS-­‐5;	  Weathers,	  Blake,	   Schnurr,	   Kaloupek,	  Marx,	  &	  Keane,	   2013).	   Special	   one-­‐day	  
CAPS-­‐5	  trainings	  are	  offered	  for	  psychologists	  and	  psychiatrists	  to	  enable	  these	  clinicians	  in	  diagnosing	  
PTSD	   with	   the	   CAPS-­‐5.	   Training	   every	   SUD	   clinician	   in	   this	   interview	   is	   not	   only	   expensive,	   but	   also	  
excessive;	  it	  probably	  suffices	  to	  train	  one	  or	  two	  clinicians	  in	  every	  SUD	  treatment	  center	  in	  using	  the	  
CAPS-­‐5.	  
My	   studies	   show	   that	   the	   efficacy	   of	   addiction	   treatment	   programs	  would	   likely	   benefit	   from	  
including	  some	  form	  of	  PTSD	  treatment	  for	  SUD	  patients	  with	  clear	  (and	  sometimes	  debilitating)	  trauma	  
exposure.	  SUD	  treatment	  centres	  should	  invest	  in	  the	  evidence	  based	  integrated	  approach	  of	  comorbid	  
SUD/PTSD.	  Clinicians	  should	  be	  educated	  and	  trained	  to	  provide	  this	  integrated	  treatment.	  Integrating	  a	  
trauma-­‐focused	   component	   in	   SUD	   treatment	   seems	   fit,	   even	   for	   patients	   with	   lower	   levels	   of	   PTSD	  
severity.	  Psycho-­‐education	  about	  the	  link	  between	  SUD	  and	  past	  trauma	  can	  be	  a	  first	  and	  non-­‐invasive	  
step	   towards	   a	   better	   understanding	   of	   symptom	   interplay.	   Furthermore,	   although	   almost	   all	   SUD	  
patients	   with	   a	   traumatic	   past	   reported	   the	   effective	   use	   of	   substances	   to	   cope	   with	   intrusions,	   the	  
inadequacy	   of	   coping	   skills	   was	   very	   specific	   for	   SUD	   patients	   with	   high	   PTSD	   severity,	   implying	   that	  
SUD/PTSD	  patients	  should	   receive	  extensive	  coping	  skill	   training,	  probably	  even	  before	  a	  past-­‐focused	  
therapy	  takes	  place.	  This	   is	  exactly	  what	   is	  suggested	   in	  a	  phase-­‐oriented	  treatment	  for	  complex	  PTSD	  
(Cloitre,	  Courtois,	  Charuvastra,	  Carapezza,	   Stolbach,	  &	  Green,	  2011).	   The	   first	  phase	  of	   this	   treatment	  
consists	   of	   improving	   coping	   skills	   and	   ameliorating	   emotion	   regulation	   strategies	   (see	   Cloitre,	   et	   al.,	  
2011).	  My	  results	  further	  show	  that	  patients	  are	  well	  aware	  of	  what	  kind	  of	  treatment	  they	  prefer.	  Most	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SUD/PTSD	  patients	  favour	  a	  simultaneous	  treatment	  of	  SUD	  and	  PTSD,	  combining	  individual	  and	  closed	  
group	   treatment,	   in	   which	   the	   person	   as	   a	   whole	   is	   treated	   (a	   focus	   primarily	   on	   SUD	   or	   PTSD	   was	  
judged	  to	  be	  insufficient).	  Following	  the	  stepped	  care	  model,	  the	  combined	  treatment	  can	  be	  done	  on	  
an	   ambulatory	   basis,	   although	  more	   severe	   cases	  may	   need	   a	   clinical	   treatment	   (Snoek	   et	   al.,	   2012).	  
Treatment	  of	  PTSD	  is	  possible	  even	  for	  non-­‐abstinent	  patients.	  Nevertheless,	  certain	  control	   is	  needed	  
so	  that	  patients	  can	  follow	  the	  therapy	  sessions	  without	  being	  under	  the	  influence	  of	  substances	  (Snoek	  
et	   al.,	   2012).	   Multimorbidity	   or	   triple	   diagnosis	   is	   obviously	   a	   more	   complex	   problem	   but	   combined	  
treatment	   seems	   useful	   in	   these	   patients	   (Snoek	   et	   al.,	   2012).	   Some	   patients	  were	   reluctant	   to	   start	  
PTSD	  treatment	  which	  is	  understandable	  in	  the	  light	  of	  their	  avoidance	  symptoms.	  With	  this	  information	  
in	   mind,	   attention	   for	   patients	   who	   are	   fearful	   of	   PTSD	   treatment	   might	   further	   improve	   SUD/PTSD	  
treatment	   results.	   The	  well	   investigated	   Seeking	   Safety	   protocol	   can	   be	   used	   in	   patients	  where	   past-­‐
focused	  trauma	  therapy	  is	  not	  possible	  (Hien	  et	  al.,	  2009;	  van	  Dam	  et	  al.,	  2012).	  This	  treatment	  can	  start	  
even	  before	  detoxification	  and	  is	  often	  prolonged	  in	  nature	  (Snoek	  et	  al.,	  2012).	  
SUD/PTSD	  patients	  are	  not	  familiar	  with	  treatment	  options	  (Chapter	  6)	  and	  factors	  as	  shame	  or	  
anxiety	   might	   further	   inhibit	   them	   to	   discuss	   trauma	   and	   trauma	   treatment	   options	   with	   their	   SUD	  
caregivers.	  When	   patients	   are	   informed	   about	   the	   SUD/PTSD	   comorbidity	   on	   a	   very	   general	  way	   this	  
might	  remove	  patient	  barriers	  to	  discuss	  trauma	  during	  SUD	  treatment.	  One	  possible	  way	  in	  achieving	  
this	   is	   to	  display	  PTSD	  brochures	  or	  posters	   in	   the	  waiting	   rooms	  of	  SUD	  treatment	  centres.	  A	  patient	  
brochure	   about	   comorbid	   SUD	   and	   anxiety	   disorders	   is	   included	   in	   the	   Dutch	   guideline	   and	   contains	  
psycho-­‐education	  concerning	  diagnosis	  and	  treatment	  possibilities.	  	  
	  
Recommendations	  for	  the	  future	  
	  
Based	   on	   the	   results,	   the	   methodological	   remarks	   and	   the	   proposed	   theoretical	   model,	   some	  
recommendations	  for	  future	  research	  can	  be	  offered.	  As	  will	  be	  noted	  in	  the	  amount	  of	  proposed	  new	  
studies,	   this	   dissertation	   surely	   does	   not	   offer	   answers	   to	   all	   aspects	   of	   the	   SUD/PTSD	   comorbidity,	  
rather	  it	  seems	  to	  raise	  more	  new	  questions	  than	  it	  answers.	  
A	  first	  recommendation	   is	  to	  study	  the	  prevalence	  of	  SUD	  in	   large	  sample	  of	  patients	  who	  are	  
treated	  for	  PTSD	  using	  the	  same	  questionnaire	  as	  we	  did	   in	  our	  prevalence	  study	  and	  to	  compare	  this	  
prevalence	   rate	   with	   SUD	   in	   a	   control	   group	   without	   PTSD.	   Part	   of	   this	   study	   can	   include	   the	  
measurement	   of	   comorbid	   disorders,	   such	   as	   depressive	   disorders,	   so	   this	   specific	   comorbid	   disorder	  
can	  be	  compared	  between	  a	  sample	  of	  PTSD	  patients	  vs.	  a	  sample	  of	  SUD/PTSD	  patients.	  Besides	  this,	  it	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is	   also	   relevant	   to	   know	  whether	   PTSD	  patients	   differ	   from	   SUD/PTSD	  patients	  with	   regard	   to	   coping	  
skills,	   motives	   for	   first	   and	   possibly	   continued	   substance	   use.	   Other	   research	   questions	   that	   merit	  
attention	   is	   how	   well	   PTSD	   treatment	   centers	   screen	   for	   SUD	   and	   what	   the	   perceptions	   of	   PTSD	  
clinicians	  are	  about	  integrated	  SUD/PTSD	  treatment?	  
Another	   subject	   worthwhile	   exploring	   is	   the	   role	   of	   gender.	   Our	   studies	   did	   not	   take	   this	  
question	  into	  account	  and	  women	  were	  clearly	  underrepresented	  in	  our	  samples.	  So,	  what	  is	  the	  role	  of	  
gender	  with	   regard	   to	  PTSD	  prevalence	   in	   SUD	  samples,	  PTSD	   severity,	   craving	   responses,	   and	   coping	  
skills?	   Since	   previous	   studies	   have	   shown	   that	   women	   display	   a	   different	   craving	   pattern	   than	   men	  
(Fattore,	  Altea,	  &	  Fratta,	  2008)	   it	  would	  be	   interesting	   to	   further	  explore	  a	  possible	  gender	  difference	  
using	  a	  cue	  reactivity	  paradigm	  in	  future	  studies.	  	  	  
Our	  results	  lend	  themselves	  to	  suggestions	  for	  intervention	  studies.	  As	  we	  found	  that	  SUD/PTSD	  
patients	  are	   reserved,	  even	  anxious	   to	   start	  PTSD	   treatment,	   it	   is	  well	  worth	   to	   investigate	  whether	  a	  
specific	   intervention,	   such	   as	   psycho-­‐education,	   has	   an	   effect	   on	   this	   reserve	   and	  whether	   SUD/PTSD	  
patients	  would	  be	  more	  inclined	  to	  start	  PTSD	  treatment	  after	  this	  psycho-­‐education.	  Another	  possible	  
intervention	  to	  be	  studied	  in	  SUD/PTSD	  samples	  is	  a	  social	  skills	  training.	  As	  SUD/PTSD	  patients	  reported	  
that	  social	  motives	  are	  an	  important	  motivating	  factor	  to	  continue	  substance	  use,	  we	  might	  expect	  that	  
when	  focusing	  on	  social	  skills	  specifically,	  this	  would	  have	  a	  positive	  influence	  on	  SUD	  related	  symptoms.	  
A	  more	  general	  coping	  skills	  training	   is	  thought	  to	  be	  very	  suitable	  for	  SUD/PTSD	  patients.	  Protocolled	  
stabilization	   programs	   like	   “Vroeger	   en	   Verder”	   (Dorrepaal	   et	   al.,	   2012)	   and	   Seeking	   Safety	   (Najavits,	  
Weiss,	  Shaw,	  &	  Muenz,	  1998)	  include	  exercises	  to	  improve	  coping	  skills.	  The	  efficacy	  of	  Seeking	  Safety	  
has	   been	   researched	   in	   more	   than	   30	   studies	   (see	   http://www.treatment-­‐innovations.org/evid-­‐all-­‐




Five	  main	   conclusions	   can	   be	   drawn	   from	   the	   research	   in	   this	   thesis.	   Firstly,	  more	   than	   one	   third	   of	  
treatment	  seeking	  SUD	  patients	  suffers	  currently	  from	  the	  consequences	  of	  a	  past	  traumatic	  event	  and	  
nearly	  all	  SUD	  patients	  are	  victims	  of	  one	  or	  more	  previous	  exposures	  to	  trauma.	  
Secondly,	  SUD/PTSD	  patients	  belong	  to	  an	  especially	  vulnerable	  subgroup	  of	  SUD	  patients;	  they	  
are	   more	   often	   unemployed	   and	   depressed,	   they	   experience	   a	   higher	   level	   of	   overall	   tension	   and	  
craving,	  and	  they	  are	  more	  prone	  to	  use	  substances	  in	  social	  situations.	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Thirdly,	  SUD/PTSD	  patients	  experience	  higher	  levels	  of	  craving	  when	  they	  are	  exposed	  to	  stress	  
or	  trauma	  triggers	  and	  this	  makes	  them	  more	  vulnerable	  for	  relapse.	  
Fourthly,	   factors	   that	   impede	   the	   implementation	   of	   integrated	   SUD/PTSD	   treatment	   are:	  
clinicians	  are	  unaware	  of	  the	  high	  prevalence	  of	  the	  comorbidity,	  SUD/PTSD	  clinicians	  and	  patients	  are	  
reserved	  to	  discuss	  trauma,	  SUD	  facilities	  do	  not	  facilitate	  integrated	  treatment,	  SUD/PTSD	  patients	  are	  
unfamiliar	  with	  treatment	  possibilities,	  and	  SUD/PTSD	  patients	  perceive	  substance	  use	  as	  a	  reinforcing	  
way	  to	  cope	  with	  stress	  and	  traumatic	  triggers.	  	  
And	  finally,	  as	  the	  inadequacy	  of	  coping	  skills	  is	  very	  specific	  for	  SUD/PTSD	  patients	  and	  as	  this	  
characteristic	   is	   seen	   as	   an	   important	   factor	   in	   the	   maintenance	   of	   comorbid	   SUD/PTSD,	   integrated	  
SUD/PTSD	   treatment	   should	   include	   both	   stabilization	   (focusing	   on	   improving	   coping	   skills)	   and	  
confrontation	  (focusing	  on	  exposure	  to	  the	  traumatic	  memory).	  































Previous	  studies	  have	  documented	  a	  strong	  link	  between	  PTSD	  and	  SUD.	  Patients	  with	  this	  comorbidity	  
bear	  the	  burden	  of	  two	  severe,	  mutually	   influencing,	  and	  often	  chronic	  disorders.	  Both	  SUD	  and	  PTSD	  
might	   push	   a	   person	   into	   social	   isolation	   and	   secrecy.	   When	   such	   a	   person	   finally	   does	   seek	   help,	  
treatment	  possibilities	  are	  limited.	  	  
When	  examining	   clinical	   guidelines	   and	   clinical	   research,	   there	   is	   a	   growing	   consensus	   that	   in	  
case	  of	  SUD/PTSD	  comorbidity	  treatment	  should	  be	  offered,	  immediately,	  and	  in	  an	  integrated	  manner.	  
Why	   is	   it	   then	   that	   SUD	   treatment	   centers	   have	   not	   implemented	   this	   integrated	   treatment	   for	  
comorbid	   SUD/PTSD?	   And	   what	   is	   missing	   that	   might	   facilitate	   bridging	   the	   gap	   between	   SUD/PTSD	  
research	  and	  clinical	  practice?	  In	  addition,	  the	  precise	  interaction	  between	  the	  two	  disorders	  is	  not	  clear	  
yet.	   It	   is	  often	  suggested	  that	  substances	  are	  used	  to	  reduce	  the	  mental	  pain	  caused	  by	  PTSD,	  but	  it	   is	  
also	  possible	  that	  the	  motives	  of	  SUD/PTSD	  patients	  to	  use	  substances	  are	  related	  to	  their	  inadequacy	  to	  
cope	  with	  stress	  in	  general.	  	  
This	   dissertation	   focuses	   on	   the	   interaction	   between	   SUD	   and	   PTSD.	   Three	   main	   aims	   are	  
addressed	   in	   this	   thesis:	   (1)	   to	   study	   the	   prevalence	   and	   the	   vulnerability	   of	   patients	  with	   SUD/PTSD	  
comorbidity,	   (2)	   to	   study	  how	   the	   craving	   response	  of	   SUD/PTSD	  patients	   interacts	  with	   personalized	  
trauma	  and	  stress	  cues,	  and	  (3)	  to	  examine	  why	  the	  implementation	  of	  integrated	  SUD/PTSD	  treatment	  
has	   been	   unsuccessful.	   To	   address	   these	   three	   aims	   I	   conducted	   five	   studies	   (Chapters	   2	   -­‐7).	   Main	  
findings	  that	  are	  reported	  in	  the	  chapters	  of	  this	  dissertation	  will	  be	  summarized.	  	  
Chapter	   2	   reports	   on	   a	   study	   with	   three	   objectives.	   Firstly,	   the	   prevalence	   of	   post-­‐traumatic	  
stress	   disorder	   (PTSD)	   and	   trauma	   exposure	   was	   compared	   between	   individuals	   with	   and	   without	  
substance	  use	  disorder	  (SUD).	  Secondly,	  we	  compared	  self-­‐rating	  of	  PTSD	  and	  clinical	  judgment.	  Thirdly,	  
an	   analysis	   of	   the	   characteristics	   of	   SUD/PTSD	   patients	  was	   performed.	   The	   sample	   consisted	   of	   423	  
patients	  with	  SUD	  and	  206	  healthy	  controls.	  All	  individuals	  were	  screened	  on	  PTSD	  using	  the	  self-­‐rating	  
inventory	  for	  PTSD.	  Significantly	  higher	  numbers	  of	  PTSD	  and	  trauma	  exposure	  were	  found	  in	  the	  SUD	  
group	   (resp.	   36.6	   and	   97.4%).	   Furthermore,	   PTSD	  went	   frequently	   unnoticed	  when	   relying	   on	   clinical	  
judgment	   alone.	  With	   regard	   to	   the	   characteristics,	   it	   was	   found	   that	   patients	  with	   SUD/	   PTSD	  were	  
significantly	  more	  often	  unemployed	  and	  had	  a	  lower	  educational	  level.	  Axis	  I	  comorbidity	  and	  especially	  
depressive	  disorders	  were	  more	  common	   in	   the	  SUD/PTSD	  group.	  From	  these	   findings	   it	   is	   concluded	  
that	  patients	  with	  SUD/PTSD	  are	  a	  substantial	  and	  vulnerable	  subgroup	  in	  addiction	  treatment	  facilities	  
and	  that	  a	  systematic	  screening	  for	  PTSD	  is	  required.	  
Previous	   research	   shows	   that	   patients	   with	   substance	   use	   disorder	   (SUD)	   and	   post-­‐traumatic	  
stress	  disorder	  (PTSD)	  experience	  more	  craving	  for	  a	  substance	  after	  exposure	  to	  their	  personal	  trauma	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cues	   compared	   to	   neutral	   cues.	   However,	   it	   is	   not	   clear	   if	   their	   substance	   cravings	   are	   triggered	   by	  
specifically	  trauma	  cues	  or	  by	  stress	  cues	  in	  general	  and	  whether	  the	  level	  of	  PTSD	  matters	  To	  examine	  
the	   impact	   of	   trauma	   and	   stress	   cues	   on	   substance	   craving	   and	   tension	   in	   SUD/PTSD	   patients,	   we	  
conducted	  an	  experimental	  study	  which	  is	  described	  in	  Chapter	  3.	  Seventy-­‐four	  patients	  attended	  three	  
exposure	  sessions	  in	  which	  the	  patient	  was	  exposed	  to	  one	  tape-­‐recorded	  script	  a	  neutral	  script,	  a	  stress	  
script	  and	  a	  trauma	  script.	  Craving	  and	  tension	  were	  measured	  before	  and	  after	  each	  cue	  exposure.	  The	  
findings	  show	  that	  patients	  high	  in	  PTSD	  severity	  craved	  more	  after	  stress	  and	  trauma	  script	  exposure,	  
compared	  to	  exposure	  to	  the	  neutral	  script	  and	  to	  patients	  low	  in	  PTSD	  severity.	  These	  findings	  suggest	  
that	  SUD/PTSD	  patients	  are	  not	  only	  more	  vulnerable	  to	  trauma	  cues,	  but	  also	  to	  more	  general	  stress	  
cues.	  	  
Despite	   empirical	   support,	   integrated	   treatment	   of	   Substance	   Use	   Disorder	   (SUD)	   and	  
Posttraumatic	  Stress	  Disorder	  (PTSD)	  is	  not	  sufficiently	  implemented	  in	  SUD	  facilities.	  To	  understand	  the	  
reasons	   for	   this	   gap	   between	   theory	   and	   practice,	  we	   conducted	   a	   qualitative	   study	   on	   the	   views	   of	  
clinicians	  with	  regard	  to	  the	  diagnosis	  and	  treatment	  of	  PTSD	  in	  SUD	  patients	  (presented	  in	  Chapter	  4).	  
An	  independent	  interviewer	  interviewed	  fourteen	  staff	  members	  of	  different	  wards	  of	  an	  addiction	  care	  
facility.	   Despite	   acknowledging	   adverse	   consequences	   of	   trauma	   exposure	   on	   SUD,	   severe	  
underdiagnosis	   of	   PTSD	   was	   mentioned	   and	   treatment	   of	   PTSD	   during	   SUD	   treatment	   was	   not	  
supported.	   Obstacles	   related	   to	   the	   underestimation	   of	   PTSD	   among	   SUD	   patients	   and	   to	   the	  
perceptions	   of	   SUD	   clinicians	   concerning	   the	   treatment	   of	   comorbid	   SUD/PTSD	   are	   reported.	   It	   is	  
concluded	   that	   SUD	   treatment	   centres	   should	   train	   their	   clinicians	   to	   enable	   them	   to	   provide	   for	  
integrated	  treatment	  of	  SUD/PTSD.	  
In	  Chapter	  5	  the	  perceptions	  of	  SUD/PTSD	  patients	  about	  the	  co-­‐occurrence	  and	  the	  symptom	  
interplay	   of	   the	   two	   disorders	   are	   addressed.	   Seventy-­‐two	   SUD	   patients	  with	   differing	   levels	   of	   PTSD	  
severity	   filled	   out	   a	   survey	   and	   three	   self-­‐report	   questionnaires	   pertaining	   to	   their	   perceptions.	  
Regression	  analysis	  was	  used	  to	  test	  whether	  PTSD	  severity	  accounts	  for	  possible	  differences	  between	  
perceptions	  about	  the	  link	  between	  SUD	  and	  consequences	  of	  trauma	  exposure.	  Patients	  perceive	  that	  
substance	  use	   is	   effective	   in	  diminishing	  PTSD	   symptoms,	   they	   feel	   that	   abstinence	  does	  not	   improve	  
PTSD	   symptomatology,	   and	   they	   hold	   positive	   expectancies	   regarding	   the	   effect	   of	   the	   substance	   on	  
their	   PTSD	   symptoms.	   These	   results	   suggest	   that	   it	   is	   hardly	   surprising	   that	   SUD/PTSD	   patients	   are	  
reluctant	  to	  start	  an	  integrated	  SUD/PTSD	  treatment.	  Treatment	  implications	  are	  discussed.	  
Finally,	   in	   the	  qualitative	  study	  presented	   in	  Chapter	  6,	  patients	  with	  comorbid	  substance	  use	  
disorder	  (SUD)	  and	  post-­‐traumatic	  stress	  disorder	  (PTSD)	  were	  interviewed	  on	  their	  ideas	  about	  the	  link	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between	  SUD	  and	  PTSD.	  Although	  they	  clearly	  reported	  self-­‐medication,	  they	  also	  gave	  a	  more	  complex	  
description	   of	   how	   they	   believe	   their	   PTSD	   influences	   their	   SUD.	   The	   results	   suggest	   that	   SUD/PTSD	  
patients	  believe	  they	  did	  not	  start	  using	  substances	  because	  of	  their	  experienced	  traumas	  or	  PTSD,	  but	  
that	   PTSD	   symptoms	   are	   nonetheless	   important	   in	   the	   maintenance	   of	   their	   addictions.	   A	   clear	   link	  
exists	  between	  craving,	  relapse,	  and	  PTSD	  symptoms.	  SUD/PTSD	  patients	  would	  prefer	  a	  “whole-­‐person	  
approach”	  when	  being	  treated	  for	  their	  PTSD.	   It	   is	  suggested	  that	  the	   integration	  of	  skills	   training	  and	  
attention	  for	  patients	  who	  are	  fearful	  of	  PTSD	  treatment	  might	  improve	  SUD/PTSD	  treatment	  results.	  
The	  thesis	  is	  concluded	  with	  Chapter	  7	  where	  the	  above	  reported	  findings	  are	  discussed	  in	  light	  
of	   the	   three	  main	   goals	   that	   are	   described	   in	   chapter	   1.	   A	  working	  model	   is	   proposed	   explaining	   the	  
SUD/PTSD	   symptom	   interplay	   and	   recommendations	   for	   clinical	   practice	   and	   for	   future	   research	   are	  
suggested.	  To	  recapitulate,	  the	  studies	  demonstrate	  that	  nearly	  all	  SUD	  patients	  have	  been	  exposed	  to	  
previous	   trauma	   and	   that	   one	   in	   three	   SUD	   patients	   still	   suffers	   from	   the	   consequences	   of	   this	   past	  
experience.	  The	  findings	  further	  stress	  the	  vulnerability	  of	  SUD/PTSD	  patients;	  SUD/PTSD	  patients	  show,	  
for	   instance,	   increased	   cravings	   both	   after	   stress	   and	   after	   trauma	   cues.	   The	   results	   of	   the	   research	  
conducted	  for	  this	  thesis	  underline	  the	  importance	  to	  address	  coping	  skills	  in	  the	  integrated	  treatment	  
of	   SUD/PTSD	   and	   emphasize	   that	   factors	   that	   impede	   the	   implementation	   of	   integrated	   SUD/PTSD	  
treatment	  should	  be	  taken	  into	  account	  by	  SUD	  facilities.	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